Update April 19 - April 25, 2021, Dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics

COVID-19 publications - Week 16 2021 972 Publications

PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]

Reliable on-line resources for Covid 19

WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap)

Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial)

The Covid-Plex trial is an investigator initiated, multicenter, parallel-group, open-label randomized clinical trial aiming to randomize patients with severe COVID-19 to standard care or standard care plus plasmapheresis and convalescent plasma.

If you are interested to participate Please contact Wladimir Szpirt, Nicholas Carlson Anders, or Perner Bo Feldt-Rasmussen. Depts. Of Intensive Care Therapy and Nephrology, Copenhagen University Hospital Rigshospitalet, Denmark

Covid-Plex trial

Mainstream Media New York Times - Corona update What to Know About India’s Coronavirus Crisis Vaccine Skepticism Was Viewed as a Knowledge Problem. It’s Gut Beliefs. How Pfizer Makes Its Covid-19 Vaccine Turkey braces for its strictest lockdown yet, as the virus surges and vaccinations lag Pakistan warns of new strictures as its daily Covid death toll sets a record. The Pfizer and Moderna vaccines are 94 percent effective at preventing hospitalization in older adults Brazil’s health authority rejects importing Russia’s Sputnik V vaccine. The European Union sues AstraZeneca over missing vaccine doses.

Washington Post - Corona update our questions about coronavirus vaccines, answered What you need to know about the coronavirus variants The pandemic’s chilling effect on free speech J&J coronavirus vaccine needs rare blood clot warning but that benefits outweigh risks jump the vaccine line? In Germany, you could face prosecution. Should I wear a mask outside? Experts weigh in on scenarios. What to expect if you’re traveling this summer

Guardian - Corona update How continental Europe is emerging from Covid lockdown Figures on Covid deaths post-jab show vaccine’s success, scientists say Australian government may make it a crime for citizens to return from Covid-ravaged countries Is Russia’s Covid vaccine anything more than a political weapon? Eurozone driven into double-dip recession as Covid takes toll

Key Articles

1. COVID-19 and thrombotic microangiopathies. Thromb Res 2021; 202:191- 198Tiwari NR, Phatak S, Sharma VR, Agarwal SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894421 This global literature review evaluated the impact of thrombotic complications in severely affected COVID-19 patients. The use of conventional prophylactic and therapeutic doses of anticoagulation was ineffective in preventing thrombotic complications in roughly one-third of patients. The review suggests several assessments as well as therapeutic strategies to improve survival and outcomes in severe COVID-19 patients.

2. Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients. Am. J. Otolaryngol. 2021; 42:103065Biadsee A, Dagan O, Ormianer Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894627 Loss of smell and taste are common clinical features in patients with symptomatic SARS-CoV-2 infections. In this small Israeli study, 97 patients were followed for a mean period of 229 days, recovery of smell and taste occurred in 52% and 61.5% respectively of the participants; however, a large number of patients continue to experience these serious complaints after 6-8 months of follow-up.

3. Retrospective observational RT-PCR analyses on 688 babies born to 843 SARS-CoV-2 positive mothers, placental analyses and diagnostic analyses limitations suggest vertical transmission is possible. Facts Views Vis Obgyn 2021; 13:53-66Bahadur G, Bhat M, Acharya S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889861 The scale of the COVID-19 pandemic ensures that the risk of getting infected does include pregnant women and their unborn fetus. The risk of vertical transmission of the SARS-C0V-2 virus was evaluated in this systematic review of 82 studies that included 862 pregnant women with a positive RT-PCR. After birth, 14 babies had a positive RT-PCR test at birth; three babies showed positive test results on days 6 and 7. Placental swabs were positive in four studies, and this was observed in 10 fetal amniotic fluid swabs as well. These results indicate a substantial likelihood of vertical transmission from mother to baby is possible

4. Cause of death based on systematic postmortem studies in patients with positive SARS-CoV2 tissue PCR during the COVID-19 pandemic. J Intern Med 2021; Romanova ES, Vasilyev VV, Startseva G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872433

5. Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients. Eur J Intern Med 2021; Reichert G, Bunel V, Dreyfuss D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875336

6. An international perspective of out-of-hospital cardiac arrest and cardiopulmonary resuscitation during the COVID-19 pandemic. Am J Emerg Med 2021; 47:192-197Ong J, O'Connell F, Mazer-Amirshahi M, Pourmand A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894661

7. An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study. Thromb J 2021; 19:26Ogawa F, Oi Y, Nakajima K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33879177

8. Angiotensin-converting enzyme 2 (ACE2): role in the pathogenesis of diseases outside of COVID-19. Nephrologe 2021; Mülling N, Rohn H.

9. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211008999Moonla C, Sosothikul D, Chiasakul T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874753

10. The effect of cardiovascular disease and acute cardiac injury on fatal COVID-19: a meta-analysis. Am J Emerg Med 2021; 48:128-139Long J, Luo Y, Wei Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895644

11. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units. Crit Care 2021; 25:155Lavinio A, Ercole A, Battaglini D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888132

12. Status Report on COVID-19 Vaccines Development. Curr. Infect. Dis. Rep. 2021; 23:9Kumar A, Dowling WE, Román RG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867863

13. Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain. Lancet Reg Health Eur 2021; 3:100041Garcia-Vidal C, Cózar-Llistó A, Meira F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870249

14. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021. Euro Surveill 2021; 26Funk T, Pharris A, Spiteri G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890566

15. The use of direct acting oral anticoagulants in patients with COVID-19 infection. J Community Hosp Intern Med Perspect 2021; 11:184-186Aly R, Gupta S, Singh B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889317

Basic Science (45 articles)

1. Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum. ACS Infect Dis 2021; Fiedler S, Piziorska MA, Denninger V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876632 2. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Antiviral Res 2021; 190:105078Zhao J, Guo S, Yi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894278 3. Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2. Aquaculture 2021; 541:736783Sumon TA, Hussain MA, Hasan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883784 4. Prediction of Anti-COVID 19 Therapeutic Power of Medicinal Moroccan Plants Using Molecular Docking. Bioinform. Biol. Insights 2021; 15:11779322211009199Nouadi B, Ezaouine A, El Messal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888980 5. Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy. Biomed. Pharmacother. 2021; 139:111626Kelleni MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894625 6. Development of ciclesonide analogues that block SARS-CoV-2 RNA replication. Bioorg. Med. Chem. Lett. 2021; 43:128052Tsuji G, Yonemitsu K, Ito T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887440 7. Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay. Biosens. Bioelectron. 2021; 184:113218Ding X, Yin K, Li Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878591 8. Online biophysical predictions for SARS-CoV-2 proteins. BMC Mol Cell Biol 2021; 22:23Kagami L, Roca-Martínez J, Gavaldá-García J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892639 9. Epidemiological and virological characteristics of respiratory tract infections in children during COVID-19 outbreak. BMC Pediatr. 2021; 21:195Zhu Y, Li W, Yang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888063 10. Computational Design and Modeling of Nanobodies toward SARS-CoV-2 Receptor Binding Domain. Chem. Biol. Drug Des. 2021; Yang J, Zhang Z, Yang F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894099 11. Comprehensive profiling and characterization of the absorbed components and metabolites in mice serum and tissues following oral administration of Qing-Fei-Pai-Du decoction by UHPLC-Q-Exactive-Orbitrap HRMS. Chin J Nat Med 2021; 19:305-320Liu W, Huang J, Zhang F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875170 12. SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts. Clin Immunol 2021; 227:108733Freda CT, Yin W, Ghebrehiwet B, Rubenstein DA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895357 13. SARS-CoV-2 Entry inhibitors targeting virus-ACE2 or virus-TMPRSS2 interactions. Curr Med Chem 2021; Lin H, Cherukupalli S, Feng D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881969 14. A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19). Curr Med Sci 2021; 41:297-305Yang BY, Wang HZ, Ma ZZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877545 15. COVID-19: A Mitochondrial Perspective. DNA Cell Biol. 2021; Prasun P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872068 16. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine 2021:103341Balestrieri E, Minutolo A, Petrone V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867312 17. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection. Epigenomics 2021; Shirvaliloo M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876664 18. Angiotensin-Converting Enzyme 2 Gene Expression in Breast Tissue. Eur J Breast Health 2021; 17:112-115Al-Benna S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870109 19. Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis. Excli j 2021; 20:585-600Ortega JT, Pujol FH, Jastrzebska B, Rangel HR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883984 20. MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-κB Pathway. Front. Immunol. 2021; 12:653344Chen B, Han J, Chen S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868293 21. Mink, SARS-CoV-2, and the Human-Animal Interface. Front. Microbiol. 2021; 12:663815Fenollar F, Mediannikov O, Maurin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868218 22. Haplotype Explorer: an infection cluster visualization tool for spatiotemporal dissection of the COVID-19 pandemic. G3 (Bethesda) 2021; Kawano-Sugaya T, Yatsu K, Sekizuka T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892501 23. Mutation rates and selection on synonymous mutations in SARS-CoV-2. Genome Biol. Evol. 2021; De Maio N, Walker CR, Turakhia Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895815 24. Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies. Genome Med. 2021; 13:62Lau BT, Pavlichin D, Hooker AC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875001 25. CRISPR/Cas-New Molecular Scissors in Diagnostics and Therapeutics of COVID-19. Indian J. Clin. Biochem. 2021:1-9Gadwal A, Roy D, Khokhar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879980 26. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int Immunopharmacol 2021; 97:107641Donyavi T, Bokharaei-Salim F, Baghi HB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895478 27. In Silico Identification of Multi-target Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins. Int. J. Pept. Res. Ther. 2021:1-11Wong FC, Ong JH, Kumar DT, Chai TT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867899 28. Modeling SARS-CoV-2 infection and its individual differences with ACE2- expressing human iPS cells. iScience 2021:102428Sano E, Deguchi S, Sakamoto A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880436 29. ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection. J Infect Dis 2021; Kala S, Meteleva K, Serghides L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880537 30. Introduction, Transmission Dynamics, and Fate of Early SARS-CoV-2 Lineages in Santa Clara County, California. J Infect Dis 2021; Villarino E, Deng X, Kemper CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893501 31. N-Terminal finger stabilizes the S1 pocket for the reversible feline drug GC376 in the SARS-CoV-2 M(pro) dimer. J. Mol. Biol. 2021:167003Arutyunova E, Bashir Khan M, Fischer C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895266 32. Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. J. Mol. Liq. 2021; 335:116185Mishra D, Maurya RR, Kumar K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879934 33. Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. J Tradit Complement Med 2021; Vardhan S, Sahoo SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868970 34. Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV- 2. Math Biosci Eng 2021; 18:2372-2383Guo W, Xie Y, A EL-H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892550 35. Novel RT-ddPCR assays for measuring the levels of subgenomic and genomic SARS-CoV-2 transcripts. Methods 2021; Telwatte S, Martin HA, Marczak R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882362 36. SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020. PeerJ 2021; 9:e11210Díaz-Vélez C, Failoc-Rojas VE, Valladares-Garrido MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868828 37. Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2). PeerJ 2021; 9:e11232Zhuang S, Tang L, Dai Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889450 38. Brazilian essential oils as source for the discovery of new anti-COVID-19 drug: a review guided by in silico study. Phytochem Rev 2021:1-20Amparo TR, Seibert JB, Silveira BM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867898 39. Tackling Covid-19 using disordered-to-order transition of residues in the spike protein upon ACE2 binding. Proteins 2021; Yesudhas D, Srivastava A, Sekijima M, Gromiha MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893649 40. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry. SLAS Discov 2021:24725552211008854Scholle MD, Liu C, Deval J, Gurard-Levin ZA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870746 41. The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2. Struct Chem 2021:1-8Saha JK, Raihan MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867777 42. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology. Top Curr Chem (Cham) 2021; 379:23Zhuo LS, Wang MS, Yang JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886017 43. Exploring the utility of extracellular vesicles in ameliorating viral infection- associated inflammation, cytokine storm and tissue damage. Transl. Oncol. 2021; 14:101095Pillalamarri N, Abdullah, Ren G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887552 44. SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications. Vet. Q. 2021:1-31Sharun K, Dhama K, Pawde AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892621 45. Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Vet Rec 2021; 188:e247Hosie MJ, Epifano I, Herder V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890314

Biomarkers - Genetics (111 articles)

1. Is Point-of-Care testing feasible and safe in care homes in England? An exploratory usability and accuracy evaluation of a Point-of-Care Polymerase Chain Reaction test for SARS-COV-2. Age Ageing 2021; Micocci M, Gordon AL, Seo MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884411 2. On-admission anemia predicts mortality in COVID-19 patients: A single center, retrospective cohort study. Am J Emerg Med 2021; 48:140-147Oh SM, Skendelas JP, Macdonald E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895645 3. Diagnostic Value of Hematological and Biochemical Parameters Combinations for Predicting Coronavirus Disease 2019 (COVID-19) in Suspected Patients. Am. J. Med. Sci. 2021; Huang D, Yang H, Yu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894184 4. [Rapid SARS-CoV-2 antigenic test: definition, legislation of use, technological principles, analytical and clinical performance comparison]. Ann. Biol. Clin. (Paris) 2021; Lim I, Gautheret-Dejean A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33881398 5. COVID-19 Nasopharyngeal Swab Causing a Traumatic Cerebrospinal Fluid Leak. ANZ J Surg 2021; Ovenden C, Bulshara V, Patel S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890357 6. Absence of Relevant Clinical Effects of SARS-COV-2 on the Affinity of Hemoglobin for O(2) in Patients with COVID-19. Arch. Bronconeumol. 2021; Pascual-Guàrdia S, Ferrer A, Díaz Ó et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875283 7. Lupus anticoagulant single positivity at acute phase is not associated with venous thromboembolism or in-hospital mortality in COVID-19. Arthritis Rheumatol 2021; Gendron N, Dragon-Durey MA, Chocron R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881229 8. Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes by disease-related blood biomarkers. Arthritis Rheumatol 2021; Kessel C, Vollenberg R, Masjosthusmann K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880885 9. Seroprevalence of SARS-CoV-2 Antibodies Among Health Care Personnel at a Health Care System in Pakistan. Asia Pac. J. Public Health 2021:10105395211011010Abbas S, Raza A, Iftikhar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880961 10. Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay. Biosens. Bioelectron. 2021; 184:113218Ding X, Yin K, Li Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878591 11. ABO blood groups, COVID-19 infection and mortality. Blood Cells Mol. Dis. 2021; 89:102571Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894687 12. The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients. BMC Infect. Dis. 2021; 21:371Wang L, Cheng X, Dong Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879073 13. Epidemiological and virological characteristics of respiratory tract infections in children during COVID-19 outbreak. BMC Pediatr. 2021; 21:195Zhu Y, Li W, Yang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888063 14. Febrile neutropenia due to COVID-19 in an immunocompetent patient. BMJ Case Rep. 2021; 14Devi YM, Sehrawat A, Panda PK, Nath UK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893137 15. COVID-19 and hyperammonemia: Potential interplay between liver and brain dysfunctions. Brain Behav Immun Health 2021:100257Bobermin LD, Quincozes- Santos A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870235 16. Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil. Braz. J. Microbiol. 2021:1-5Conte DD, Carvalho JMA, de Souza Luna LK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871824 17. Classical and Counter-regulatory Renin-angiotensin System: potential key roles in COVID-19 pathophysiology. CJC Open 2021; Almutlaq M, Alamro AA, Alroqi F, Barhoumi T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875979 18. Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application. Clin Immunol 2021; 227:108727Zuo W, Zhao X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887436 19. Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru. Clin Infect Dis 2021; Tovar M, Peinado J, Palomino S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881476 20. Sample pooling: strain or solution? Clin Microbiol Infect 2021; Grobe N, Cherif A, Wang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878507 21. Laboratory predictors of severe Coronavirus Disease 2019 and lung function in followed-up. Clin. Respir. J. 2021; Pan M, Wang RR, Chen X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896114 22. High-Resolution CT Chest Findings in Suspected COVID-19 Pneumonia Patients With Negative Real-Time Polymerase Chain Reaction Assay. Cureus 2021; 13:e14023Yusuf S, Ahmad H, Zeb R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889463 23. Clinical Performance of SARS-CoV-2 IgG and IgM Tests Using an Automated Chemiluminescent Assay. Curr Med Sci 2021; 41:318-322Zhou JA, Zeng HL, Deng LY, Li HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877548 24. Are sniffer dogs a reliable approach for diagnosing SARS-CoV-2 infection? Diagnosis (Berl) 2021; Lippi G, Mattiuzzi C, Henry BM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33873262 25. Addressing Pediatric Mental Health during COVID-19 and other Disasters: A National Tabletop Exercise. Disaster Med Public Health Prep 2021:1-13Gupta S, Schreiber M, McGuire T, Newton C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33867004 26. Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine 2021:103339Castro de Moura M, Davalos V, Planas-Serra L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867313 27. Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019. EClinicalMedicine 2021; 34:100829Ranjeva S, Pinciroli R, Hodell E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875978 28. Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population. Elife 2021; 10Tu YP, Iqbal J, O'Leary T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876726 29. Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV- 2, Brazil, 2020. Emerg Infect Dis 2021; 27Amorim MR, Souza WM, Barros ACG, Jr. et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871331 30. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses. Emerg Microbes Infect 2021:1- 28Yang Y, Wang X, Du RH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870851 31. Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On. Eur J Case Rep Intern Med 2021; 8:002378Schofield JR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869099 32. COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia. Eur J Case Rep Intern Med 2021; 8:002348Singh B, Ayad S, Kaur P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869094 33. SARS-CoV-2 antibodies: comparison of three high-throughput immunoassays versus the neutralization test. Eur. J. Clin. Invest. 2021:e13573Laterza R, Schirinzi A, Bruno R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870493 34. Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China. Eur. J. Epidemiol. 2021; 36:429- 439Bushman M, Worby C, Chang HH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33881667 35. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel. Eur. J. Epidemiol. 2021:1-8Reicher S, Ratzon R, Ben-Sahar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884542 36. The contribution of testing in the fight against COVID-19: Evidence from Italy. Eur. J. Public Health 2021; De Matteis A, Turkmen Ceylan FB, Adrianopoli M, Ertek S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876825 37. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021. Euro Surveill 2021; 26Funk T, Pharris A, Spiteri G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890566 38. Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis. Excli j 2021; 20:585-600Ortega JT, Pujol FH, Jastrzebska B, Rangel HR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883984 39. Retrospective observational RT-PCR analyses on 688 babies born to 843 SARS-CoV-2 positive mothers, placental analyses and diagnostic analyses limitations suggest vertical transmission is possible. Facts Views Vis Obgyn 2021; 13:53-66Bahadur G, Bhat M, Acharya S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889861 40. Vascular Inflammation as a Therapeutic Target in COVID-19 "Long Haulers": HIITing the Spot? Front Cardiovasc Med 2021; 8:643626Christensen RH, Berg RMG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869305 41. Genetics Insight for COVID-19 Susceptibility and Severity: A Review. Front. Immunol. 2021; 12:622176Fricke-Galindo I, Falfán-Valencia R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868239 42. The Association Between Alpha-1 Adrenergic Receptor Antagonists and In- Hospital Mortality From COVID-19. Front Med (Lausanne) 2021; 8:637647Rose L, Graham L, Koenecke A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869251 43. SARS-CoV-2 Diagnostic Tests: Algorithm and Field Evaluation From the Near Patient Testing to the Automated Diagnostic Platform. Front Med (Lausanne) 2021; 8:650581Yin N, Debuysschere C, Decroly M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889587 44. First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity. Front Med (Lausanne) 2021; 8:626000Zrelovs N, Ustinova M, Silamikelis I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889583 45. Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections. Front. Physiol. 2021; 12:663869McReynolds CB, Cortes-Puch I, Ravindran R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868029 46. SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients. Front Plant Sci 2021; 12:589940Makatsa MS, Tincho MB, Wendoh JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868324 47. Association of neutrophil-to-lymphocyte and lymphocyte-to-C-reactive protein ratios with COVID-19-related mortality. Gac Med Mex 2020; 156:553- 558Albarrán-Sánchez A, González-Ríos RD, Alberti-Minutti P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877103 48. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with COVID-19-associated pneumonia. Gac Med Mex 2020; 156:527-531Carpio-Orantes LD, García-Méndez S, Hernández-Hernández SN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877106 49. Mutation rates and selection on synonymous mutations in SARS-CoV-2. Genome Biol. Evol. 2021; De Maio N, Walker CR, Turakhia Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895815 50. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium. Genome Med. 2021; 13:66Kasela S, Ortega VE, Martorella M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883027 51. Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies. Genome Med. 2021; 13:62Lau BT, Pavlichin D, Hooker AC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875001 52. IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Genome Med. 2021; 13:64Zhang F, Mears JR, Shakib L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879239 53. Strategy for a Risk-stratified Use of Rapid Antigen Testing: Containing the SARS-CoV-2 Pandemic by Integrating Rapid Testing into Case and Contact Tracing Management. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2021; Arnold L, Stratil J. 54. Commentary: mobile laboratories for SARS-CoV-2 diagnostics: what Europe could learn from the East African Community to assure trade in times of border closures. Global Health 2021; 17:49Gehre F, Lagu H, Achol E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892773 55. Examining spatial inequality in COVID-19 positivity rates across New York City ZIP codes. Health Place 2021; 69:102574Yang TC, Kim S, Zhao Y, Choi SE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895489 56. How Iran responded to expanding need for laboratory services for COVID-19? Health Policy Technol 2021; 10:100506Salehi-Vaziri M, Arashkia A, Mostafavi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880324 57. CRISPR/Cas-New Molecular Scissors in Diagnostics and Therapeutics of COVID-19. Indian J. Clin. Biochem. 2021:1-9Gadwal A, Roy D, Khokhar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879980 58. An Integrated Approach of the Potential Underlying Molecular Mechanistic Paradigms of SARS-CoV-2-Mediated Coagulopathy. Indian J. Clin. Biochem. 2021:1-17Goyal A, Prasad R, Goel P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875909 59. The Role of Procalcitonin in Antibiotic Decision-Making in Covid-19 Infection. Infect Control Hosp Epidemiol 2021:1-24Fabre V, Karaba S, Amoah J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866995 60. Virological COVID-19 surveillance in Bavaria, Germany suggests no SARS- CoV-2 spread prior to the first German case in January 2020. Infection 2021:1- 4Eberle U, Heinzinger S, Konrad R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891281 61. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection 2021:1-12Thibeault C, Mühlemann B, Helbig ET et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890243 62. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int Immunopharmacol 2021; 97:107641Donyavi T, Bokharaei-Salim F, Baghi HB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895478 63. The role of hemogram parameters and CRP in predicting mortality in COVID- 19 infection. Int J Clin Pract 2021:e14256Acar E, Demir A, Yıldırım B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887100 64. Combined predictive performance of age and neutrophilic percentage on admission for severe novel coronavirus disease 2019. Int J Clin Pract 2021:e14257Chen Y, Zhi H, Zhang K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33884718 65. Predictive value of d-dimer/albumin ratio and fibrinogen/albumin ratio for in- hospital mortality in patients with COVID-19. Int J Clin Pract 2021:e14263Küçükceran K, Ayranci MK, Girişgin AS, Koçak S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891337 66. First COVID-19 Cases with High Secondary Infection among Health Workers, Sana'a Capital, April 2020: Lessons Learned and Future Opportunities. Int J Infect Dis 2021; Al-Sakkaf E, Ghaleb Y, Al-Dabis E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895407 67. Comparative analysis of antigen and molecular tests for the detection of Sars- CoV-2 and related variants: a study on 4266 samples. Int J Infect Dis 2021; Caputo V, Bax C, Colantoni L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33878460 68. Serum Calcium and Vitamin D levels correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman. Int J Infect Dis 2021; Osman W, Al Fahdi F, Khamis F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892191 69. Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Int J Infect Dis 2021; Sughayer MA, Mansour A, Al Nuirat A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892190 70. Laboratory diagnosis of COVID-19: current status and challenges. Iran J Microbiol 2021; 13:1-7Mathew BJ, Vyas AK, Khare P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889356 71. Differential alteration trend of white blood cells (WBCs) and monocytes count in severe and non-severe COVID-19 patients within a 7-day follow-up. Iran J Microbiol 2021; 13:8-16Pirsalehi A, Salari S, Baghestani A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889357 72. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol 2021; Dorgham K, Quentric P, Gökkaya M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894209 73. Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients. J Clin Virol 2021; 139:104821Zonneveld R, Jurriaans S, van Gool T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882373 74. The impact of COVID-19 testing on length of hospital stay and patient flow in hospitals. J Community Hosp Intern Med Perspect 2021; 11:180-183Olanipekun T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889316 75. Secondary transmission of SARS-CoV-2 through wastewater: Concerns and tactics for treatment to effectively control the pandemic. J. Environ. Manage. 2021; 290:112668Thakur AK, Sathyamurthy R, Velraj R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895445 76. Outcomes of asymptomatic hospital employees in Covid-19-post-exposition quarantine during the 2(nd) pandemic wave in Zurich. J Hosp Infect 2021; Uçkay I, Steinwender L, Burkhard J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891983 77. Real-world SARS CoV-2 Testing in Northern England during the first wave of the COVID-19 Pandemic. J Infect 2021; Farooq HZ, Davies E, Brown B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892016 78. Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. J Infect 2021; Li KK, Woo YM, Stirrup O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895226 79. Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR. J Infect 2021; Stockdale AJ, Fyles F, Farrell C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892014 80. Letter of concern re: "Immunochromatographic test for the detection of SARS- CoV-2 in saliva. J Infect Chemother. 2021 Feb;27(2):384-386. doi: 10.1016/j.jiac.2020.11.016.". J Infect Chemother 2021; Sberna G, Lalle E, Capobianchi MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888419 81. ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection. J Infect Dis 2021; Kala S, Meteleva K, Serghides L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880537 82. Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19. J Infect Dis 2021; Syed F, Li W, Relich RF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885811 83. Introduction, Transmission Dynamics, and Fate of Early SARS-CoV-2 Lineages in Santa Clara County, California. J Infect Dis 2021; Villarino E, Deng X, Kemper CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893501 84. Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples. J King Saud Univ Sci 2021; 33:101439Ibrahim EH, Ghramh HA, Kilany M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33879983 85. In silico approach for identifying natural lead molecules against SARS-COV-2. J. Mol. Graph. Model. 2021; 106:107916Gupta SS, Kumar A, Shankar R, Sharma U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892297 86. Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19. J. Neurol. 2021:1-6Geis T, Brandstetter S, Toncheva AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893540 87. Treatment of Severe Hypertriglyceridemia With Insulin Infusions in Severe COVID-19: A Case Series. J. Pharm. Pract. 2021:8971900211010473Thomas CM, Vicent M, Moore S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882724 88. Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model. J R Soc Interface 2021; 18:20200947Ejima K, Kim KS, Iwanami S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878277 89. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 2021; 4:100100Wallukat G, Hohberger B, Wenzel K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880442 90. Comparison of four PCR and two point of care assays used in the laboratory detection of SARS-CoV-2. J. Virol. Methods 2021:114165Kenyeres B, Ánosi N, Bányai K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872650 91. D-Dimer and Serum ferritin as an Independent Risk Factor for Severity in COVID-19 Patients. Mater Today Proc 2021; A MH, Taha ZB, Gailan Malek A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868964 92. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio 2021; 12Adeniji OS, Giron LB, Purwar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879594 93. The role of carbohydrate antigen 125 in COVID-19. Med. Hypotheses 2021; 151:110590Dökümcü E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33873150 94. Novel RT-ddPCR assays for measuring the levels of subgenomic and genomic SARS-CoV-2 transcripts. Methods 2021; Telwatte S, Martin HA, Marczak R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882362 95. Combined RT-qPCR and pyrosequencing of a Spike glycoprotein polybasic cleavage motif can uncover pediatric SARS-CoV-2 infections associated with heterogeneous presentation. Mol Cell Pediatr 2021; 8:4Weil PP, Hentschel J, Schult F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893880 96. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts. mSphere 2021; 6Bortz RH, 3rd, Florez C, Laudermilch E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883259 97. SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020. mSphere 2021; 6Han H, Yi J, Cheng G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883260 98. COVID-19 and mutations a threat level assessment. Nepal J Epidemiol 2021; 11:983-987Robinson J, Banerjee I, Leclézio A, Sathian B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868743 99. Angiotensin-converting enzyme 2 (ACE2): role in the pathogenesis of diseases outside of COVID-19. Nephrologe 2021; Mülling N, Rohn H. 100. A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis. Open Heart 2021; 8DiNicolantonio JJ, McCarty MF, Barroso-Aranda J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879509 101. COVID-19 severity in relation to sociodemographics and vitamin D use. Open Med (Wars) 2021; 16:591-609Abdulateef DS, Rahman HS, Salih JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869781 102. Expanding molecular diagnostic capacity for COVID-19 in Ethiopia: operational implications, challenges and lessons learnt. Pan Afr. Med. J. 2021; 38:68Kebede A, Lanyero B, Beyene B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33889234 103. SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020. PeerJ 2021; 9:e11210Díaz-Vélez C, Failoc-Rojas VE, Valladares-Garrido MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868828 104. Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients. Proc Natl Acad Sci U S A 2021; 118Ni X, Ouyang W, Jeong H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893178 105. SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR- negative COVID-19 patients during pandemic. Respir Res 2021; 22:119Schneider J, Mijočević H, Ulm K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892720 106. Evaluating the presence of SARS-CoV-2 RNA in the particulate matters during the peak of COVID-19 in Padua, northern Italy. Sci Total Environ 2021; 784:147129Pivato A, Amoruso I, Formenton G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894607 107. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex. SLAS Discov 2021:24725552211008863Khalili Yazdi A, Li F, Devkota K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874769 108. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry. SLAS Discov 2021:24725552211008854Scholle MD, Liu C, Deval J, Gurard-Levin ZA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870746 109. A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19: Is Plasma Exchange an Alternative? SN Compr Clin Med 2021:1-4Ramos-Ruperto L, García- Pérez E, Hernández-Maraver D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870092 110. Using Quantitative D-Dimer to Determine the Need for Pulmonary CT Angiography in COVID-19 Patients. Spartan Med Res J 2021; 6:18652Mikhjian G, Elghoroury A, Cronovich K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870000 111. COVID-19 related callback in blood donors; Outcomes in blood donors and patients. Transfus. Apher. Sci. 2021:103129Balagholi S, Maghsudlu M, Amini- Kafiabad S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879420

Children (26 articles)

1. Pediatric Trainees as Parents: Perspectives from a Pandemic. Acad. Pediatr. 2021; Wilder JL, Hark CM, Marcus CH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872822 2. Epidemiological and virological characteristics of respiratory tract infections in children during COVID-19 outbreak. BMC Pediatr. 2021; 21:195Zhu Y, Li W, Yang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888063 3. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan. BMJ Paediatr Open 2021; 5:e001034Iio K, Matsubara K, Miyakoshi C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33884312 4. Paediatric emergency department dog bite attendance during the COVID-19 pandemic: an audit at a tertiary children's hospital. BMJ Paediatr Open 2021; 5:e001040Tulloch JSP, Minford S, Pimblett V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884313 5. Impact of COVID-19 on the Children with Cancer in 6 Pediatric Oncology Units (POU's) of Pakistan-a Multi-Center Study. Cancer Invest. 2021:1-11Raza MR, Maqsood S, Rana ZA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866889 6. Diabetic Ketoacidosis at Onset of Pediatric Type-1 Diabetes Triggered by Covid-19: An Original Case Report. Cureus 2021; 13:e13958Benyakhlef S, Abdellaoui W, Tahri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880293 7. Internet-Related Behaviors and Psychological Distress Among Schoolchildren During the COVID-19 School Hiatus. Cyberpsychol Behav Soc Netw 2021; Chen CY, Chen IH, Pakpour AH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33877905 8. Addressing Pediatric Mental Health during COVID-19 and other Disasters: A National Tabletop Exercise. Disaster Med Public Health Prep 2021:1-13Gupta S, Schreiber M, McGuire T, Newton C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33867004 9. The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children. Front. Endocrinol. (Lausanne) 2021; 12:669302Alaqeel A, Aljuraibah F, Alsuhaibani M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868185 10. Influences of digital media use on children and adolescents with ADHD during COVID-19 pandemic. Global Health 2021; 17:48Shuai L, He S, Zheng H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874977 11. COVID-19 and severe ENT infections in pediatric patients. IS there a relationship? Int J Pediatr Otorhinolaryngol 2021; 145:110714Enrique GL, Margarita BB, Ángel MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894522 12. Comparing telehealth with office-based visits for common pediatric otolaryngology complaints. Int J Pediatr Otorhinolaryngol 2021; 145:110712Kolb CM, Born K, Banker K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887549 13. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature. Ital. J. Pediatr. 2021; 47:95Medaglia AA, Siracusa L, Gioè C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874991 14. Impact of COVID-19 pandemic and related isolation measures on violence against children in Egypt. J. Egypt. Public Health Assoc. 2021; 96:11AboKresha SA, Abdelkreem E, Ali RAE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880660 15. Attitude and practices of parents toward their children's oral health care during COVID-19 pandemic. J. Indian Soc. Pedod. Prev. Dent. 2021; 39:22- 28Goswami M, Grewal M, Garg A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33885383 16. "It's ok, mom. I got it!": Exploring the experiences of young adults with intellectual disabilities in a postsecondary program affected by the COVID-19 pandemic from their perspective and their families' perspective. J Intellect Disabil 2021:17446295211002346Spencer P, Van Haneghan JP, Baxter A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878973 17. Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19. J. Neurol. 2021:1-6Geis T, Brandstetter S, Toncheva AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893540 18. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt. J. Pediatr. Endocrinol. Metab. 2021; Sherif EM, Elhenawy YI, Matter RM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882200 19. Multisystem Inflammatory Syndrome in Children (MIS-C) and the Prothrombotic State: Coagulation Profiles and Rotational Thromboelastometry in a MIS-C Cohort. J Thromb Haemost 2021; Al-Ghafry M, Vagrecha A, Malik M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872443 20. Learning to Interpret Pediatric Vocal Fold Mobility: A Laryngeal Ultrasound Training Module. Laryngoscope 2021; Alexander NL, Tran B, Zhu H, Ongkasuwan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890677 21. Combined RT-qPCR and pyrosequencing of a Spike glycoprotein polybasic cleavage motif can uncover pediatric SARS-CoV-2 infections associated with heterogeneous presentation. Mol Cell Pediatr 2021; 8:4Weil PP, Hentschel J, Schult F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893880 22. Acute Fulminant Cerebellitis in Children With COVID-19: A Rare But a Treatable Complication. Pediatr. Neurol. 2021; 119:45-47Sharma S, Ruparelia J, Bhaskar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894640 23. Online action planning forums to develop a roadmap to mitigate the impact of COVID-19 on the delivery of global children's surgical care. Pediatr. Surg. Int. 2021:1-13Abbas A, Samad L, Ozgediz D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880597 24. Adolescent psychopathological profiles and the outcome of the COVID-19 pandemic: Longitudinal findings from the UK Millennium Cohort Study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2021:110330Essau CA, de la Torre-Luque A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887389 25. Home education for children with autism spectrum disorder during the COVID- 19 pandemic: Indonesian mothers experience. Res. Dev. Disabil. 2021; 114:103954Daulay N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882385 26. [Predictors of process-related and structuring parental support during distance learning due to Corona-pandemic]. Z Erziehwiss 2021:1-24Sander A, Schäfer L, van Ophuysen S. http://www.ncbi.nlm.nih.gov/pubmed/?term=3387591

Clinical Features (52 articles)

1. Muscle manifestations and CK levels in COVID infection: results of a large cohort of patients inside a Pandemic COVID-19 Area. Acta Myol. 2021; 40:1-7De Rosa A, Verrengia EP, Merlo I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870093 2. Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients. Am. J. Otolaryngol. 2021; 42:103065Biadsee A, Dagan O, Ormianer Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894627 3. Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence. Am. J. Otolaryngol. 2021; 42:103014Rebholz H, Pfaffeneder-Mantai F, Knoll W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33873048 4. Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load? Am. J. Otolaryngol. 2021:103037Vaira LA, Lechien JR, De Riu G, Saussez S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875304 5. Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'. Ann. Rheum. Dis. 2021; Martelli Júnior H, Marques NP, Marques NCT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883160 6. Emerging roles of coronavirus in autoimmune diseases. Arch Med Res 2021; Zhou SY, Zhang C, Shu WJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875273 7. Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent. Autoimmun Rev 2021:102822Vollmer O, Tacquard C, Dieudonné Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872769 8. COVID-19 in Northeast Bosnia and Herzegovina and patient's length of hospitalization. BMC Infect. Dis. 2021; 21:367Trnacevic A, Mujkanovic A, Al- Salloum N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874896 9. Beware of traumatic anosmia in COVID-19 pandemic. Cjem 2021:1-2Nagamine T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881763 10. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID- 19 patients: A prospective study. Clin. Neurophysiol. 2021; Frithiof R, Rostami E, Kumlien E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875374 11. Ocular Manifestations of Hospitalized COVID-19 Patients in a Tertiary Care Academic Medical Center in the United States: A Cross-Sectional Study. Clin. Ophthalmol. 2021; 15:1551-1556Feng Y, Park J, Zhou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880013 12. The associations of obsessive-compulsive symptom dimensions and general severity with suicidal ideation in patients with obsessive-compulsive disorder: The role of specific stress responses to COVID-19. Clin. Psychol. Psychother. 2021; Khosravani V, Samimi Ardestani SM, Bastan FS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881790 13. Clinical Characteristics of the First 100 Patients of COVID-19 in Tobruk, Libya: A Brief Report from Low-Resource Settings. Disaster Med Public Health Prep 2021:1-10Ismail F, Farag A, Haq S, Kamal MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867007 14. Olfactory Cleft Opacification in COVID-19 Related Smell Loss: CT Findings and Correlation With Objective Testing. Ear Nose Throat J 2021:1455613211011285Yıldız E, Balcı A, Selendili O, Kuzu S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881955 15. Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019. EClinicalMedicine 2021; 34:100829Ranjeva S, Pinciroli R, Hodell E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875978 16. Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk. EClinicalMedicine 2021; 34:100835Valdes AM, Moon JC, Vijay A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880438 17. Prevalence of Incidental Gynecomastia by Chest Computed Tomography in Patients with a Prediagnosis of COVID-19 Pneumonia. Eur J Breast Health 2021; 17:173-179Aslan Ö, Bayraktaroğlu S, Çinkooğlu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870118 18. Acute Epiglottitis Due to COVID-19 Infection. Eur J Case Rep Intern Med 2021; 8:002280Emberey J, Velala SS, Marshall B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869090 19. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study. Eur J Clin Microbiol Infect Dis 2021:1- 5Armange L, Bénézit F, Picard L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893570 20. Spectrum and Clinical Characteristics of Symptomatic and Asymptomatic Coronavirus Disease 2019 (COVID-19) With and Without Pneumonia. Front Med (Lausanne) 2021; 8:645651Zeng H, Ma Y, Zhou Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869253 21. Deafness after COVID-19? German version. HNO 2021; Gerstacker K, Speck I, Riemann S et al. 22. Prevalence and Recovery from Newly Onset Anosmia and Ageusia in Covid 19 Patients at our Teritary Care Centre. Indian J Otolaryngol Head Neck Surg 2021:1-8Kandakure VT, Valvi HR, Khokle P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868972 23. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection 2021:1-12Thibeault C, Mühlemann B, Helbig ET et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890243 24. Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China. Int J Biol Sci 2021; 17:1119-1124Chen Z, Wang B, Mao S, Ye Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867834 25. Clinical, SinoNasal, and Long-Term Smell and Taste Outcomes in Mildly Symptomatic COVID-19 Patients. Int J Clin Pract 2021:e14260Tarifi A, Al Shdaifat AA, Al-Shudifat AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884722 26. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - a possible pattern? Observational study and review of the literature. Int J Infect Dis 2021; Birlutiu V, Feiereisz AI, Oprinca G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887455 27. COVID-19 Toes and Other Skin Lesions During the Pandemic: Emerging Entities? Int. J. Low. Extrem. Wounds 2021:15347346211011843Vas PRJ, Georgiadis GS, Papanas N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891517 28. COVID-19 and severe ENT infections in pediatric patients. IS there a relationship? Int J Pediatr Otorhinolaryngol 2021; 145:110714Enrique GL, Margarita BB, Ángel MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894522 29. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med 2021:1-11Corradini E, Ventura P, Ageno W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893976 30. Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? J Eur Acad Dermatol Venereol 2021; Signa S, Sementa AR, Coccia MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871076 31. Outcomes of asymptomatic hospital employees in Covid-19-post-exposition quarantine during the 2(nd) pandemic wave in Zurich. J Hosp Infect 2021; Uçkay I, Steinwender L, Burkhard J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891983 32. High Frequency of Smell and Taste Dysfunction in Health Care Professionals With COVID-19 Working in Allergy Departments. J. Investig. Allergol. Clin. Immunol. 2021; 31:151-161Antolín Amérigo D, Cubero JL, Colás C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876736 33. Newly detected rapid eye movement associated sleep apnea after coronavirus disease 2019 as a possible cause for chronic fatigue: two case reports. J Med Case Rep 2021; 15:211Koczulla AR, Stegemann A, Gloeckl R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888154 34. Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study. J. Neurol. Neurosurg. Psychiatry 2021; Tsivgoulis G, Fragkou PC, Karofylakis E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879534 35. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt. J. Pediatr. Endocrinol. Metab. 2021; Sherif EM, Elhenawy YI, Matter RM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882200 36. Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke. J. Stroke Cerebrovasc. Dis. 2021; 30:105805Patel U, Malik P, Mehta D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892314 37. An unusual and atypical presentation of the novel coronavirus: A case report and brief review of the literature. J Taibah Univ Med Sci 2021; Alshoabi SA, Haider KH, Mostafa MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867909 38. Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study. Lancet Reg Health Eur 2021; 4:100096Yegorov S, Goremykina M, Ivanova R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880458 39. Transient Global Amnesia as a Possible First Manifestation of COVID-19. Neurohospitalist 2021; 11:84-86Hussein HM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868565 40. Myelopathy associated with SARS-COV-2 infection. A systematic review. Neurol. Res. 2021:1-9Artemiadis A, Liampas A, Hadjigeorgiou L, Zis P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870878 41. Persistent Symptoms in Patients Recovering From COVID-19 in Denmark. Open Forum Infect Dis 2021; 8:ofab042Leth S, Gunst JD, Mathiasen V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875970 42. Disparity in clinical characteristics between 2019 novel coronavirus pneumonia and leptospirosis. Open Med (Wars) 2021; 16:494-497Li B, Bao C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869775 43. Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China. Open Med (Wars) 2021; 16:367-374Wang S, Zhang Q, Wang P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869774 44. Characteristics of patients discontinuing outpatient services under long-term care insurance and its effect on frailty during COVID-19. PeerJ 2021; 9:e11160Hirose T, Sawaya Y, Shiba T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868818 45. Functional Outcomes and Post-Discharge Care Sought by Patients with COVID-19 Compared to Matched Controls After Completing Inpatient Acute Rehabilitation. Pm r 2021; Jain E, Harmon EY, Sonagere MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870659 46. Otolaryngology manifestations of COVID-19: a contemporary viewpoint. Postgrad. Med. J. 2021; Tuang GJ, Abdul Wahab AF, Husain S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879550 47. Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients. Proc Natl Acad Sci U S A 2021; 118Ni X, Ouyang W, Jeong H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893178 48. Can vital signs recorded in patients' homes aid decision making in emergency care? A Scoping Review. Resusc Plus 2021; 6:100116Hamza M, Alsma J, Kellett J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870237 49. A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19: Is Plasma Exchange an Alternative? SN Compr Clin Med 2021:1-4Ramos-Ruperto L, García- Pérez E, Hernández-Maraver D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870092 50. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy. Transpl Infect Dis 2021:e13625Camargo JF, Mendoza MA, Lin R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896088 51. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients. Turk J Med Sci 2021; Karataş A, Malkan Ü Y, Velet M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878857 52. Epidemiological and clinical characteristics of 65 hospitalized patients with COVID-19 in Liaoning, China. World J Clin Cases 2021; 9:2205-2217Zhang W, Ban Y, Wu YH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869596

CNS (23 articles)

1. Investigating the effects of the COVID-19 pandemic on the reasons for application to the emergency department in patients with neurological symptoms. Acta Neurol. Belg. 2021:1-7Haki C, Kaya H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881754 2. Electrodiagnostic findings in patients with non-COVID-19- and COVID-19- related acute respiratory distress syndrome. Acta Neurol. Scand. 2021; Scarpino M, Bonizzoli M, Lazzeri C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890282 3. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID- 19 patients: A prospective study. Clin. Neurophysiol. 2021; Frithiof R, Rostami E, Kumlien E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875374 4. Early life stress and neural development: Implications for understanding the developmental effects of COVID-19. Cogn. Affect. Behav. Neurosci. 2021:1- 12Smith KE, Pollak SD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891280 5. Neurological Manifestations of COVID-19 in Absence of Respiratory Symptoms or Fever. Cureus 2021; 13:e13887Mohamed A, Qureshi AS, Mohamed SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868851 6. Bell's Palsy as a Late Neurologic Manifestation of COVID-19 Infection. Cureus 2021; 13:e13881Oke IO, Oladunjoye OO, Oladunjoye AO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868845 7. Excited Catatonia - A Delayed Neuropsychiatric Complication of COVID-19 Infection. Cureus 2021; 13:e13891Zain SM, Muthukanagaraj P, Rahman N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880247 8. Neurological manifestations of patients with mild-to-moderate COVID-19 attending a public hospital in Lima, Peru. eNeurologicalSci 2021; 23:100338Carcamo Garcia MH, Garcia Choza DD, Salazar Linares BJ, Diaz MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875971 9. Neuro-COVID frequency and short-term outcome in the northern Portuguese population. Eur. J. Neurol. 2021; Oliveira V, Seabra M, Rodrigues R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884707 10. The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients. Front. Aging Neurosci. 2021; 13:632673Alonso-Bellido IM, Bachiller S, Vázquez G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889082 11. Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review. J. Neuroimmunol. 2021; 355:577577Sheikh AB, Chourasia PK, Javed N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895700 12. SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients. J. Neurol. 2021:1-8Morassi M, Palmerini F, Nici S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884450 13. Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran. J. Neurovirol. 2021:1-3Hosseini MJ, Halaji M, Nejad JH, Ranjbar R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876411 14. COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin. J. Stroke Cerebrovasc. Dis. 2021; 30:105822Mansoor T, Alsarah AA, Mousavi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895426 15. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol. Biol. Rep. 2021:1-7Rahman A, Tabassum T, Araf Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891272 16. Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long- COVID Spectrum. Mov Disord 2021; Leta V, Rodríguez-Violante M, Abundes A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890344 17. Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis. Mult Scler Relat Disord 2021; 52:102922Bose G, Galetta K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895693 18. Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19. Neurobiol Stress 2021:100326Duan K, Premi E, Pilotto A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869679 19. Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19. Neurobiol Stress 2021; 14:100326Duan K, Premi E, Pilotto A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869679 20. The Neurobiology of Modern Viral Scourges: ZIKV and COVID-19. Neuroscientist 2021:10738584211009149Mittal S, Federman HG, Sievert D, Gleeson JG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874789 21. Uptake of telehealth in Parkinson's disease clinical care and research during the COVID-19 pandemic. Parkinsonism Relat. Disord. 2021; 86:97-100Shivkumar V, Subramanian T, Agarwal P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895540 22. Acute Fulminant Cerebellitis in Children With COVID-19: A Rare But a Treatable Complication. Pediatr. Neurol. 2021; 119:45-47Sharma S, Ruparelia J, Bhaskar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894640 23. Painless Idiopathic Neuralgic Amyotrophy After COVID-19 Vaccination: A Case Report. Pm r 2021; Diaz-Segarra N, Edmond A, Gilbert C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886164 Coagulation (24 articles)

1. An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review. Acta Haematol. 2021:1-5Kornowski Cohen M, Sheena L, Shafir Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895748 2. Systematic Review of Microthrombi in COVID-19 Autopsies. Acta Haematol. 2021:1-8Parra-Medina R, Herrera S, Mejia J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33873184 3. Pulmonary thromboembolism post-COVID convalescent plasma therapy: adding fuel to a smoldering fire! Adv Respir Med 2021; Marwah V, Choudhary R, Peter D, Bhati G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881163 4. Randomized Clinical Trial to Evaluate a Routine Full Anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) Admitted to Hospital: Rationale and Design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV Trial. Am. Heart J. 2021; Lopes RD, de Barros ESPGM, Furtado RHM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891907 5. Lupus anticoagulant single positivity at acute phase is not associated with venous thromboembolism or in-hospital mortality in COVID-19. Arthritis Rheumatol 2021; Gendron N, Dragon-Durey MA, Chocron R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881229 6. Dialysis circuit clotting in critically ill patients with COVID-19 infection. BMC Nephrol. 2021; 22:141Khoo BZE, Lim RS, See YP, Yeo SC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879086 7. Case of right ventricular and aortic thrombi in a patient with severe COVID-19. BMJ Case Rep. 2021; 14Afari H, Tefera L, Rosovsky RP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875503 8. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211008999Moonla C, Sosothikul D, Chiasakul T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874753 9. SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts. Clin Immunol 2021; 227:108733Freda CT, Yin W, Ghebrehiwet B, Rubenstein DA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895357 10. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units. Crit Care 2021; 25:155Lavinio A, Ercole A, Battaglini D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888132 11. Submassive Pulmonary Embolism in Mild COVID-19 Without Lung Infiltrates. Cureus 2021; 13:e13978Manek G, Gupta M, Congrete S, Datta D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880305 12. An Unusual Case of Gastrointestinal Bleeding in a Patient With COVID-19. Cureus 2021; 13:e13901Sanku K, Siddiqui AH, Paul V, Ali M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880257 13. Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients. Eur J Intern Med 2021; Reichert G, Bunel V, Dreyfuss D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875336 14. Rationales and uncertainties for aspirin use in COVID-19: a narrative review. Fam Med Community Health 2021; 9Sayed Ahmed HA, Merrell E, Ismail M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879541 15. An Integrated Approach of the Potential Underlying Molecular Mechanistic Paradigms of SARS-CoV-2-Mediated Coagulopathy. Indian J. Clin. Biochem. 2021:1-17Goyal A, Prasad R, Goel P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875909 16. Thromboembolic Disease in COVID-19. J. Clin. Imaging Sci. 2021; 11:16Tarmey T, Cullen G, Patel TY, Tandon YK. http://www.ncbi.nlm.nih.gov/pubmed/? term=33880241 17. The use of direct acting oral anticoagulants in patients with COVID-19 infection. J Community Hosp Intern Med Perspect 2021; 11:184-186Aly R, Gupta S, Singh B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889317 18. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). J Thromb Haemost 2021; Thaler J, Ay C, Gleixner KV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877735 19. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid. J. Thromb. Thrombolysis 2021:1-8Paredes-Ruiz D, Gómez-Cuervo C, Gómez-Martín C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890200 20. Microvascular thrombosis and clinical implications. Med Clin (Barc) 2021; Páramo JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875227 21. Fatal Retroperitoneal Hematoma Associated with Covid-19 Prophylactic Anticoagulation Protocol. Radiol Case Rep 2021; Teta M, Drabkin MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880136 22. An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study. Thromb J 2021; 19:26Ogawa F, Oi Y, Nakajima K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879177 23. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy. Thromb Res 2021; 203:1-4Rhoades R, Leong R, Kopenitz J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894473 24. COVID-19 and thrombotic microangiopathies. Thromb Res 2021; 202:191- 198Tiwari NR, Phatak S, Sharma VR, Agarwal SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894421

Complications (58 articles)

1. Development of a Prone Team and Exploration of Staff Perceptions During COVID-19. AACN Adv. Crit. Care 2021:e1-e10Miguel K, Snydeman C, Capasso V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878151 2. An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review. Acta Haematol. 2021:1-5Kornowski Cohen M, Sheena L, Shafir Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895748 3. Pulmonary thromboembolism post-COVID convalescent plasma therapy: adding fuel to a smoldering fire! Adv Respir Med 2021; Marwah V, Choudhary R, Peter D, Bhati G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881163 4. Acute hypoxemia due to lung collapse in COVID-19: the role of therapeutic bronchoscopy. Adv Respir Med 2021; Pb S, Madan K, Mohan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881156 5. Priority Setting of Ventilators in the COVID-19 Pandemic from the Public's Perspective. AJOB Empir Bioeth 2021:1-13Asghari F, Parsapour A, Shamsi Gooshki E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881385 6. Incidence and Risk Factors for Secondary Pulmonary Infections in Patients Hospitalized with Coronavirus Disease 2019 Pneumonia. Am. J. Med. Sci. 2021; Chong WH, Chieng H, Tiwari A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894182 7. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS. Am. J. Surg. 2021; Raff LA, Reid TD, Johnson D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894980 8. Approach to Sedation and Analgesia in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation. Ann. Pharmacother. 2021:10600280211010751Dreucean D, Harris JE, Voore P, Donahue KR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882694 9. Functional electrical stimulation-cycling favours erectus position restoration and walking in patients with critical COVID-19. A proof-of-concept controlled study. Ann. Phys. Rehabil. Med. 2021; Mateo S, Bergeron V, Cheminon M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895378 10. COVID-19 Nasopharyngeal Swab Causing a Traumatic Cerebrospinal Fluid Leak. ANZ J Surg 2021; Ovenden C, Bulshara V, Patel S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890357 11. Lupus anticoagulant single positivity at acute phase is not associated with venous thromboembolism or in-hospital mortality in COVID-19. Arthritis Rheumatol 2021; Gendron N, Dragon-Durey MA, Chocron R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881229 12. Dialysis circuit clotting in critically ill patients with COVID-19 infection. BMC Nephrol. 2021; 22:141Khoo BZE, Lim RS, See YP, Yeo SC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879086 13. Case of right ventricular and aortic thrombi in a patient with severe COVID-19. BMJ Case Rep. 2021; 14Afari H, Tefera L, Rosovsky RP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875503 14. Febrile neutropenia due to COVID-19 in an immunocompetent patient. BMJ Case Rep. 2021; 14Devi YM, Sehrawat A, Panda PK, Nath UK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893137 15. Pneumatosis intestinalis and intestinal perforation in a case of multisystem inflammatory syndrome in children. BMJ Case Rep. 2021; 14Heza L, Olive A, Miller J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888480 16. Life-threatening DRESS syndrome with kidney damage following severe COVID-19 in a patient with Down syndrome. BMJ Case Rep. 2021; 14Mata L, Torres-Zevallos H, Guerreros AG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875507 17. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021; 14Patel SU, Khurram R, Lakhani A, Quirk B. http://www.ncbi.nlm.nih.gov/pubmed/? term=33888484 18. Pneumatocele after recovering from COVID-19. BMJ Case Rep. 2021; 14Sugimoto H, Era Y, Sugimoto K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875514 19. Severe metabolic ketoacidosis as a primary manifestation of SARS-CoV-2 infection in non-diabetic pregnancy. BMJ Case Rep. 2021; 14van Amesfoort JE, Werter DE, Painter RC, Hermans FJR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875510 20. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211008999Moonla C, Sosothikul D, Chiasakul T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874753 21. The Clinical Outcomes of COVID-19 infection in Patients with a History of Thyroid Cancer: A Nationwide Study. Clin. Endocrinol. (Oxf.) 2021; Sahin M, Haymana C, Demirci I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872399 22. The impact of frailty on survival in elderly intensive care patients with COVID- 19: the COVIP study. Crit Care 2021; 25:149Jung C, Flaatten H, Fjølner J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874987 23. Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? Crit Care 2021; 25:153Wicky PH, Niedermann MS, Timsit JF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882991 24. A Case of Isolated SARS-CoV-2 Fulminant Myopericarditis Without Respiratory Failure. Cureus 2021; 13:e14003Afriyie F, Fohle E, Dekowski SS, Kumar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884244 25. Diabetic Ketoacidosis at Onset of Pediatric Type-1 Diabetes Triggered by Covid-19: An Original Case Report. Cureus 2021; 13:e13958Benyakhlef S, Abdellaoui W, Tahri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880293 26. Newly Diagnosed Acute Myeloid Leukemia in a Patient With Severe SARS- CoV-2 Infection. Cureus 2021; 13:e14480Papamichalis P, Tsinti G, Papapostolou E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880315 27. Clostridium Difficile and Noncirrhotic Hyperammonnemia in a Patient With COVID-19 Infection. Cureus 2021; 13:e14533Ramalingam S, Gunasekaran K, Arora H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880318 28. Calculating outcome predictors of COVID-19 requires inclusion of multiple determinants. Disaster Med Public Health Prep 2021:1-4Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888177 29. Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: A systematic review and meta-analysis. Expert Rev. Respir. Med. 2021; Dmytriw AA, Chibbar R, Chen PPY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882768 30. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya. F1000Res 2021; 10:113Asmarawati TP, Rosyid AN, Suryantoro SD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868645 31. Construction and Performance Testing of a Fast-Assembly COVID-19 (FALCON) Emergency Ventilator in a Model of Normal and Low-Pulmonary Compliance Conditions. Front. Physiol. 2021; 12:642353White LA, Mackay RP, Solitro GF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868006 32. Case Study use of high-flow nasal cannula in COVID-19 has improved effectiveness, safety and tolerability when applied in lateral position compared with prone positioning. Intensive Crit Care Nurs 2021:103061Sanz-Moncusí M, Rosselló-Sancho J, Garcia-Alamino JM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875340 33. SIADH and severe COVID-19 pneumonia in elderly patients: a therapeutic challenge in developing countries. Intern Emerg Med 2021:1-3Concepción Zavaleta MJ, Ildefonso Najarro SP, Moreno Marreros DM, Concepción Urteaga LA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893977 34. Thromboembolic Disease in COVID-19. J. Clin. Imaging Sci. 2021; 11:16Tarmey T, Cullen G, Patel TY, Tandon YK. http://www.ncbi.nlm.nih.gov/pubmed/? term=33880241 35. SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: An unfavourable conjunction? J Cyst Fibros 2021; Olcese C, Casciaro R, Pirlo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883098 36. Quantitative fit testing of filtering face-piece respirators during the COVID-19 pandemic reveals anthropometric deficits in most respirators available in Iran. J Environ Health Sci Eng 2021:1-13Fakherpour A, Jahangiri M, Seif M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875931 37. Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis. J Eur Acad Dermatol Venereol 2021; Polat Ekinci A, Büyükbabani N, Meşe S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871106 38. The Incidence, Diagnosis, and Outcomes of COVID-19-associated Pulmonary Aspergillosis (CAPA): A Systematic Review. J Hosp Infect 2021; Chong WH, Neu KP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891985 39. A fatal case of COVID-19-associated invasive pulmonary aspergillosis. J Infect Chemother 2021; Iwanaga Y, Kawanami T, Yamasaki K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867266 40. The Pulsatile Modification Improves Hemodynamics and Attenuates Inflammatory Responses in Extracorporeal Membrane Oxygenation. J Inflamm Res 2021; 14:1357-1364Li G, Zeng J, Liu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880051 41. Neurosensory dysphagia in a COVID-19 patient. J. Neurol. 2021:1-3Zanon A, Cacciaguerra L, Martelli G, Filippi M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33876325 42. Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia. J. Neurovirol. 2021:1-4Borrelli S, Dachy B, Gazagnes MD, Du Pasquier R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33876412 43. Multisystem Inflammatory Syndrome in Children (MIS-C) and the Prothrombotic State: Coagulation Profiles and Rotational Thromboelastometry in a MIS-C Cohort. J Thromb Haemost 2021; Al-Ghafry M, Vagrecha A, Malik M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872443 44. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). J Thromb Haemost 2021; Thaler J, Ay C, Gleixner KV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877735 45. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid. J. Thromb. Thrombolysis 2021:1-8Paredes-Ruiz D, Gómez-Cuervo C, Gómez-Martín C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890200 46. Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study. Lancet Reg Health Eur 2021; 5:100097Bennett KE, Mullooly M, O'Loughlin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880459 47. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol. Biol. Rep. 2021:1-7Rahman A, Tabassum T, Araf Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891272 48. Incidence and Mortality of COVID-19-associated Pulmonary Aspergillosis: A Systematic Review and Meta-analysis. Mycoses 2021; Mitaka H, Kuno T, Takagi H, Patrawalla P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896063 49. A Case of Severe Acute Respiratory Syndrome Coronavirus 2 Treatment With Remdesivir in a Hepatitis C-Coinfected Patient Resulting in Temporary Viral Control and Posttreatment Flare. Open Forum Infect Dis 2021; 8:ofab100da Cunha MR, Rodrigues IC, Trigueiros F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33880393 50. Co-infection of hepatitis E virus and Plasmodium falciparum malaria: A genuine risk in sub-Saharan Africa. Parasit Vectors 2021; 14:215Sahra S, Jahangir A, Iqbal QZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879247 51. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia (Nathan) 2021; 13:5Feldman C, Anderson R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894790 52. Pholcodine-induced Stevens-Johnson syndrome in a patient with COVID-19. Postgrad. Med. J. 2021; Bulat V, Likic R, Pondeljak N, Azdajic MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879549 53. Hypothesis: AA amyloidosis is a factor causing systemic complications after coronavirus disease. Prion 2021; 15:53-55Galkin AP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876719 54. Fatal Retroperitoneal Hematoma Associated with Covid-19 Prophylactic Anticoagulation Protocol. Radiol Case Rep 2021; Teta M, Drabkin MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880136 55. An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study. Thromb J 2021; 19:26Ogawa F, Oi Y, Nakajima K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879177 56. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy. Thromb Res 2021; 203:1-4Rhoades R, Leong R, Kopenitz J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894473 57. COVID-19 and thrombotic microangiopathies. Thromb Res 2021; 202:191- 198Tiwari NR, Phatak S, Sharma VR, Agarwal SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894421 58. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients. Turk J Med Sci 2021; Karataş A, Malkan Ü Y, Velet M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878857

Cured – Recovered (17 articles)

1. Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients. Am. J. Otolaryngol. 2021; 42:103065Biadsee A, Dagan O, Ormianer Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894627 2. Incidence of COVID-19 recurrence among large cohort of healthcare employees. Ann. Epidemiol. 2021; Veronica F, Anne R, Christopher B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895245 3. Study protocol medical rehabilitation after COVID-19 disease: an observational study with a comparison group with obstructive airway disease / Re_Co. BMC Health Serv. Res. 2021; 21:373Rutsch M, Frommhold J, Buhr- Schinner H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888104 4. 'Long COVID' syndrome. BMJ Case Rep. 2021; 14Taribagil P, Creer D, Tahir H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875508 5. Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing. Clin Infect Dis 2021; Qureshi AI, Baskett WI, Huang W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895814 6. Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020. Emerg Infect Dis 2021; 27Resende PC, Bezerra JF, Teixeira Vasconcelos RH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883059 7. Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On. Eur J Case Rep Intern Med 2021; 8:002378Schofield JR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869099 8. COVID-19: Is reinfection possible? Excli j 2021; 20:522-536Costa AOC, de Carvalho Aragão Neto H, Lopes Nunes AP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883981 9. Vascular Inflammation as a Therapeutic Target in COVID-19 "Long Haulers": HIITing the Spot? Front Cardiovasc Med 2021; 8:643626Christensen RH, Berg RMG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869305 10. Recovery From Coronavirus Disease 2019 Among Older Adults in Post-acute Skilled Nursing Facilities. J. Am. Med. Dir. Assoc. 2021; Shi S, Lo OY, Newmeyer N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894176 11. New-onset Diabetes in "Long COVID". J. Diabetes 2021; Sathish T, Anton MC, Sivakumar T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893710 12. A Multidisciplinary NHS COVID-19 Service to Manage Post-COVID-19 Syndrome in the Community. J. Prim. Care Community Health 2021; 12:21501327211010994Parkin A, Davison J, Tarrant R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880955 13. Speech-Language Pathologists' Role in the Multi-Disciplinary Management and Rehabilitation of Patients with Covid-19. J Rehabil Med Clin Commun 2020; 3:1000037Mohapatra B, Mohan R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33884139 14. Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long- COVID Spectrum. Mov Disord 2021; Leta V, Rodríguez-Violante M, Abundes A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890344 15. Persistent Symptoms in Patients Recovering From COVID-19 in Denmark. Open Forum Infect Dis 2021; 8:ofab042Leth S, Gunst JD, Mathiasen V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875970 16. [Post-COVID syndrome: A reflection and opinion paper]. Rev. Esp. Quimioter. 2021; Bouza E, Cantón Moreno R, De Lucas Ramos P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878844 17. Post COVID-19 MSSA pneumonia. SAGE Open Med Case Rep 2021; 9:2050313x211005996Chaudhry B, Alekseyev K, Didenko L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889412

Cardiovascular disease (44 articles)

1. Does taking an angiotensin inhibitor increase the risk for COVID-19? - a systematic review and meta-analysis. Aging (Albany NY) 2021; 13Ma Z, Wang MP, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886504 2. Randomized Clinical Trial to Evaluate a Routine Full Anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) Admitted to Hospital: Rationale and Design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV Trial. Am. Heart J. 2021; Lopes RD, de Barros ESPGM, Furtado RHM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891907 3. The effect of cardiovascular disease and acute cardiac injury on fatal COVID- 19: a meta-analysis. Am J Emerg Med 2021; 48:128-139Long J, Luo Y, Wei Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895644 4. An international perspective of out-of-hospital cardiac arrest and cardiopulmonary resuscitation during the COVID-19 pandemic. Am J Emerg Med 2021; 47:192-197Ong J, O'Connell F, Mazer-Amirshahi M, Pourmand A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894661 5. Cardiac Complications and Pertaining Mortality Rate in COVID-19 Patients; a Systematic Review and Meta-Analysis. Arch Acad Emerg Med 2021; 9:e18Toloui A, Moshrefiaraghi D, Madani Neishaboori A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870205 6. Emergency department admissions for myocardial infarction and stroke in France during the first wave of the COVID-19 pandemic: National temporal trends and regional disparities. Arch Cardiovasc Dis 2021; Olié V, Carcaillon- Bentata L, Thiam MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893038 7. Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19. Atherosclerosis 2021; Scoccia A, Gallone G, Cereda A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883086 8. Case of right ventricular and aortic thrombi in a patient with severe COVID-19. BMJ Case Rep. 2021; 14Afari H, Tefera L, Rosovsky RP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875503 9. Cardiorenal syndrome in COVID-19. BMJ Case Rep. 2021; 14Ali UA, Sadiq MS, Yunus MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893131 10. How has technology been used to deliver cardiac rehabilitation during the COVID-19 pandemic? An international cross-sectional survey of healthcare professionals conducted by the BACPR. BMJ Open 2021; 11:e046051O'Doherty AF, Humphreys H, Dawkes S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33879492 11. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan. BMJ Paediatr Open 2021; 5:e001034Iio K, Matsubara K, Miyakoshi C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33884312 12. Classical and Counter-regulatory Renin-angiotensin System: potential key roles in COVID-19 pathophysiology. CJC Open 2021; Almutlaq M, Alamro AA, Alroqi F, Barhoumi T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875979 13. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211008999Moonla C, Sosothikul D, Chiasakul T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874753 14. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat? Clin Sci (Lond) 2021; 135:1009-1014Simko F, Baka T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881142 15. A Case of Isolated SARS-CoV-2 Fulminant Myopericarditis Without Respiratory Failure. Cureus 2021; 13:e14003Afriyie F, Fohle E, Dekowski SS, Kumar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884244 16. Submassive Pulmonary Embolism in Mild COVID-19 Without Lung Infiltrates. Cureus 2021; 13:e13978Manek G, Gupta M, Congrete S, Datta D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880305 17. Cardiovascular Complications in Major 21st Century Viral Epidemics and Pandemics: an Insight into COVID-19. Curr. Cardiol. Rev. 2021; Hussain M, Collier P, Moudgil R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874873 18. Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation. Curr. Heart Fail. Rep. 2021:1-8Zaccone G, Tomasoni D, Italia L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890193 19. Marantic Endocarditis Associated with COVID-19: A Rare Case Report of a Potentially Deadly Disease. Eur J Case Rep Intern Med 2021; 8:002409Chan KH, Joseph O, Ahmed E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869101 20. Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review. Fundam. Clin. Pharmacol. 2021; Gault N, Esposito-Farese M, Revest M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876439 21. Characteristics of the 24-hour ambulatory blood pressure monitoring in a COVID-19 survivor. Future Cardiol 2021; Wasim D, Alme B, Jordal S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876965 22. Early Detection and Successful Management of Acute Mesenteric Ischaemia in Symptomatic COVID-19 Patient. Indian J Surg 2021:1-3Balani P, Bhuiyan AS, Dalal VN, Maheshwari GS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867749 23. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature. Ital. J. Pediatr. 2021; 47:95Medaglia AA, Siracusa L, Gioè C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874991 24. Initial Findings From the North American COVID-19 Myocardial Infarction Registry. J Am Coll Cardiol 2021; 77:1994-2003Garcia S, Dehghani P, Grines C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888249 25. The Clinical Challenge of ST-Segment Elevation Myocardial Infarction and COVID-19. J Am Coll Cardiol 2021; 77:2004-2006Kornowski R, Orvin K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888250 26. Left ventricular free wall rupture as a result of delayed presentation of an inferior ST-elevation myocardial infarction due to fear of COVID-19: case report. J. Cardiothorac. Surg. 2021; 16:106Nasr GH, Glovaci D, Mikhail A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888133 27. Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID- 19 Patients. J Cardiothorac Vasc Anesth 2021; Xu Q, Samanapally H, Nathala P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867235 28. Letter regarding 'Neurointervention for emergent large vessel occlusion strokes during the COVID-19 pandemic'. J. Neurointerv. Surg. 2021; Hamidianjahromi A, Mowla A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875553 29. Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran. J. Neurovirol. 2021:1-3Hosseini MJ, Halaji M, Nejad JH, Ranjbar R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876411 30. Characteristics and outcomes of COVID-19-Positive Individuals Admitted for Inpatient Rehabilitation in Toronto, Canada. J Rehabil Med Clin Commun 2021; 4:1000053Journeay WS, Robinson LR, Titman R, Macdonald SL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884155 31. COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin. J. Stroke Cerebrovasc. Dis. 2021; 30:105822Mansoor T, Alsarah AA, Mousavi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895426 32. Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke. J. Stroke Cerebrovasc. Dis. 2021; 30:105805Patel U, Malik P, Mehta D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892314 33. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid. J. Thromb. Thrombolysis 2021:1-8Paredes-Ruiz D, Gómez-Cuervo C, Gómez-Martín C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890200 34. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 2021; 4:100100Wallukat G, Hohberger B, Wenzel K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880442 35. Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic. JTCVS Open 2021; Parcha V, Kalra R, Glenn AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870234 36. Microvascular thrombosis and clinical implications. Med Clin (Barc) 2021; Páramo JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875227 37. Angiotensin-converting enzyme 2 (ACE2): role in the pathogenesis of diseases outside of COVID-19. Nephrologe 2021; Mülling N, Rohn H. 38. Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts. Open Heart 2021; 8Ruperti-Repilado FJ, Tobler D, Greutmann M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883228 39. Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China. Open Med (Wars) 2021; 16:367-374Wang S, Zhang Q, Wang P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869774 40. Arrhythmias and Electrocardiographic findings in Coronavirus disease 2019: a systematic review and meta-analysis. Pacing Clin. Electrophysiol. 2021; Garcia- Zamora S, Lee S, Haseeb S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890684 41. Knowledge levels, attitudes, and perceptions of individuals with different demographic characteristics on COVID-19: The case of Turkey. Perspect. Psychiatr. Care 2021; Ates E, Ok E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33884642 42. Ambient air pollution and cardiovascular disease: learnt from the COVID-19 pandemic. Postgrad. Med. 2021; Ejaz A, Malik AO, Lopez-Candales A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888043 43. The impact of the COVID-19 pandemic on acute coronary syndrome admissions to a tertiary care hospital in Portugal. Rev. Port. Cardiol. 2021; Calvão J, Amador AF, Costa CMD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892971 44. COVID-19 and thrombotic microangiopathies. Thromb Res 2021; 202:191- 198Tiwari NR, Phatak S, Sharma VR, Agarwal SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894421

Diagnosis (6 articles) 1. Missed diagnosis in the COVID-19 era: Are we losing ourselves? Adv Respir Med 2021; M A, Mohan A, Madan K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33881164 2. Mortality attributable to COVID-19 in nursing home residents: a retrospective study. Aging Clin. Exp. Res. 2021:1-7Veronese N, Koyanagi A, Stangherlin V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893989 3. Diagnostic Value of Hematological and Biochemical Parameters Combinations for Predicting Coronavirus Disease 2019 (COVID-19) in Suspected Patients. Am. J. Med. Sci. 2021; Huang D, Yang H, Yu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894184 4. End-to-End AI-Based Point-of-Care Diagnosis System for Classifying Respiratory Illnesses and Early Detection of COVID-19: A Theoretical Framework. Front Med (Lausanne) 2021; 8:585578Belkacem AN, Ouhbi S, Lakas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869239 5. The Diagnostic Yield of the Multidisciplinary Discussion in Patients With COVID-19 Pneumonia. Front Med (Lausanne) 2021; 8:637872Calabrese F, Pezzuto F, Giraudo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869252 6. Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran. J. Neurovirol. 2021:1-3Hosseini MJ, Halaji M, Nejad JH, Ranjbar R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876411

DM-MS-Obesity (13 articles)

1. [Obesity and COVID-19: Present and Future]. Acta Med Port 2021; Gregório MJ, Santos A, Graça P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877962 2. SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts. Clin Immunol 2021; 227:108733Freda CT, Yin W, Ghebrehiwet B, Rubenstein DA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895357 3. A Retrospective Study Assessing the Effect of Diabetes on Mortality in Patients With COVID-19 at a Teaching Hospital in the United Kingdom. Cureus 2021; 13:e13902Ahmed FW, Kirresh OZ, Robinson AV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880258 4. Diabetic Ketoacidosis at Onset of Pediatric Type-1 Diabetes Triggered by Covid-19: An Original Case Report. Cureus 2021; 13:e13958Benyakhlef S, Abdellaoui W, Tahri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880293 5. COVID-19 may increase the risk of insulin resistance in adult patients without diabetes: A 6-month prospective study. Endocr. Pract. 2021; Chen M, Zhu B, Chen D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887468 6. The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism. Endocrine 2021:1-9Mahrooz A, Muscogiuri G, Buzzetti R, Maddaloni E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886062 7. The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children. Front. Endocrinol. (Lausanne) 2021; 12:669302Alaqeel A, Aljuraibah F, Alsuhaibani M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868185 8. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Front. Endocrinol. (Lausanne) 2021; 12:609470Corrao S, Pinelli K, Vacca M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868163 9. New-onset Diabetes in "Long COVID". J. Diabetes 2021; Sathish T, Anton MC, Sivakumar T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893710 10. Treatment of Severe Hypertriglyceridemia With Insulin Infusions in Severe COVID-19: A Case Series. J. Pharm. Pract. 2021:8971900211010473Thomas CM, Vicent M, Moore S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882724 11. Does higher Body Mass Index increase COVID-19 severity?: a systematic review and meta-analysis. Obes Med 2021:100340Chowdhury AI, Alam MR, Rabbi MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875972 12. Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near. Brief Correspondence on a Single Center Experience: Cohort Study. Obes. Surg. 2021:1-5Pizza F, D'Antonio D, Dell'Isola C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877505 13. Alphabet strategy for diabetes care: A checklist approach in the time of COVID-19 and beyond. World J. Diabetes 2021; 12:407-419Upreti R, Lee JD, Kotecha S, Patel V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889287 Education and training and science (69 articles)

1. Using Dynamic Virtual Microscopy to Train Pathology Residents During the Pandemic: Perspectives on Pathology Education in the Age of COVID-19. Acad Pathol 2021; 8:23742895211006819Christian RJ, VanSandt M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884292 2. Impact of COVID-19 Pandemic on Training and Well-Being in Radiology Residency: A National Survey of Diagnostic Radiology Trainees in Saudi Arabia. Acad Radiol 2021; Alhasan AS, Alahmadi SM, Altayeb YA, Daqqaq TS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893029 3. COVID-19 pandemic preparation: using simulation for systems-based learning to prepare the largest healthcare workforce and system in Canada. Adv Simul (Lond) 2020; 5:22Dubé M, Kaba A, Cronin T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875011 4. A REVIEW ON EMERGING PATHOGENESIS OF COVID-19 AND POINTS OF CONCERN FOR RESEARCH COMMUNITIES IN NIGERIA. Afr J Infect Dis 2021; 15:36-43Muhammad M, Ibrahim SA, Yarube IU, Bello B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889801 5. The impact of COVID-19 on women surgeons and trainees: The transformation of medical students, surgical residents, and attending surgeons. Am. J. Surg. 2021; Guetter CR, Nosanov LB, Henry MCW, Oropallo A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892923 6. Medical Student Attitudes Toward Blood Donation in Times of Increased Need. Am. Surg. 2021:31348211011083Khatun R, Otaibi BW, Ssentongo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877939 7. Working in Creative Partnership with Students to Co-Produce Neuroanatomy e-Learning Resources in a new era of Blended Learning. Anat Sci Educ 2021; Border S, Woodward C, Kurn O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33871948 8. Body donation, teaching and research in dissection rooms in Spain in times of Covid-19. Anat Sci Educ 2021; Manzanares-Céspedes MC, Dalmau-Pastor M, Simon de Blas C, Vázquez-Osorio MT. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891806 9. COVID-19 and Comparative Health Policy Learning; the Experience of 10 Countries. Arch Iran Med 2021; 24:260-272Raoofi A, Takian A, Haghighi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878884 10. NewsMeSH: A new classifier designed to annotate health news with MeSH headings. Artif. Intell. Med. 2021; 114:102053Pita Costa J, Rei L, Stopar L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875160 11. Knowledge, Attitude, and Practice in Indonesian Health Care Workers Regarding COVID-19. Asia Pac. J. Public Health 2021:10105395211011017Rizki SA, Kurniawan J, Budimulia P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870724 12. Online medical conference became favorite in China during COVID-19, will it become a routine model in the future? Asian J. Surg. 2021; Peng D, Cheng YX, Liu XY, Wang CY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879360 13. COVID-19 and the Need for Global Critical Care Training. Why Ventilators Alone Are Not the Answer. ATS Sch 2020; 2:13-18Brotherton BJ, Mbugua E, Halestrap P, Lee BW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870319 14. ATS Core Curriculum 2020. Adult Pulmonary Medicine. ATS Sch 2020; 1:416- 435Channick CL, Garrison G, Huie TJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870311 15. Training and Deployment of Medical Students as Respiratory Therapist Extenders during COVID-19. ATS Sch 2020; 1:145-151Hester TB, Cartwright JD, DiGiovine DG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870278 16. The Fast Literature Assessment and Review (FLARE) Initiative. A Collaborative Effort for Timely Literature Appraisal during the Coronavirus Disease Pandemic. ATS Sch 2020; 1:186-193Petri CR, Brenner LN, Calhoun TF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870283 17. Determinants of COVID-19-related knowledge and preventive behaviours among students in reopened secondary schools: cross-sectional study. BMJ Open 2021; 11:e050189Handebo S, Adugna A, Kassie A, Shitu K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895723 18. Crisis within a crisis, COVID-19 knowledge and awareness among the Syrian population: a cross-sectional study. BMJ Open 2021; 11:e043305Mohsen F, Bakkar B, Armashi H, Aldaher N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33879483 19. Conducting an ongoing HIV clinical trial during the COVID-19 pandemic in Uganda: a qualitative study of research team and participants' experiences and lessons learnt. BMJ Open 2021; 11:e048825Muwanguzi PA, Kutyabami P, Osingada CP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883157 20. Rethinking the role of Research Ethics Committees in the light of Regulation (EU) No 536/2014 on Clinical Trials and the COVID-19 pandemic. Br. J. Clin. Pharmacol. 2021; Tusino S, Furfaro M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891323 21. Evidence-based primary prevention and health promotion: methods and procedures in 5 research consortia. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2021; Brandes M, Muellmann S, Allweiss T et al. 22. COVID-19: A call for mentorship in radiology. Clin Imaging 2021; 79:48-51Perry R, Parikh J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872916 23. COVID-19: A call for mentorship in radiology. Clin Imaging 2021; 79:48-51Perry R, Parikh JR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872916 24. Comparative analysis of Student's live online learning readiness during the coronavirus (COVID-19) pandemic in the higher education sector. Comput Educ 2021; 168:104211Tang YM, Chen PC, Law KMY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879955 25. Conducting conservation social science surveys online. Conserv. Biol. 2021; Wardropper CB, Dayer AA, Goebel MS, Martin VY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887800 26. Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic. Contemp Clin Trials 2021; 105:106407Moon SJE, Dabbs AD, Hergenroeder AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887443 27. Online examination course instead of classroom teaching: adaptation of medical student teaching during the COVID-19 pandemic. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2021; Wiedenmann C, Wacker K, Böhringer D et al. 28. Knowledge, attitude and practice of patients with chronic diseases towards COVID-19 pandemic in Dessie town hospitals, Northeast Ethiopia. Diabetes Metab Syndr 2021; 15:847-856Addis SG, Nega AD, Miretu DG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33873054 29. Comparison of students' use and acceptance of emergency online learning due to COVID-19 in the USA, Mexico, Peru, and Turkey. Educ Inf Technol (Dordr) 2021:1-23Aguilera-Hermida AP, Quiroga-Garza A, Gómez-Mendoza S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867810 30. Environmental health research and the COVID-19 pandemic: A turning point towards sustainability. Environ. Res. 2021; 197:111157Yang X, Lo K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887273 31. Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine. Epidemiol. Prev. 2021; 45:28-36Lilli C, Biggeri A, Zingaretti C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884840 32. The influence of the COVID-19 outbreak on European trainees in obstetrics and gynaecology: A survey of the impact on training and trainee. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 261:52-58Boekhorst F, Khattak H, Topcu EG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892209 33. The impact of COVID-19 on obstetrics and gynaecology trainees; how do we move on? Facts Views Vis Obgyn 2021; 13:9-14Mallick R, Odejinmi F, Sideris M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889856 34. The Urgent Need for Management of Biological Samples and Data Accessibility in Latin America. Front. Pharmacol. 2021; 12:620043Vargas RJ, Cobar OM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867983 35. Mental Health, Social and Emotional Well-Being, and Perceived Burdens of University Students During COVID-19 Pandemic Lockdown in Germany. Front Psychiatry 2021; 12:643957Kohls E, Baldofski S, Moeller R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889102 36. Gender Differences in Digital Learning During COVID-19: Competence Beliefs, Intrinsic Value, Learning Engagement, and Perceived Teacher Support. Front. Psychol. 2021; 12:637776Korlat S, Kollmayer M, Holzer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868109 37. How E-Learning Environmental Stimuli Influence Determinates of Learning Engagement in the Context of COVID-19? SOR Model Perspective. Front. Psychol. 2021; 12:584976Yang J, Peng MY, Wong S, Chong W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868072 38. The Importance of Understanding COVID-19: The Role of Knowledge in Promoting Adherence to Protective Behaviors. Front Public Health 2021; 9:581497Miller LMS, Gee PM, Katz RA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33889557 39. A Glimpse of the First Eight Months of the COVID-19 Literature on Microsoft Academic Graph: Themes, Citation Contexts, and Uncertainties. Front Res Metr Anal 2020; 5:607286Chen C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870064 40. Intellectual Structure of Coronavirus Research: A Perspective From an Author Cocitation Analysis. Front Res Metr Anal 2020; 5:595370Mei J, Zhao D, Strotmann A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870058 41. Decolonizing Science Diplomacy: A Case Study of the Dominican Republic's COVID-19 Response. Front Res Metr Anal 2021; 6:637187Mencía-Ripley A, Paulino-Ramírez R, Jiménez JA, Camilo O. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870069 42. Tracking and Mining the COVID-19 Research Literature. Front Res Metr Anal 2020; 5:594060Porter AL, Zhang Y, Huang Y, Wu M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870056 43. Knowledge, attitudes, practices and fear of COVID-19 among Iranians: A quick online survey. Health Soc Care Community 2021; Ghaderi E, Mahmoodi H, Sharifi Saqqezi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891794 44. Information Needs of Pregnant Women in the COVID-19 Pandemic from Experts' Point of View: A Qualitative Study. Int J Community Based Nurs Midwifery 2021; 9:139-151Rezaei F, Masaeli Z, Atighechian G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875966 45. Web-based Medical Education During COVID-19 Lockdown: A Step Back or a Leap to the Future? Int. J. Low. Extrem. Wounds 2021:15347346211011848Eleftheriou A, Rokou A, Argyriou C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890811 46. Senior BSN students' confidence, comfort, and perception of readiness for clinical practice: the impacts of COVID-19. Int. J. Nurs. Educ. Scholarsh. 2021; 18Musallam E, B AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882201 47. Telemental health policies for college students during COVID-19. J. Am. Coll. Health 2021:1-5Huilgol YS, Torous J, Gold JA, Goldman ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891526 48. COVID-19 Trial Graph: A Linked Graph for COVID-19 Clinical Trials. J Am Med Inform Assoc 2021; Du J, Wang Q, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895839 49. A fusion of data science and feed-forward neural network-based modelling of COVID-19 outbreak forecasting in IRAQ. J. Biomed. Inform. 2021; 118:103766Aljaaf AJ, Mohsin TM, Al-Jumeily D, Alloghani M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895377 50. Reimagining the pipeline: Saturday Academy at New York University College of Dentistry goes virtual. J. Dent. Educ. 2021; Burns LE, Pezzullo C, Dief S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893653 51. Pandemics and education: A historical review. J. Dent. Educ. 2021; Spielman AI, Sunavala-Dossabhoy G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876429 52. Endoscopy Training in COVID-19: Challenges and Hope for a Better Age. J Gastroenterol Hepatol 2021; Koo CS, Siah KTH, Koh CJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871079 53. Association Between Perceived Resilience and Mental Well-Being of Saudi Nursing Students During COVID-19 Pandemic: A Cross-Sectional Study. J. Holist. Nurs. 2021:8980101211009063Grande RAN, Berdida DJE, Villagracia HN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876982 54. Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report. J Med Case Rep 2021; 15:213Farhadi R, Mehrpisheh S, Ghaffari V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892788 55. Implementing the National Incident Management System at schools of nursing in response to COVID-19. J. Prof. Nurs. 2021; 37:255-260de Tantillo L, Christopher R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867077 56. Development and Utilization of a Medical Student Surgery Podcast During COVID-19. J. Surg. Res. 2021; 265:95-99Anteby R, Amiel I, Cordoba M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894454 57. Pretesting a poster that communicates principles of COVID-19 prevention at educational institutions in Depok City, Indonesia. J. Vis. Commun. Med. 2021:1- 9Rachmawati A, Artini NNA, Mukaromah Y, Pratomo H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876713 58. Teaching Telemedicine: The Next Frontier for Medical Educators. JMIR Med Educ 2021; 7:e29099Alcocer Alkureishi M, Lenti G, Choo ZY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878011 59. One Year of Pandemic Learning Response: Benefits of Massive Online Delivery of the World Health Organization's Technical Guidance. JMIR Public Health Surveill 2021; 7:e28945Utunen H, Van Kerkhove MD, Tokar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881404 60. Coordinating a Postgraduate Orthopaedic Exam During the COVID-19 Pandemic. Malays Orthop J 2021; 15:16-20Mohamed-Haflah NH, Abdullah S, Abdul-Rani R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880143 61. Self-Illusion and Medical Expertise in the Era of COVID-19. Open Forum Infect Dis 2021; 8:ofab058Claessens A, Keita-Perse O, Berthier F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880387 62. Knowledge levels, attitudes, and perceptions of individuals with different demographic characteristics on COVID-19: The case of Turkey. Perspect. Psychiatr. Care 2021; Ates E, Ok E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33884642 63. What are the main areas of research on COVID-19? Postgrad. Med. J. 2021; Cifuentes-Faura J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883253 64. Complexities of COVID-19 Demonstrate the Need for More Interdisciplinary Research Training in Graduate School. Public Health Rep. 2021:333549211013320Benavidez GA, Mandelbaum J, Fisk CE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882745 65. Home education for children with autism spectrum disorder during the COVID- 19 pandemic: Indonesian mothers experience. Res. Dev. Disabil. 2021; 114:103954Daulay N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882385 66. Undergraduate palliative care teaching in times of COVID-19. Schmerz 2021; Scherg A, Ilse B, Elsner F. 67. Risk Perception and Behavioral Response to COVID-19: A Survey of University Students and Staff in the Iraqi Kurdistan Region. Soc Work Public Health 2021:1-12Shabu SA, K MA, Mahmood KI, Shabila NP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866952 68. COVID-19 Impact in Neurosurgery Residency: Grit in the Face of Pandemic. World Neurosurg 2021; Algattas H, Roy S, Agarwal N, Maroon J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894398 69. [Annual meeting of the German Society for Rheumatology going virtual- successfully defying the pandemic]. Z. Rheumatol. 2021:1-7Richter JG, Chehab G, Knitza J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877456

Elderly (16 articles)

1. Maximal aerobic capacity exercise testing protocols for elderly individuals in the era of COVID-19. Aging Clin. Exp. Res. 2021:1-5Venturelli M, Cè E, Paneroni M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881755 2. Mortality attributable to COVID-19 in nursing home residents: a retrospective study. Aging Clin. Exp. Res. 2021:1-7Veronese N, Koyanagi A, Stangherlin V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893989 3. Aging and emotion regulation during the COVID-19 pandemic. Aging Ment. Health 2021:1-8Wolfe HE, Isaacowitz DM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870771 4. Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients. Alzheimers Dement 2021; Tahira AC, Verjovski-Almeida S, Ferreira ST. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881211 5. The multidimensional prognostic index (MPI) for the prognostic stratification of older inpatients with COVID-19: A multicenter prospective observational cohort study. Arch. Gerontol. Geriatr. 2021; 95:104415Pilotto A, Azzini M, Cella A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882420 6. COVID-19 as the sole cause of death is uncommon in frail home healthcare individuals: a population-based study. BMC Geriatr. 2021; 21:262Nilsson L, Andersson C, Sjödahl R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879078 7. The impact of frailty on survival in elderly intensive care patients with COVID- 19: the COVIP study. Crit Care 2021; 25:149Jung C, Flaatten H, Fjølner J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874987 8. Measuring the outsized impact of COVID-19 in the evolving setting of aged care facilities. EClinicalMedicine 2021; 34:100825Cassone M, Mody L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880439 9. Covid-19: a call for mobilizing geriatric expertise. Eur. Geriatr. Med. 2021:1- 4O'Hanlon S, Dhesi J, Aronson L, Inouye SK. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891278 10. The presence of care homes and excess deaths during the COVID-19 pandemic: Evidence from Italy. Health Econ. 2021; Alacevich C, Cavalli N, Giuntella O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884695 11. Combined predictive performance of age and neutrophilic percentage on admission for severe novel coronavirus disease 2019. Int J Clin Pract 2021:e14257Chen Y, Zhi H, Zhang K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33884718 12. Resilience in Older Adults during the COVID-19 Pandemic: A Socioecological Approach. J. Gerontol. B Psychol. Sci. Soc. Sci. 2021; Igarashi H, Kurth ML, Lee HS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881504 13. Digital Inclusion of Older Adults during COVID-19: Lessons from a Case Study of Older Adults Technology Services (OATS). J Gerontol Soc Work 2021:1- 13Weil J, Kamber T, Glazebrook A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882782 14. The Effect of Loneliness on Death Anxiety in the Elderly During the COVID-19 Pandemic. Omega (Westport) 2021:302228211010587Guner TA, Erdogan Z, Demir I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878967 15. [COVID-19 and elderly people in nursing homes: Impact according to the modality of residence]. Rev Esp Geriatr Gerontol 2021; Barrera-Algarín E, Estepa- Maestre F, Sarasola-Sánchez-Serrano JL, Malagón-Siria JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892992 16. [Covid-19 infectious disease is also a psychogeriatric disease]. Soins Gerontol. 2021; 26:37-39Thomas P, Hazif-Thomas C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894913

Epidemiology (85 articles)

1. -fuzzy measure model for COVID-19 disease. Adv Differ Equ 2021; 2021:202Ghaffari A, Saadati R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33880117 2. A REVIEW ON EMERGING PATHOGENESIS OF COVID-19 AND POINTS OF CONCERN FOR RESEARCH COMMUNITIES IN NIGERIA. Afr J Infect Dis 2021; 15:36-43Muhammad M, Ibrahim SA, Yarube IU, Bello B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889801 3. 100 DAYS OF COVID-19: RISK FACTORS AND CONFIRMED CASES IN 19 AFRICAN COUNTRIES. Afr J Infect Dis 2021; 15:31-35Shallie PD, Haffejee F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889800 4. Dynamics of the COVID-19 epidemic in urban and rural areas in the United States. Ann. Epidemiol. 2021; Cuadros DF, Branscum AJ, Mukandavire Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894385 5. Assessment of Contact Tracing for COVID-19 among People Experiencing Homelessness, Salt Lake County Health Department, March-May 2020. Ann. Epidemiol. 2021; Fields VL, Kiphibane T, Eason JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894384 6. A swaying between successive pandemic waves and pandemic fatigue: Where does Jordan stand? Ann Med Surg (Lond) 2021; 65:102298Al-Tammemi AB, Tarhini Z, Akour A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880181 7. Crowd management COVID-19. Annu Rev Control 2021; Polanco LD, Siller M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867812 8. The Impact of COVID-19 on First Nations People Health Assessments in Australia. Asia Pac. J. Public Health 2021:10105395211011012Robertson R, Mian M, Sreedharan S, Lau P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870726 9. [Proposal for territorial analysis to face the SARS-CoV-2 pandemic based on the Profile of pneumonia and Influenza in Ecuador 2016-2018]. Aten. Primaria 2021; 53:102021Ríos Quituizaca P, Calderón L, Piedra S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887602 10. Epidemiological and virological characteristics of respiratory tract infections in children during COVID-19 outbreak. BMC Pediatr. 2021; 21:195Zhu Y, Li W, Yang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888063 11. Modelling the impact of the tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns. BMJ Open 2021; 11:e050346Laydon DJ, Mishra S, Hinsley WR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888533 12. Lack of cross-transmission of SARS-CoV-2 between passenger's cabins on the Diamond Princess cruise ship. Build. Environ. 2021; 198:107839Xu P, Jia W, Qian H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875902 13. COVID-19 pandemic and its average recovery time in Indian states. Clin Epidemiol Glob Health 2021; 11:100740George N, Tyagi NK, Prasad JB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875974 14. Not all COVID-19 pandemic waves are alike. Clin Microbiol Infect 2021; Domingo P, Pomar V, Mur I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887469 15. Analysis and Prediction of COVID-19 Pandemic in Bangladesh by Using ANFIS and LSTM Network. Cognit. Comput. 2021:1-10Chowdhury AA, Hasan KT, Hoque KKS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868501 16. South African Jewish Responses to COVID-19. Contemp Jew 2021:1-18Gilbert S, Gilbert L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867601 17. The Novel Coronavirus (COVID-19) Pandemic and the Response in Low-to- Middle Income Countries. Curr. Breast Cancer Rep. 2021:1-6Shahzad H, Mubarik F, Sattar AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880139 18. Unknown uncertainties in the COVID-19 pandemic: Multi-dimensional identification and mathematical modelling for the analysis and estimation of the casualties. Digit Signal Process 2021; 114:103058Tutsoy O, Balikci K, Ozdil NF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879984 19. COVID-19 resurgence: lessons learnt to inform the South African response. Disaster Med Public Health Prep 2021:1-17Dzobo M, Hlongwa M, Denhere K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867001 20. Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV- 2, Brazil, 2020. Emerg Infect Dis 2021; 27Amorim MR, Souza WM, Barros ACG, Jr. et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871331 21. Investigation of the urbanization contribution to the COVID-19 outbreak in Iran and the MECA countries. Environ Dev Sustain 2021:1-22Bijari NB, Mahdinia MH, Mansouri Daneshvar MR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880075 22. Effect of Large-Scale Social Restriction (PSBB) during COVID-19 on Outdoor Air Quality: Evidence from Five Cities in DKI Jakarta Province, Indonesia. Environ. Res. 2021:111164Rizky Anugerah A, Suksessanno Muttaqin P, Purnama DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872645 23. Simple quantitative assessment of the outdoor versus indoor airborne transmission of viruses and COVID-19. Environ. Res. 2021:111189Rowe BR, Canosa A, Drouffe JM, Mitchell JBA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872644 24. Meteorological conditions are heterogeneous factors for COVID-19 risk in China. Environ. Res. 2021:111182Xiao S, Qi H, Ward MP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872647 25. Epidemiologic Characteristics of a COVID-19 Outbreak Caused by Religious Activities in Daegu, Korea. Epidemiol Health 2021:e2021024Kim JY, Lee YM, Lee H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872485 26. Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China. Eur. J. Epidemiol. 2021; 36:429- 439Bushman M, Worby C, Chang HH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33881667 27. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel. Eur. J. Epidemiol. 2021:1-8Reicher S, Ratzon R, Ben-Sahar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884542 28. Corona and Coffee on your commute: A spatial analysis of COVID-19 mortality and commuting flows in England in 2020. Eur. J. Public Health 2021; Francetic I, Munford L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871592 29. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021. Euro Surveill 2021; 26Funk T, Pharris A, Spiteri G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890566 30. COVID-19: Is reinfection possible? Excli j 2021; 20:522-536Costa AOC, de Carvalho Aragão Neto H, Lopes Nunes AP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883981 31. Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis. Excli j 2021; 20:585-600Ortega JT, Pujol FH, Jastrzebska B, Rangel HR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883984 32. First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity. Front Med (Lausanne) 2021; 8:626000Zrelovs N, Ustinova M, Silamikelis I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889583 33. Reopening America's Schools During the COVID-19 Pandemic: Protecting Asian Students From Stigma and Discrimination. Front Sociol 2020; 5:588936Akiba D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869517 34. The Role Played by Public Universities in Mitigating the Coronavirus Catastrophe in Brazil: Solidarity, Research and Support to Local Governments Facing the Health Crisis. Front Sociol 2021; 6:610297Arrais CA, Corcioli G, Medina GDS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869552 35. Haplotype Explorer: an infection cluster visualization tool for spatiotemporal dissection of the COVID-19 pandemic. G3 (Bethesda) 2021; Kawano-Sugaya T, Yatsu K, Sekizuka T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892501 36. Mutation rates and selection on synonymous mutations in SARS-CoV-2. Genome Biol. Evol. 2021; De Maio N, Walker CR, Turakhia Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895815 37. Population-level mortality burden from novel coronavirus (COVID-19) in Europe and North America. Genus 2021; 77:7Soneji S, Beltrán-Sánchez H, Yang JW, Mann C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879923 38. Contact tracing apps for the COVID-19 pandemic: a systematic literature review of challenges and future directions for neo-liberal societies. Health Inf Sci Syst 2021; 9:18Akinbi A, Forshaw M, Blinkhorn V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868671 39. Examining spatial inequality in COVID-19 positivity rates across New York City ZIP codes. Health Place 2021; 69:102574Yang TC, Kim S, Zhao Y, Choi SE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895489 40. Predictive Modeling of Covid-19 Data in the US: Adaptive Phase-Space Approach. IEEE Open J Eng Med Biol 2020; 1:207-213Marmarelis VZ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870202 41. Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study. Infect Dis Poverty 2021; 10:53Lin SN, Rui J, Chen QP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874998 42. Virological COVID-19 surveillance in Bavaria, Germany suggests no SARS- CoV-2 spread prior to the first German case in January 2020. Infection 2021:1- 4Eberle U, Heinzinger S, Konrad R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891281 43. Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China. Int J Biol Sci 2021; 17:1119-1124Chen Z, Wang B, Mao S, Ye Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867834 44. First COVID-19 Cases with High Secondary Infection among Health Workers, Sana'a Capital, April 2020: Lessons Learned and Future Opportunities. Int J Infect Dis 2021; Al-Sakkaf E, Ghaleb Y, Al-Dabis E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895407 45. Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Int J Infect Dis 2021; Sughayer MA, Mansour A, Al Nuirat A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892190 46. On the fractional SIRD mathematical model and control for the transmission of COVID-19: The first and the second waves of the disease in Iran and Japan. ISA Trans. 2021; Mohammadi H, Rezapour S, Jajarmi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867134 47. COVID-19 pandemic and air transportation: Successfully navigating the paper hurricane. J Air Transp Manag 2021; 94:102062Sun X, Wandelt S, Zheng C, Zhang A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875908 48. A fusion of data science and feed-forward neural network-based modelling of COVID-19 outbreak forecasting in IRAQ. J. Biomed. Inform. 2021; 118:103766Aljaaf AJ, Mohsin TM, Al-Jumeily D, Alloghani M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895377 49. Epidemiological observations on breaking COVID-19 transmission: from the experience of Taiwan. J. Epidemiol. Community Health 2021; MacDonald I, Hsu JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893185 50. Policy Disparities in Response to COVID-19 between China and South Korea. J Epidemiol Glob Health 2021; Chen H, Shi L, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876595 51. COVID-19: The Second Wave is not due to Cooling-down in Autumn. J Epidemiol Glob Health 2021; Langel W. http://www.ncbi.nlm.nih.gov/pubmed/? term=33876601 52. Comparison of Predictive Models and Impact Assessment of Lockdown for COVID-19 over the United States. J Epidemiol Glob Health 2021; Makinde OS, Adeola AM, Abiodun GJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876598 53. Role of Ascertainment Bias in Determining Case Fatality Rate of COVID-19. J Epidemiol Glob Health 2021; Smith MP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33876593 54. Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. J Infect 2021; Li KK, Woo YM, Stirrup O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895226 55. COVID-19 transmission in Hong Kong despite universal masking. J Infect 2021; Martín-Sánchez M, Lim WW, Yeung A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895227 56. COVID-19 outbreak at a reception centre for asylum seekers in Espoo, Finland. J Migr Health 2021; 3:100043Turunen T, Kontunen K, Sugulle K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880457 57. Negative Effects of COVID-19 Stay-at-Home Mandates on Physical Intervention Outcomes: A Preliminary Study. J. Parkinsons Dis. 2021; Templeton JM, Poellabauer C, Schneider S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867363 58. State estimation-based control of COVID-19 epidemic before and after vaccine development. J Process Control 2021; 102:1-14Rajaei A, Raeiszadeh M, Azimi V, Sharifi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867698 59. Utilizing the ACCESS Model to Understand Communication With the Ultraorthodox Community in Beit Shemesh During the First Wave of COVID-19. J. Transcult. Nurs. 2021:10436596211009575Romem A, Pinchas-Mizrachi R, Zalcman BG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882735 60. JUE Insight: Migration, Transportation Infrastructure, and the Spatial Transmission of COVID-19 in China. J Urban Econ 2021:103351Li B, Ma L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879932 61. A Recursive Model of the Spread of COVID-19: Modelling Study. JMIR Public Health Surveill 2021; 7:e21468Ilyin SO. http://www.ncbi.nlm.nih.gov/pubmed/? term=33871381 62. Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study. Lancet Reg Health Eur 2021; 4:100096Yegorov S, Goremykina M, Ivanova R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880458 63. Sexual Minority Disparities in Health and Well-being as a Consequence of the COVID-19 Pandemic Differ by Sexual Identity. LGBT Health 2021; Fish JN, Salerno J, Williams ND et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887160 64. Modelling and predicting the spread of COVID-19 cases depending on restriction policy based on mined recommendation rules. Math Biosci Eng 2021; 18:2789-2812Yakovyna V, Shakhovska N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892572 65. SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020. mSphere 2021; 6Han H, Yi J, Cheng G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883260 66. COVID-19 Pandemic in Lebanon: One Year Later, What Have We Learnt? mSystems 2021; 6Koweyes J, Salloum T, Haidar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879497 67. Estimation of COVID-19 outbreak size in Harbin, China. Nonlinear Dyn 2021:1- 9Song H, Jia Z, Jin Z, Liu S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867676 68. Social distancing mediated generalized model to predict epidemic spread of COVID-19. Nonlinear Dyn 2021:1-9Yasir KA, Liu WM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867677 69. SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020. PeerJ 2021; 9:e11210Díaz-Vélez C, Failoc-Rojas VE, Valladares-Garrido MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868828 70. A random walk Monte Carlo simulation study of COVID-19-like infection spread. Physica A 2021; 574:126014Triambak S, Mahapatra DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875903 71. Multifaceted strategies for the control of COVID-19 outbreaks in long-term care facilities in Ontario, Canada. Prev. Med. 2021; 148:106564Vilches TN, Nourbakhsh S, Zhang K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878351 72. The Impact of COVID-19 on the Latinx Population: A Scoping Literature Review. Public Health Nurs. 2021; Moore KS. http://www.ncbi.nlm.nih.gov/pubmed/? term=33876506 73. Decision support system for ranking relevant indicators for reopening strategies following COVID-19 lockdowns. Qual Quant 2021:1-29Almulhim TS, Barahona I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867586 74. A renewal equation model to assess roles and limitations of contact tracing for disease outbreak control. R Soc Open Sci 2021; 8:202091Scarabel F, Pellis L, Ogden NH, Wu J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868698 75. Investigation of fractal-fractional order model of COVID-19 in Pakistan under Atangana-Baleanu Caputo (ABC) derivative. Results Phys 2021; 24:104046Arfan M, Alrabaiah H, Rahman MU et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868907 76. A COVID-19 outbreak on board ship: Analysis of the sociotechnical system of epidemiological management in the French Navy. Saf Sci 2021; 140:105296Chassery L, Texier G, Pommier De Santi V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875906 77. Evaluating the presence of SARS-CoV-2 RNA in the particulate matters during the peak of COVID-19 in Padua, northern Italy. Sci Total Environ 2021; 784:147129Pivato A, Amoruso I, Formenton G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894607 78. Understanding the Geographical Spread of COVID-19 in Relation with Goods Regional Routes and Governmental Decrees: The Lombardy Region Case Study. SN Comput Sci 2021; 2:203Tosi D, Chiappa M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870214 79. Quantifying the small-area spatio-temporal dynamics of the Covid-19 pandemic in Scotland during a period with limited testing capacity. Spat Stat 2021:100508Lee D, Robertson C, Marques D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868908 80. COVID-19 related callback in blood donors; Outcomes in blood donors and patients. Transfus. Apher. Sci. 2021:103129Balagholi S, Maghsudlu M, Amini- Kafiabad S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879420 81. Assessing regional risk of COVID-19 infection from Wuhan via high-speed rail. Transp Policy (Oxf) 2021; 106:226-238Li T, Rong L, Zhang A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867701 82. SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications. Vet. Q. 2021:1-31Sharun K, Dhama K, Pawde AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892621 83. Epidemiological and clinical characteristics of 65 hospitalized patients with COVID-19 in Liaoning, China. World J Clin Cases 2021; 9:2205-2217Zhang W, Ban Y, Wu YH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869596 84. COVID-19 pandemic: Are hard lockdowns ineffective?: Why the Bendavid et al. Study does not provide sufficient evidence for this Assumption. Z. Allgemeinmed. 2021; 97:103-107Glechner A, Stratil JM, Bombana M et al. 85. Sönnichsen A. One year of COVID - An end in sight? Editorial ZFA 1/2021. Z Allg Med 2021; 97: 1. Kochen MM, Kaduszkiewicz H, Niebling W, Rabady S. Trivialization or denial? Comment on the editorial "One year of COVID - An end in sight?" by Andreas Sönnichsen. Z Allg Med 2021; 97: B1-B2. Z. Allgemeinmed. 2021; 97:127Schwabe N. Gastro-enterology (10 articles)

1. Gastrointestinal manifestations related to infection with SARS-COV-2: Appendicular syndrome (A case report). Ann Med Surg (Lond) 2021:102288Elbakouri A, El Azhary A, Bouali M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868674 2. COVID-19 in patients with hepatobiliary and pancreatic diseases: a single- centre cross-sectional study in East London. BMJ Open 2021; 11:e045077Dayem Ullah AZM, Sivapalan L, Kocher HM, Chelala C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875444 3. COVID-19-Induced Bile Duct Casts and Cholangitis: A Case Report. Cureus 2021; 13:e14560Sanders D, Bomman S, Irani S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889467 4. An Unusual Case of Gastrointestinal Bleeding in a Patient With COVID-19. Cureus 2021; 13:e13901Sanku K, Siddiqui AH, Paul V, Ali M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880257 5. Fulminant hepatic failure in a patient testing re-positive for SARS-CoV-2: a case report. Int. J. Emerg. Med. 2021; 14:24Aldossary B, Hassan A, Moussa M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882839 6. DECREASE IN VIRAL HEPATITIS DIAGNOSES DURING THE COVID-19 PANDEMIC IN THE NETHERLANDS. J Hepatol 2021; Sonneveld MJ, Veldhuijzen IK, van de Laar T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887356 7. A Case of Severe Acute Respiratory Syndrome Coronavirus 2 Treatment With Remdesivir in a Hepatitis C-Coinfected Patient Resulting in Temporary Viral Control and Posttreatment Flare. Open Forum Infect Dis 2021; 8:ofab100da Cunha MR, Rodrigues IC, Trigueiros F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33880393 8. Co-infection of hepatitis E virus and Plasmodium falciparum malaria: A genuine risk in sub-Saharan Africa. Parasit Vectors 2021; 14:215Sahra S, Jahangir A, Iqbal QZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879247 9. The impact of the novel coronavirus pandemic on gastrointestinal operative volume in the United States. Surg. Endosc. 2021:1-7Purdy AC, Smith BR, Hohmann SF, Nguyen NT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871720 10. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study. Virulence 2021; 12:1199-1208Xiao Y, Wu D, Shi X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870852

Guidelines (8 articles)

1. GOLD 2021 guidelines for COPD - what's new and why. Adv Respir Med 2021; Gupta N, Malhotra N, Ish P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881161 2. Systematic review of international guidelines for head and neck oncology management in COVID-19 patients. Eur Arch Otorhinolaryngol 2021:1-37Gascon L, Fournier I, Chiesa-Estomba C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891167 3. Guidelines for clinical management of SARS-CoV-2 infection. Gac Med Mex 2020; 156:576-583García-Álvarez JL, García-Vigil JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877121 4. Development of a Resource Guide to Support the Engagement of Mental Health Providers and Patients With Digital Health Tools: Multimethod Study. J Med Internet Res 2021; 23:e25773Strudwick G, McLay D, Lo B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885374 5. One Year of Pandemic Learning Response: Benefits of Massive Online Delivery of the World Health Organization's Technical Guidance. JMIR Public Health Surveill 2021; 7:e28945Utunen H, Van Kerkhove MD, Tokar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881404 6. Fatal Retroperitoneal Hematoma Associated with Covid-19 Prophylactic Anticoagulation Protocol. Radiol Case Rep 2021; Teta M, Drabkin MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880136 7. Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic. Respir Investig 2021; Shibata Y, Muro S, Yokoyama A, Hashimoto S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893068 8. Guidance for the clinical management of infants born to mothers with suspected/confirmed COVID-19 in Singapore. Singapore Med J 2021; Yeo KT, Biswas A, Ho SKY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866749

Imaging (20 articles)

1. Echocardiographic Abnormalities as Independent Prognostic Factors of In- Hospital Mortality among COVID-19 Patients. Arch Acad Emerg Med 2021; 9:e21Pishgahi M, Karimi Toudeshki K, Safari S, Yousefifard M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870208 2. Artificial intelligence (AI) for medical imaging to combat coronavirus disease (COVID-19): a detailed review with direction for future research. Artif Intell Rev 2021:1-31Soomro TA, Zheng L, Afifi AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875900 3. Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19. Atherosclerosis 2021; Scoccia A, Gallone G, Cereda A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883086 4. DenseCapsNet: Detection of COVID-19 from X-ray images using a capsule neural network. Comput. Biol. Med. 2021; 133:104399Quan H, Xu X, Zheng T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892307 5. High-Resolution CT Chest Findings in Suspected COVID-19 Pneumonia Patients With Negative Real-Time Polymerase Chain Reaction Assay. Cureus 2021; 13:e14023Yusuf S, Ahmad H, Zeb R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889463 6. Lung ultrasound may be a valuable aid in decision making for patients admitted with COVID-19 disease. Eur Clin Respir J 2021; 8:1909521Falster C, Jacobsen N, Wulff Madsen L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33889342 7. Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region. Eur Radiol 2021:1-6Thomas C, Naudin M, Tasu JP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871709 8. Chest CT Images for COVID-19: Radiologists and Computer-Based Detection. Front Mol Biosci 2021; 8:614207Dou Q, Liu J, Zhang W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869276 9. Chest radiography patterns of COVID-19 pneumonia in Kumasi, Ghana. Ghana Med. J. 2020; 54:264-268Badu-Peprah A, Anyitey-Kokor I, Ackon A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883775 10. Point-of-care ultrasound (PoCUS) in the early diagnosis of novel coronavirus 2019 disease (COVID-19) in a first-level emergency department during a SARS- CoV-2 outbreak in Italy: a real-life analysis. Intern Emerg Med 2021:1-12Bianchi S, Savinelli C, Paolucci E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33881727 11. Comparing Visual Scoring of Lung Injury with a Quantifying AI-Based Scoring in Patients with COVID-19. J Belg Soc Radiol 2021; 105:16Biebau C, Dubbeldam A, Cockmartin L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870080 12. Chest CT Diagnosis of COVID-19: Accuracy using CO-RADS and CT- Involvement Scoring. J Belg Soc Radiol 2021; 105:17Van Berkel B, Vandevenne J, Coursier K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870081 13. Ultrasonography as a diagnostic aid for a neonate with gingival swelling in a COVID-19 neonatal intensive care unit. J. Indian Soc. Pedod. Prev. Dent. 2021; 39:101-103Kakade A, Deshmukh B, Agarwal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885396 14. Cost benefit analysis of portable chest radiography through glass: Initial experience at a tertiary care centre during COVID-19 pandemic. J Med Imaging Radiat Sci 2021; Liu TY, Rai A, Ditkofsky N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875400 15. REPLY TO LETTER TO THE EDITOR: POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19. J Nucl Med 2021; Pillarsetty N, Carter L, Lewis JS, Reiner T. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893187 16. The role of PoCUS in the assessment of COVID-19 patients. J Ultrasound 2021:1-9Karp J, Burke K, Daubaras SM, McDermott C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870480 17. Smart access development for classifying lung disease with chest x-ray images using deep learning. Mater Today Proc 2021; Kumaraguru T, Abirami P, Darshan KM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880332 18. Detection of COVID-19 from CT scan images: A spiking neural network-based approach. Neural Comput Appl 2021:1-14Garain A, Basu A, Giampaolo F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879976 19. SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR- negative COVID-19 patients during pandemic. Respir Res 2021; 22:119Schneider J, Mijočević H, Ulm K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892720 20. An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study. Thromb J 2021; 19:26Ogawa F, Oi Y, Nakajima K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3387917

Immune response (31 articles)

1. Profound dysregulation of T cell homeostasisand function in patients with severe COVID-19. Allergy 2021; Adamo S, Chevrier S, Cervia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884644 2. Emerging roles of coronavirus in autoimmune diseases. Arch Med Res 2021; Zhou SY, Zhang C, Shu WJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875273 3. Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes by disease-related blood biomarkers. Arthritis Rheumatol 2021; Kessel C, Vollenberg R, Masjosthusmann K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880885 4. Seroprevalence of SARS-CoV-2 Antibodies Among Health Care Personnel at a Health Care System in Pakistan. Asia Pac. J. Public Health 2021:10105395211011010Abbas S, Raza A, Iftikhar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880961 5. Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination. BMJ Case Rep. 2021; 14Uwaydah AK, Hassan NMM, Abu Ghoush MS, Shahin KMM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883119 6. A combination of cross-neutralizing antibodies synergizes to prevent SARS- CoV-2 and SARS-CoV pseudovirus infection. Cell Host Microbe 2021; Liu H, Yuan M, Huang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894127 7. Beware of traumatic anosmia in COVID-19 pandemic. Cjem 2021:1-2Nagamine T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881763 8. Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application. Clin Immunol 2021; 227:108727Zuo W, Zhao X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887436 9. Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru. Clin Infect Dis 2021; Tovar M, Peinado J, Palomino S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881476 10. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study. Crit Care 2021; 25:148Bhatraju PK, Morrell ED, Zelnick L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874973 11. Clinical Performance of SARS-CoV-2 IgG and IgM Tests Using an Automated Chemiluminescent Assay. Curr Med Sci 2021; 41:318-322Zhou JA, Zeng HL, Deng LY, Li HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877548 12. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine 2021:103341Balestrieri E, Minutolo A, Petrone V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867312 13. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses. Emerg Microbes Infect 2021:1- 28Yang Y, Wang X, Du RH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870851 14. SARS-CoV-2 antibodies: comparison of three high-throughput immunoassays versus the neutralization test. Eur. J. Clin. Invest. 2021:e13573Laterza R, Schirinzi A, Bruno R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870493 15. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel. Eur. J. Epidemiol. 2021:1-8Reicher S, Ratzon R, Ben-Sahar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884542 16. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with COVID-19-associated pneumonia. Gac Med Mex 2020; 156:527-531Carpio-Orantes LD, García-Méndez S, Hernández-Hernández SN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877106 17. IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Genome Med. 2021; 13:64Zhang F, Mears JR, Shakib L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879239 18. Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Int J Infect Dis 2021; Sughayer MA, Mansour A, Al Nuirat A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892190 19. Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients. J Clin Virol 2021; 139:104821Zonneveld R, Jurriaans S, van Gool T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882373 20. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol 2021; Rabinowich L, Grupper A, Baruch R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892006 21. Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples. J King Saud Univ Sci 2021; 33:101439Ibrahim EH, Ghramh HA, Kilany M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33879983 22. Multisystem Inflammatory Syndrome in Children (MIS-C) and the Prothrombotic State: Coagulation Profiles and Rotational Thromboelastometry in a MIS-C Cohort. J Thromb Haemost 2021; Al-Ghafry M, Vagrecha A, Malik M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872443 23. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 2021; 4:100100Wallukat G, Hohberger B, Wenzel K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880442 24. SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population. Kidney Int 2021; Anft M, Blazquez-Navarro A, Paniskaki K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887319 25. Low immunization rates among kidney transplant recipients who received two doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 2021; Benotmane I, Gautier-Vargas G, Cognard N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887315 26. Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients on haemodialysis. A call to arms. Kidney Int 2021; Billany RE, Selvaskandan H, Adenwalla SF et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887316 27. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio 2021; 12Adeniji OS, Giron LB, Purwar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879594 28. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma. mBio 2021; 12Natarajan H, Crowley AR, Butler SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879585 29. SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020. mSphere 2021; 6Han H, Yi J, Cheng G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883260 30. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives. Pulmonology 2021; Boechat JL, Chora I, Morais A, Delgado L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867315 31. Prolonged humoral and cellular immunity in COVID-19-recovered patients. Saudi J. Biol. Sci. 2021; Alsayb MA, Dakhilallah DAA, Makhdoom HQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867805

Management miscellaneous diseases (56 articles)

1. The impact of the COVID-19 pandemic and governor mandated stay at home order on emergency department super utilizers. Am J Emerg Med 2021; 48:114- 119Alwood S, Musso MW, Jones GN et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892402 2. The impact of the COVID-19 pandemic on the utilization of emergency department services for the treatment of injuries. Am J Emerg Med 2021; 47:187-191Harmon KJ, Fliss MD, Marshall SW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892334 3. Increased complications in patients who test COVID-19 positive after elective surgery and implications for pre and postoperative screening. Am. J. Surg. 2021; Prasad NK, Lake R, Englum BR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894979 4. Medical Student Attitudes Toward Blood Donation in Times of Increased Need. Am. Surg. 2021:31348211011083Khatun R, Otaibi BW, Ssentongo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877939 5. COVID-19 pandemic: pain, quality of life and impact on public health in the confinement in Spain. Ann Palliat Med 2021; Iglesias-López E, García-Isidoro S, Castellanos-Sánchez VO. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894721 6. The impact of distance cataract surgical wet laboratory training on cataract surgical competency of ophthalmology residents. BMC Med. Educ. 2021; 21:219Geary A, Wen Q, Adrianzén R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33874941 7. Paediatric emergency department dog bite attendance during the COVID-19 pandemic: an audit at a tertiary children's hospital. BMJ Paediatr Open 2021; 5:e001040Tulloch JSP, Minford S, Pimblett V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884313 8. Did COVID-19 related delays in surgical management lead to patient morbidity in the orthopaedic oncological population? Bone Jt Open 2021; 2:236- 242Fitzgerald MJ, Goodman HJ, Kenan S, Kenan S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870729 9. Insights into patient preferences for elective surgery during the COVID-19 pandemic. Bone Jt Open 2021; 2:261-270Hotchen AJ, Khan SA, Khan MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882713 10. Management of odontogenic cervicofacial infections presenting to oral and maxillofacial units during the first wave of the COVID-19 pandemic in the United Kingdom. Br. J. Oral Maxillofac. Surg. 2021; Puglia FA, Ubhi H, Dawoud B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892990 11. Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to "A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan". Breast Cancer 2021:1-2Ozaki A, Tachibana K, Ohtake T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880708 12. Prostate cancer survivorship, deaths, and health care management. Cancer 2021; Bauer JE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882148 13. Impact of COVID-19 on the Children with Cancer in 6 Pediatric Oncology Units (POU's) of Pakistan-a Multi-Center Study. Cancer Invest. 2021:1-11Raza MR, Maqsood S, Rana ZA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866889 14. E-Handover in Surgery Improves Clinical Efficiency and Adherence to COVID- 19 Infection Control Measures. Cureus 2021; 13:e13967Jacob N, Chaudhary O, Darwish NM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880300 15. Dental team and infection control for the COVID-19: (A short review of the current guidelines). Dent. Res. J. (Isfahan) 2020; 17:409-411Torabinia N, Nilchian F, Razavi SM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889344 16. Graft-Versus-Host Disease-Like Reactions in the Gastrointestinal Tract in a Patient with SARS-CoV-2 Infection. Dig Endosc 2021; Ozawa N, Yamazaki K, Kushima R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876462 17. The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects. Drug Discov Today 2021; Qiu T, Wang Y, Liang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892148 18. National approaches to managing cancer care: responses of countries in the MENA region to the COVID-19 pandemic. Ecancermedicalscience 2021; 15:1189Benbrahim Z, Mula-Hussain L, Al-Shamsi HO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889198 19. Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic. Ecancermedicalscience 2021; 15:1202Lombe D, Sullivan R, Caduff C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889211 20. Systematic review of international guidelines for head and neck oncology management in COVID-19 patients. Eur Arch Otorhinolaryngol 2021:1-37Gascon L, Fournier I, Chiesa-Estomba C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891167 21. Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey. Eur J Breast Health 2021; 17:188-196Mathelin C, Ame S, Anyanwu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870120 22. Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital. Eur. J. Dermatol. 2021; Ninosu N, Roehrich F, Diehl K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871361 23. Impact of the COVID-19 pandemic on access to health care services among patients with Multiple Sclerosis in the Lazio region, Italy. Eur. J. Neurol. 2021; Colais P, Cascini S, Balducci M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33896086 24. The cost of living with cancer during the second wave of COVID-19: A mixed methods study of Danish cancer patients' perspectives. Eur. J. Oncol. Nurs. 2021; 52:101958Dieperink KB, Ikander T, Appiah S, Tolstrup LK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878634 25. Impact of the first COVID-19 shutdown on patient volumes and surgical procedures of a Level I trauma center. Eur. J. Trauma Emerg. Surg. 2021:1- 11Kreis CA, Ortmann B, Freistuehler M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33881555 26. Can we safely use systemic treatment in atopic dermatitis during the COVID- 19 pandemic? Overview of selected conventional and biologic systemic therapies. Expert Rev. Clin. Immunol. 2021; Marko M, Pawliczak R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866905 27. Deep Brain Stimulation for Parkinson's Disease During the COVID-19 Pandemic: Patient Perspective. Front. Hum. Neurosci. 2021; 15:628105Zhang C, Zhang J, Qiu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867957 28. Outcomes of COVID-19 Negative Hip Fracture Patients During the Acute and Subacute Pandemic. Geriatr Orthop Surg Rehabil 2021; 12:21514593211006692Onizuka N, Topor LN, Schroder LK, Switzer JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868768 29. The role of community pharmacists in increasing access and use of self-care interventions for sexual and reproductive health in the Eastern Mediterranean Region: examples from Egypt, Jordan, Lebanon and Somalia. Health Res. Policy Syst. 2021; 19:49El Bizri L, Jarrar LG, Ali WKA, Omar AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882956 30. Community-led HIV self-testing for men who have sex with men in Lebanon: lessons learned and impact of COVID-19. Health Res. Policy Syst. 2021; 19:50Maatouk I, Nakib ME, Assi M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882944 31. COVID-19 Management in Clinical Dental Care. Part I: Epidemiology, Public Health Implications, and Risk Assessment. Int. Dent. J. 2021; Melo P, Barbosa JM, Jardim L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879353 32. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada. Int. J. Drug Policy 2021:103237Ali F, Russell C, Nafeh F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893026 33. Learning from organisational changes in the management of breast cancer patients during the COVID-19 pandemic: Preparing for a second wave at a breast unit in northern Italy. Int. J. Health Plann. Manage. 2021; Ferro A, Cristofolini P, Garcia-Etienne CA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890324 34. Oral isotretinoin treatment in patients with acne vulgaris during the COVID-19 pandemic: A retrospective cohort study in a tertiary care hospital. J Cosmet Dermatol 2021; Demirel Öğüt N, Kutlu Ö, Erbağcı E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884755 35. Management of patients with X-linked hypophosphatemic rickets during Covid-19 pandemic lockdown. J. Pediatr. Endocrinol. Metab. 2021; Baroncelli GI, Bertelloni S, Cosci ODCM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887813 36. Cancer survivors' perceived vulnerability to COVID-19 and impacts on cognitive, affective, and behavioral responses to the pandemic. J. Psychosoc. Oncol. 2021:1-19Slivjak Et MA, Fishbein Jn MA, Nealis M MPH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886442 37. COVID-19 - Changes in Workload and Clinical Practice in Trauma and Orthopaedics in a District General Hospital in the United Kingdom. Malays Orthop J 2021; 15:100-104Faria G, Virani S, Tadros BJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880155 38. Impact of COVID-19 on Clinical Practices during Lockdown: A pan India Survey of Orthopaedic Surgeons. Malays Orthop J 2021; 15:55-62Jain VK, Upadhyaya GK, Iyengar KP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33880149 39. Orthopaedic Practices and Surgeries during COVID-19 in Pakistan - A Survey Based Study. Malays Orthop J 2021; 15:72-78Saad-Ilyas M, Zehra U, Khan UU et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880151 40. Increased dispensing of prescription medications in Australia early in the COVID-19 pandemic. Med. J. Aust. 2021; Mian M, Sreedharan S, Giles S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884634 41. Evaluation of Parents' Knowledge and Attitudes Towards Pediatric Dental Practice during the COVID-19 Pandemic. Oral Health Prev Dent 2021; 19:271- 277Surme K, Akman H, Cime Akbaydogan L, Akin M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881290 42. Orthopaedic surgeons' perceptions and attitudes on COVID-19 related changes in practice: an international cross-sectional survey. Pan Afr. Med. J. 2021; 38:96Meraghni N, Bouyoucef H, Larbi RS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889262 43. Effects of COVID -19 pandemic and lockdown on people with multiple system atrophy participating in a therapeutic education program. Parkinsonism Relat. Disord. 2021; 86:78-80Cámara A, Compta Y, Pérez-Soriano A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33873000 44. Online action planning forums to develop a roadmap to mitigate the impact of COVID-19 on the delivery of global children's surgical care. Pediatr. Surg. Int. 2021:1-13Abbas A, Samad L, Ozgediz D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880597 45. Integrated management is effective in the prevention and control of COVID-19 in the blood purification center: joint efforts from multiple departments. Ren Replace Ther 2021; 7:19Yin J, Yin J, Tian Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868717 46. Hospitalization and Mortality from COVID-19 of Patients with Rheumatic Inflammatory Diseases in Andalusia. Reumatol. Clin. 2021; Mena-Vázquez N, Manrique Arija S, Rojas-Giménez M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895100 47. Knowledge, awareness, attitude and practice of dental practitioners regarding Covid-19 pandemic and infection control: a cross sectional study in Kolkata metropolitan region. Rocz. Panstw. Zakl. Hig. 2021; 72:95-101Bera R, Kalia P, Hiremath S, Jaiswal D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883104 48. Management of colorectal cancer in the era of COVID-19: Challenges and suggestions. Sci. Prog. 2021; 104:368504211010626Alam W, Bouferraa Y, Haibe Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878982 49. Prevention and control measures of the coronavirus disease 2019 (COVID-19) in low-risk departments: The spine surgery department example. Sci. Prog. 2021; 104:368504211009670Zheng Y, Zhang X, Fang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878962 50. Surgical volume reduction and the announcement of triage during the 1st wave of the COVID-19 pandemic in Japan: a cohort study using an interrupted time series analysis. Surg. Today 2021:1-8Okuno T, Takada D, Shin JH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881619 51. Multicenter study of US trauma centers examining the effect of the COVID-19 pandemic on injury causes, diagnoses and procedures. Trauma Surg Acute Care Open 2021; 6:e000655Salottolo K, Caiafa R, Mueller J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884307 52. Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study. Tumori 2021:3008916211009974Jereczek-Fossa BA, Palazzi MF, Tonoli S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885350 53. Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis. Vaccine 2021; Daniels V, Saxena K, Roberts C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875269 54. [Examination of patients with glaucoma during the COVID-19 pandemic]. Vestn. Oftalmol. 2021; 137:75-83Kurysheva NI, Pechenkina AA, Goncharova AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881266 55. Long-term control of melanoma brain metastases with co-occurring intracranial infection and involuntary drug reduction during COVID-19 pandemic: A case report. World J Clin Cases 2021; 9:2373-2379Wang Y, Lian B, Cui CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869616 56. Colorectal cancer screening in the COVID-19 era. World. J. Gastrointest. Oncol. 2021; 13:238-251Kadakuntla A, Wang T, Medgyesy K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889276

Management (45 articles)

1. Development of a Prone Team and Exploration of Staff Perceptions During COVID-19. AACN Adv. Crit. Care 2021:e1-e10Miguel K, Snydeman C, Capasso V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878151 2. Models will only get us so far: planning for place of care and death. Age Ageing 2021; Borgstrom E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878163 3. Priority Setting of Ventilators in the COVID-19 Pandemic from the Public's Perspective. AJOB Empir Bioeth 2021:1-13Asghari F, Parsapour A, Shamsi Gooshki E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881385 4. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS. Am. J. Surg. 2021; Raff LA, Reid TD, Johnson D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894980 5. Functional electrical stimulation-cycling favours erectus position restoration and walking in patients with critical COVID-19. A proof-of-concept controlled study. Ann. Phys. Rehabil. Med. 2021; Mateo S, Bergeron V, Cheminon M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895378 6. Using CPAP in COVID-19 patients outside of the intensive care setting: a comparison of survival and outcomes between dialysis and non-dialysis dependent patients. BMC Nephrol. 2021; 22:144Floyd L, Stauss M, Storrar J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882842 7. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat? Clin Sci (Lond) 2021; 135:1009-1014Simko F, Baka T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881142 8. Perspectives of Internal Medicine Physicians Regarding Medication Abortion Provision in the Primary Care Setting. Contraception 2021; Wolgemuth T, Judge- Golden C, Lane K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894250 9. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units. Crit Care 2021; 25:155Lavinio A, Ercole A, Battaglini D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888132 10. Essential Health and Nutrition Service Provision during the COVID-19 Pandemic: Lessons from Select Ethiopian Woredas. Curr Dev Nutr 2021; 5:nzab024Workicho A, Kershaw MJ, Berhanu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884343 11. Deploying Healthcare Providers during COVID-19 Pandemic. Disaster Med Public Health Prep 2021:1-13Shander A, Mesrobian J, Weiss J, Javidroozi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866981 12. Possible Potential Effects of Honey and Its Main Components Against Covid- 19 Infection. Dose Response 2021; 19:1559325820982423Abedi F, Ghasemi S, Farkhondeh T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867892 13. Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China. Eur. J. Epidemiol. 2021; 36:429- 439Bushman M, Worby C, Chang HH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33881667 14. COVID-SCORE Spain: Public perceptions of key government COVID-19 control measures. Eur. J. Public Health 2021; White TM, Cash-Gibson L, Martin-Moreno JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872348 15. Can single-use bronchoscopes help prevent nosocomial COVID-19 infections? Expert Rev. Med. Devices 2021; Barron S, Kennedy MP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891519 16. Rationales and uncertainties for aspirin use in COVID-19: a narrative review. Fam Med Community Health 2021; 9Sayed Ahmed HA, Merrell E, Ismail M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879541 17. Cooking at Home and Adherence to the Mediterranean Diet During the COVID- 19 Confinement: The Experience From the Croatian COVIDiet Study. Front Nutr 2021; 8:617721Pfeifer D, Rešetar J, Gajdoš Kljusurić J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869262 18. Construction and Performance Testing of a Fast-Assembly COVID-19 (FALCON) Emergency Ventilator in a Model of Normal and Low-Pulmonary Compliance Conditions. Front. Physiol. 2021; 12:642353White LA, Mackay RP, Solitro GF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868006 19. The Effect of Persuasive Messages in Promoting Home-Based Physical Activity During COVID-19 Pandemic. Front. Psychol. 2021; 12:644050Carfora V, Catellani P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868116 20. Who Gets Cured? COVID-19 and Developing a Critical Medical Sociology and Anthropology of Cure. Front Sociol 2020; 5:613548Berghs M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869531 21. In Search of Wise Management of Medical Resources and Personnel in the Long Combat With Coronavirus. Front Sociol 2020; 5:40Hu YR, Wang M, Zhang B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869447 22. Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review. Fundam. Clin. Pharmacol. 2021; Gault N, Esposito-Farese M, Revest M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876439 23. Guidelines for clinical management of SARS-CoV-2 infection. Gac Med Mex 2020; 156:576-583García-Álvarez JL, García-Vigil JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877121 24. Nonpharmaceutical interventions contribute to the control of COVID-19 in China based on a pairwise model. Infect Dis Model 2021; 6:643-663Luo XF, Feng S, Yang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869909 25. Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: a randomized clinical trial. Int J Infect Dis 2021; Siami Z, Aghajanian S, Mansouri S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878462 26. Acceptability of COVID-19 Vaccine in Africa. Int J MCH AIDS 2021; 10:134- 138Wirsiy FS, Nkfusai CN, Ako-Arrey DE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868778 27. Case Study use of high-flow nasal cannula in COVID-19 has improved effectiveness, safety and tolerability when applied in lateral position compared with prone positioning. Intensive Crit Care Nurs 2021:103061Sanz-Moncusí M, Rosselló-Sancho J, Garcia-Alamino JM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875340 28. The use of direct acting oral anticoagulants in patients with COVID-19 infection. J Community Hosp Intern Med Perspect 2021; 11:184-186Aly R, Gupta S, Singh B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889317 29. Quantitative fit testing of filtering face-piece respirators during the COVID-19 pandemic reveals anthropometric deficits in most respirators available in Iran. J Environ Health Sci Eng 2021:1-13Fakherpour A, Jahangiri M, Seif M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875931 30. The mechanisms between illness representations of COVID-19 and behavioral intention to visit hospitals for scheduled medical consultations in a Chinese general population. J Health Psychol 2021:13591053211008217She R, Luo S, Lau MM, Lau JTF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878946 31. The Pulsatile Modification Improves Hemodynamics and Attenuates Inflammatory Responses in Extracorporeal Membrane Oxygenation. J Inflamm Res 2021; 14:1357-1364Li G, Zeng J, Liu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880051 32. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021; 14:1487-1510Rowaiye AB, Okpalefe OA, Onuh Adejoke O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33889008 33. Letter regarding 'Neurointervention for emergent large vessel occlusion strokes during the COVID-19 pandemic'. J. Neurointerv. Surg. 2021; Hamidianjahromi A, Mowla A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875553 34. Chemo-Preventive Effect of Vegetables and Fruits Consumption on the COVID-19 Pandemic. J Nutr Food Sci 2021; 4Yedjou CG, Alo RA, Liu J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884222 35. COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin. J. Stroke Cerebrovasc. Dis. 2021; 30:105822Mansoor T, Alsarah AA, Mousavi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895426 36. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). J Thromb Haemost 2021; Thaler J, Ay C, Gleixner KV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877735 37. Recommendations for ethical decision making regarding hospital visitation during the COVID-19 pandemic. Medizinische Klinik - Intensivmedizin und Notfallmedizin 2021; Rogge A, Naeve-Nydahl M, Nydahl P et al. 38. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol. Biol. Rep. 2021:1-7Rahman A, Tabassum T, Araf Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891272 39. Challenges facing nurse managers during and beyond COVID-19 pandemic in relation to perceived organizational support. Nurs. Forum 2021; Gab Allah AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870510 40. A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis. Open Heart 2021; 8DiNicolantonio JJ, McCarty MF, Barroso-Aranda J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879509 41. Promoting Population Behavioral Health in a Safety-Net Health System During the COVID-19 Pandemic. Psychiatr. Serv. 2021:appips202000546Lim CT, Fulwiler CE, Carson NJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882680 42. Probiotics/ prebiotics in viral respiratory infections: implication for emerging pathogens. Recent Pat Biotechnol 2021; Heidari Z, Tajbakhsh A, Gheibi-Hayat SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874878 43. Rapid Response System Adaptations at 40 US Hospitals During the COVID-19 Pandemic. Resusc Plus 2021:100121Mitchell OJL, Doran O, Yuriditsky E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870236 44. Guidance for the clinical management of infants born to mothers with suspected/confirmed COVID-19 in Singapore. Singapore Med J 2021; Yeo KT, Biswas A, Ho SKY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866749 45. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy. Thromb Res 2021; 203:1-4Rhoades R, Leong R, Kopenitz J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894473

Mental – public health (104 articles)

1. Battling Burnout at the Frontlines of Health Care Amid COVID-19. AACN Adv. Crit. Care 2021:e1-e9Howell BAM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882576 2. The associations of life quality, depression, and cognitive impairment with mortality in older adults with COVID-19: a prospective, observational study. Acta Clin. Belg. 2021:1-8Bayrak M, Çadirci K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870876 3. Severe mental illness is associated with increased mortality and severe course of COVID-19. Acta Psychiatr. Scand. 2021; Barcella CA, Polcwiartek C, Mohr GH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894064 4. Effects of social support on mental health for critical care nurses during the coronavirus disease 2019 (COVID-19) pandemic in Japan: A web-based cross- sectional study. Acute Med Surg 2021; 8:e645Tatsuno J, Unoki T, Sakuramoto H, Hamamoto M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868689 5. KNOWLEDGE AND REASONS FOR ANXIETY AMONG NURSES TOWARDS COVID -19 IN NIGERIA. Afr J Infect Dis 2021; 15:16-23Odikpo LC, Abazie HO, Emon D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889798 6. Aging and emotion regulation during the COVID-19 pandemic. Aging Ment. Health 2021:1-8Wolfe HE, Isaacowitz DM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870771 7. COVID-19 in oncology palliative care: psychological stress from the perspective of psychodynamics at work. Ann Palliat Med 2021; de Azeredo Siqueira AS, Teixeira ER, de Oliveira da Cunha DA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894722 8. COVID-19 pandemic: pain, quality of life and impact on public health in the confinement in Spain. Ann Palliat Med 2021; Iglesias-López E, García-Isidoro S, Castellanos-Sánchez VO. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894721 9. The effect of prohibiting outside food during COVID-19 pandemic on the body weight of schizophrenic patients taking olanzapine or clozapine: a retrospective self-controlled study. Ann Palliat Med 2021; Zhang C, Wang X, Hu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894724 10. Impact of COVID-19 pandemic related lockdown on Suicide: Analysis of newspaper reports during pre-lockdown and lockdown period in Bangladesh and India. Asian J Psychiatr 2021; 60:102649Kar SK, Menon V, Arafat SMY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887672 11. Investigating smoking and nicotine dependence among people with severe mental illness during the COVID-19 pandemic: analysis of linked data from a UK Closing the Gap cohort. BJPsych Open 2021; 7:e86Peckham E, Allgar V, Crosland S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888178 12. A qualitative study of physician perceptions and experiences of caring for critically ill patients in the context of resource strain during the first wave of the COVID-19 pandemic. BMC Health Serv. Res. 2021; 21:374Parsons Leigh J, Kemp LG, de Grood C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888096 13. Anxiety and facial self-contacts: possible impact on COVID-19 transmission in dental practice. BMC Oral Health 2021; 21:200Carrillo-Diaz M, Lacomba-Trejo L, Del Valle-González A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879144 14. The impact of the COVID-19 pandemic on mental health in the general population: a comparison between Germany and the UK. BMC Psychol 2021; 9:60Knolle F, Ronan L, Murray GK. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892807 15. Attitudes, behaviours and barriers to public health measures for COVID-19: a survey to inform public health messaging. BMC Public Health 2021; 21:765Lang R, Benham JL, Atabati O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882896 16. How do Canadian public health agencies respond to the COVID-19 emergency using social media: a protocol for a case study using content and sentiment analysis. BMJ Open 2021; 11:e041818Kothari A, Foisey L, Donelle L, Bauer M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888527 17. Remote care for mental health: qualitative study with service users, carers and staff during the COVID-19 pandemic. BMJ Open 2021; 11:e049210Liberati E, Richards N, Parker J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888531 18. Fears of compassion magnify the harmful effects of threat of COVID-19 on mental health and social safeness across 21 countries. Clin. Psychol. Psychother. 2021; Matos M, McEwan K, Kanovský M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880832 19. Excited Catatonia - A Delayed Neuropsychiatric Complication of COVID-19 Infection. Cureus 2021; 13:e13891Zain SM, Muthukanagaraj P, Rahman N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880247 20. The 5-factor model of psychological response to COVID-19: its correlation with anxiety and depression. Curr. Psychol. 2021:1-13Aboul-Ata MA, Qonsua FT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875911 21. Frequency and perceived effectiveness of mental health providers' coping strategies during COVID-19. Curr. Psychol. 2021:1-10Reilly SE, Soulliard ZA, McCuddy WT, Mahoney JJ, 3rd. http://www.ncbi.nlm.nih.gov/pubmed/? term=33867779 22. How are OCD patients and their families coping with the COVID-19 pandemic? A qualitative study. Curr. Psychol. 2021:1-11Tandt HLN, Van Parys H, Leyman L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867778 23. Internet-Related Behaviors and Psychological Distress Among Schoolchildren During the COVID-19 School Hiatus. Cyberpsychol Behav Soc Netw 2021; Chen CY, Chen IH, Pakpour AH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33877905 24. Addressing Pediatric Mental Health during COVID-19 and other Disasters: A National Tabletop Exercise. Disaster Med Public Health Prep 2021:1-13Gupta S, Schreiber M, McGuire T, Newton C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33867004 25. Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study. Eur. J. Epidemiol. 2021:1-6Batty GD, Deary IJ, Gale CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893922 26. Spiritual Well-Being and Mental Health During the COVID-19 Pandemic in Italy. Front Psychiatry 2021; 12:626944Coppola I, Rania N, Parisi R, Lagomarsino F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868047 27. Psychological Health, Sleep Quality, Behavior, and Internet Use Among People During the COVID-19 Pandemic: A Cross-Sectional Study. Front Psychiatry 2021; 12:632496Elhadi M, Alsoufi A, Msherghi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868049 28. Prevalence of Mental Health Problems and Its Associated Factors Among Recovered COVID-19 Patients During the Pandemic: A Single-Center Study. Front Psychiatry 2021; 12:602244Khademi M, Vaziri-Harami R, Shams J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868043 29. Mental Health, Social and Emotional Well-Being, and Perceived Burdens of University Students During COVID-19 Pandemic Lockdown in Germany. Front Psychiatry 2021; 12:643957Kohls E, Baldofski S, Moeller R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889102 30. Correlates of Psychological Distress Among Pakistani Adults During the COVID-19 Outbreak: Parallel and Serial Mediation Analyses. Front. Psychol. 2021; 12:647821Ashraf F, Zareen G, Nusrat A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868122 31. An Exploratory Study of Police Officers' Perceptions of Health Risk, Work Stress, and Psychological Distress During the COVID-19 Outbreak in China. Front. Psychol. 2021; 12:632970Huang Q, Bodla AA, Chen C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868096 32. COVID-19: Are School Counseling Services Ready? Students' Psychological Symptoms, School Counselors' Views, and Solutions. Front. Psychol. 2021; 12:647740Karaman MA, Eşici H, Tomar İ H, Aliyev R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868121 33. Psychological Differences Among Healthcare Workers of a Rehabilitation Institute During the COVID-19 Pandemic: A Two-Step Study. Front. Psychol. 2021; 12:636129Panzeri A, Rossi Ferrario S, Cerutti P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868105 34. Prolonged COVID 19 Outbreak and Psychological Response of Nurses in Italian Healthcare System: Cross-Sectional Study. Front. Psychol. 2021; 12:608413Ranieri J, Guerra F, Perilli E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33889106 35. Culturally Grounded Scapegoating in Response to Illness and the COVID-19 Pandemic. Front. Psychol. 2021; 12:632641Yang Q, Young IF, Wan J, Sullivan D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889110 36. Cultural Sources of Strength and Resilience: A Case Study of Holistic Wellness Boxes for COVID-19 Response in Indigenous Communities. Front Sociol 2021; 6:612637Aulandez KMW, Walls ML, Weiss NM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869563 37. Commentary: COVID-19 and mental health equity in the United States. Front Sociol 2020; 5:584390Condon EM, Dettmer AM, Gee DG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869513 38. Understanding Grief During the First-Wave of COVID-19 in the United Kingdom-A Hypothetical Approach to Challenges and Support. Front Sociol 2021; 6:607645Fang C, Comery A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869550 39. Impact of coronaphobia on treatment and follow-up compliance of cancer patients. Future Oncol 2021; Akagunduz B, Ozer M, Karacin C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880932 40. Mental disorder prevalence among populations impacted by coronavirus pandemics: A multilevel meta-analytic study of COVID-19, MERS & SARS. Gen. Hosp. Psychiatry 2021; 70:124-133Boden M, Cohen N, Froelich JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894561 41. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19. Glob Public Health 2021:1-14Li M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891518 42. Cyberbullying, social stigma, and self-esteem: the impact of COVID-19 on students from East and Southeast Asia at the University of Jordan. Heliyon 2021; 7:e06711Alsawalqa RO. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869877 43. Does 'COVID-19 phobia' stimulate career anxiety?: Experience from a developing country. Heliyon 2021; 7:e06346Mahmud MS, Rahman MM, Masud-Ul- Hasan M, Islam MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869821 44. Psychological pressure and changes in food consumption: the effect of COVID-19 crisis. Heliyon 2021; 7:e06607Russo C, Simeone M, Demartini E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869860 45. Tsunami of economic turmoil to hit the healthcare in 2021-2022: COVID-19 pandemic is just an earthquake. Hosp Pract (1995) 2021:1-8Arredondo E, Kashyap R, Surani S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866912 46. Perceived quarantine competence, attitudes, and practices among the public during the coronavirus pandemic: A Saudi descriptive study. Int J Clin Pract 2021:e14242Almarwani AM, Aljohani MS, Eweda G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884727 47. About Anxiety levels and Anti-anxiety drugs among quarantined Undergraduate Jordanian Students during COVID-19 Pandemic. Int J Clin Pract 2021:e14249Alqudah A, Al-Smadi A, Oqal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884714 48. Impact of COVID-19 on post-traumatic stress symptoms in the general population: An integrative review. Int. J. Ment. Health Nurs. 2021; Hong S, Kim H, Park MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884723 49. Association between resilience and burnout of front-line nurses at the peak of the COVID-19 pandemic: Positive and negative affect as mediators in Wuhan. Int. J. Ment. Health Nurs. 2021; Zhang X, Jiang X, Ni P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893718 50. Senior BSN students' confidence, comfort, and perception of readiness for clinical practice: the impacts of COVID-19. Int. J. Nurs. Educ. Scholarsh. 2021; 18Musallam E, B AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882201 51. The quality of life, resources, and coping during the first weeks of the COVID‑19 pandemic in people seeking psychological counselling before the pandemic. Int. J. Occup. Med. Environ. Health 2021; Chwaszcz J, Palacz-Chrisidis A, Wiechetek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885045 52. COVID-19: The future of nursing will determine the fate of our health services. Int Nurs Rev 2021; 68:9-11Catton H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891771 53. Factors affecting frontline Korean nurses' mental health during the COVID-19 pandemic. Int Nurs Rev 2021; Cho M, Kim O, Pang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894067 54. Nurses' experiences in response to COVID-19 in a psychiatric ward in Singapore. Int Nurs Rev 2021; Gao Z, Tan FPL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894062 55. Clinician mental health, nursing shortages and the COVID-19 pandemic: Crises within crises. Int Nurs Rev 2021; 68:12-14Turale S, Nantsupawat A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891772 56. Drawing on emotions: the evolving role of art therapy. Ir. J. Psychol. Med. 2021:1-3Cheng C, Elamin ME, May H, Kennedy M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870885 57. Cannabis withdrawal induced brief psychotic disorder: a case study during the national lockdown secondary to the COVID-19 pandemic. J. Addict. Dis. 2021:1-8Marín J, Pérez de Mendiola X, Fernández S, Chart JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884940 58. Letters from the pandemic: Nursing student narratives of change, challenges and thriving at the outset of COVID-19. J. Adv. Nurs. 2021; Heilferty CM, Phillips LJ, Mathios R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871891 59. Mental health services in primary care: Evidence for the feasibility of telehealth during the COVID-19 pandemic. J Affect Disord Rep 2021; 5:100146Frank HE, Grumbach NM, Conrad SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870261 60. Mental health services in primary care: Evidence for the feasibility of telehealth during the COVID-19 pandemic. J Affect Disord Rep 2021; 5:100146Frank HE, Grumbach NM, Conrad SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870261 61. Custodial Grandparent's Job Loss During the COVID-19 Pandemic and Its Relationship With Parenting Stress and Mental Health. J. Appl. Gerontol. 2021:7334648211006222Wu Q, Xu Y, Jedwab M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870739 62. Impact of COVID-19 pandemic and related isolation measures on violence against children in Egypt. J. Egypt. Public Health Assoc. 2021; 96:11AboKresha SA, Abdelkreem E, Ali RAE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880660 63. Association Between Perceived Resilience and Mental Well-Being of Saudi Nursing Students During COVID-19 Pandemic: A Cross-Sectional Study. J. Holist. Nurs. 2021:8980101211009063Grande RAN, Berdida DJE, Villagracia HN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876982 64. "It's ok, mom. I got it!": Exploring the experiences of young adults with intellectual disabilities in a postsecondary program affected by the COVID-19 pandemic from their perspective and their families' perspective. J Intellect Disabil 2021:17446295211002346Spencer P, Van Haneghan JP, Baxter A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878973 65. Intimate Partner Violence Experiences During COVID-19 Among Male Couples. J Interpers Violence 2021:8862605211005135Walsh AR, Sullivan S, Stephenson R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866839 66. Development of a Resource Guide to Support the Engagement of Mental Health Providers and Patients With Digital Health Tools: Multimethod Study. J Med Internet Res 2021; 23:e25773Strudwick G, McLay D, Lo B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885374 67. Impact of the COVID-19 Pandemic on Health Care Utilization in a Large Integrated Health Care System: Retrospective Cohort Study. J Med Internet Res 2021; 23:e26558Xu S, Glenn S, Sy L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882020 68. Impact of the COVID-19 lockdown on screen media use in patients referred for ADHD to child and adolescent psychiatry: an introduction to problematic use of the internet in ADHD and results of a survey. J Neural Transm (Vienna) 2021:1-11Werling AM, Walitza S, Drechsler R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885969 69. Survey of attitudes of individuals who underwent remote prenatal check-ups and consultations in response to the COVID-19 pandemic. J. Obstet. Gynaecol. Res. 2021; Nakagawa K, Umazume T, Mayama M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880830 70. Negative Effects of COVID-19 Stay-at-Home Mandates on Physical Intervention Outcomes: A Preliminary Study. J. Parkinsons Dis. 2021; Templeton JM, Poellabauer C, Schneider S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867363 71. Anxiety and COVID-19: A study of online content readability. J Prev Interv Community 2021:1-9Seidel EJ, Hillyer GC, Basch CH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871313 72. Psychosocial impact of the COVID-19 pandemic on cancer patients, survivors and caregivers. J. Psychosoc. Oncol. 2021:1-7Amaniera I, Bach C, Vachani C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870877 73. The impact of COVID-19 on the professional and personal lives of pediatric oncology social workers. J. Psychosoc. Oncol. 2021:1-15Wiener L, Fry A, Pelletier W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886433 74. Spiritual Support During COVID-19 in England: A Scoping Study of Online Sources. J Relig Health 2021:1-22Papadopoulos I, Lazzarino R, Wright S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871782 75. State health disparities research in Rural America: Gaps and future directions in an era of COVID-19. J Rural Health 2021; Cacari Stone L, Roary MC, Diana A, Grady PA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881778 76. Mobile Sensing Apps and Self-management of Mental Health During the COVID-19 Pandemic: Web-Based Survey. JMIR Form Res 2021; 5:e24180Suruliraj B, Bessenyei K, Bagnell A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872181 77. Learning the Mental Health Impact of COVID-19 in the United States With Explainable Artificial Intelligence: Observational Study. JMIR Ment Health 2021; 8:e25097Jha IP, Awasthi R, Kumar A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33877051 78. Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: A longitudinal analysis of 200,000 Western and Northern Europeans. Lancet Reg Health Eur 2021; 2:100020Varga TV, Bu F, Dissing AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870246 79. A mental health informatics study on the mediating effect of the regulatory emotional self-efficacy. Math Biosci Eng 2021; 18:2775-2788Xu Z, Du J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892571 80. Experiences of critical care nurses fighting against COVID-19: A qualitative phenomenological study. Nurs. Forum 2021; Chegini Z, Arab-Zozani M, Rajabi MR, Kakemam E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895986 81. The psychosocial impact on frontline nurses of caring for patients with COVID-19 during the first wave of the pandemic in New York City. Nurs. Outlook 2021; Kovner C, Raveis VH, Van Devanter N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894986 82. Associations between COVID-19 perceptions, anxiety, and depressive symptoms among adults living in the United States. Nurs. Outlook 2021; Wierenga KL, Moore SE, Pressler SJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894985 83. The Effect of Loneliness on Death Anxiety in the Elderly During the COVID-19 Pandemic. Omega (Westport) 2021:302228211010587Guner TA, Erdogan Z, Demir I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878967 84. It's a conspiracy: Covid-19 conspiracies link to psychopathy, Machiavellianism and collective narcissism. Pers. Individ. Dif. 2021; 171:110559Hughes S, Machan L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867616 85. Investigation of psychiatric symptoms in individuals in Turkey during the COVID-19 outbreak. Perspect. Psychiatr. Care 2021; Kök Eren H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896012 86. Adolescent psychopathological profiles and the outcome of the COVID-19 pandemic: Longitudinal findings from the UK Millennium Cohort Study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2021:110330Essau CA, de la Torre-Luque A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887389 87. Supporting the Mental Health Workforce During and After COVID-19. Psychiatr. Serv. 2021:appips202000509Druss BG, Cohen AN, Brister T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882690 88. OCD during COVID-19: Understanding clinical and non-clinical anxiety in the community. Psychiatry Res 2021; 300:113910Acenowr CP, Coles ME. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872852 89. Longitudinal changes in psychological distress in the UK from 2019 to September 2020 during the COVID-19 pandemic: Evidence from a large nationally representative study. Psychiatry Res 2021; 300:113920Daly M, Robinson E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882397 90. Predictors and consequences of loneliness during the COVID-19 Pandemic. Psychiatry Res 2021; 300:113934Rumas R, Shamblaw AL, Jagtap S, Best MW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882398 91. The role of the COVID-19 pandemic in altered psychological well-being, mental health and sleep: an online cross-sectional study. Psychol Health Med 2021:1- 9Allen SF, Stevenson J, Lazuras L, Akram U. http://www.ncbi.nlm.nih.gov/pubmed/? term=33878999 92. Follow-up to a randomized controlled trial of the effect of self-affirmation on anxiety during the COVID-19 pandemic. Psychol Health Med 2021:1-6Li S, Xu Q, Zhou A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882760 93. Effects of group psychological intervention combined with pulmonary rehabilitation exercises on anxiety and sleep disorders in patients with mild coronavirus disease 2019 (COVID-19) infections in a Fangcang hospital. Psychol Health Med 2021:1-11Liu Y, Yang YQ, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877926 94. Using social media data to assess the impact of COVID-19 on mental health in China. Psychol. Med. 2021:1-8Zhu Y, Cao L, Xie J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875036 95. Home education for children with autism spectrum disorder during the COVID- 19 pandemic: Indonesian mothers experience. Res. Dev. Disabil. 2021; 114:103954Daulay N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882385 96. Sleep deficit in COVID-19 health-care workers may increase the infection risk. Scand J Public Health 2021:14034948211007679Ishikura IA, Rosa DS, Hachul H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870776 97. Maternal insomnia during the COVID-19 pandemic: associations with depression and anxiety. Soc. Psychiatry Psychiatr. Epidemiol. 2021:1-9Wang J, Zhou Y, Qian W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891160 98. When public health messages become stressful: Managing chronic disease during COVID-19. Soc Sci Humanit Open 2021; 4:100150Coupet S, Nicolas G, Louder CN, Meyer M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880443 99. Social factors and worry associated with COVID-19: Evidence from a large survey in China. Soc. Sci. Med. 2021; 277:113934Zhou M, Guo W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878665 100. [Covid-19 infectious disease is also a psychogeriatric disease]. Soins Gerontol. 2021; 26:37-39Thomas P, Hazif-Thomas C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894913 101. Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation. Transfus. Clin. Biol. 2021; Maheshwari A, Varshney M, Gupta K, Bajpai M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895379 102. Global health disparities in vulnerable populations of psychiatric patients during the COVID-19 pandemic. World J Psychiatry 2021; 11:94-108Diaz A, Baweja R, Bonatakis JK, Baweja R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33889535 103. [Predictors of process-related and structuring parental support during distance learning due to Corona-pandemic]. Z Erziehwiss 2021:1-24Sander A, Schäfer L, van Ophuysen S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875915 104. Predicted impacts of government policies and actions on the SARS-CoV-2 disease in the northwestern Himalayan region, India. Z Gesundh Wiss 2021:1- 9Haq SM, Yaqoob U, Hassan M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33880322

Meta-analyses - systematic reviews (15 articles)

1. Does taking an angiotensin inhibitor increase the risk for COVID-19? - a systematic review and meta-analysis. Aging (Albany NY) 2021; 13Ma Z, Wang MP, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886504 2. Hospital-Level Variation in Death for Critically Ill Patients with COVID-19. Am J Respir Crit Care Med 2021; Churpek MM, Gupta S, Spicer AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891529 3. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211008999Moonla C, Sosothikul D, Chiasakul T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874753 4. Kidney disease and COVID-19 disease severity-systematic review and meta- analysis. Clin. Exp. Med. 2021:1-11Singh J, Malik P, Patel N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891214 5. The Association of Acute Kidney Injury With Disease Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Cureus 2021; 13:e13894Menon T, Sharma R, Kataria S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880250 6. Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: A systematic review and meta-analysis. Expert Rev. Respir. Med. 2021; Dmytriw AA, Chibbar R, Chen PPY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882768 7. Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:660688Barreira DF, Lourenço RA, Calisto R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889590 8. Mental disorder prevalence among populations impacted by coronavirus pandemics: A multilevel meta-analytic study of COVID-19, MERS & SARS. Gen. Hosp. Psychiatry 2021; 70:124-133Boden M, Cohen N, Froelich JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894561 9. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med 2021:1-17Chaudhuri D, Sasaki K, Karkar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876268 10. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol 2021; Dorgham K, Quentric P, Gökkaya M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894209 11. Incidence and Mortality of COVID-19-associated Pulmonary Aspergillosis: A Systematic Review and Meta-analysis. Mycoses 2021; Mitaka H, Kuno T, Takagi H, Patrawalla P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896063 12. Development and implementation of a potential coronavirus disease 2019 (COVID-19) vaccine: A systematic review and meta-analysis of vaccine clinical trials. Nepal J Epidemiol 2021; 11:959-982Sathian B, Asim M, Banerjee I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868742 13. Does higher Body Mass Index increase COVID-19 severity?: a systematic review and meta-analysis. Obes Med 2021:100340Chowdhury AI, Alam MR, Rabbi MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875972 14. Arrhythmias and Electrocardiographic findings in Coronavirus disease 2019: a systematic review and meta-analysis. Pacing Clin. Electrophysiol. 2021; Garcia- Zamora S, Lee S, Haseeb S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890684 15. Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis. Sleep Med. 2021; 82:47-53Hariyanto TI, Kurniawan A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892451

Mortality (32 articles)

1. Severe mental illness is associated with increased mortality and severe course of COVID-19. Acta Psychiatr. Scand. 2021; Barcella CA, Polcwiartek C, Mohr GH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894064 2. Mortality attributable to COVID-19 in nursing home residents: a retrospective study. Aging Clin. Exp. Res. 2021:1-7Veronese N, Koyanagi A, Stangherlin V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893989 3. Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients. Alzheimers Dement 2021; Tahira AC, Verjovski-Almeida S, Ferreira ST. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881211 4. Hospital-Level Variation in Death for Critically Ill Patients with COVID-19. Am J Respir Crit Care Med 2021; Churpek MM, Gupta S, Spicer AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891529 5. Determinants of mortality of patients with COVID-19 in Wuhan, China: a case- control study. Ann Palliat Med 2021; Li J, Yang L, Zeng Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894714 6. Risk factors for mortality of coronavirus disease 2019 (COVID-19) patients during the early outbreak of COVID-19: a systematic review and meta-analysis. Ann Palliat Med 2021; Wu Y, Li H, Zhang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894729 7. Cardiac Complications and Pertaining Mortality Rate in COVID-19 Patients; a Systematic Review and Meta-Analysis. Arch Acad Emerg Med 2021; 9:e18Toloui A, Moshrefiaraghi D, Madani Neishaboori A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870205 8. Lupus anticoagulant single positivity at acute phase is not associated with venous thromboembolism or in-hospital mortality in COVID-19. Arthritis Rheumatol 2021; Gendron N, Dragon-Durey MA, Chocron R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881229 9. ABO blood groups, COVID-19 infection and mortality. Blood Cells Mol. Dis. 2021; 89:102571Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894687 10. COVID-19 as the sole cause of death is uncommon in frail home healthcare individuals: a population-based study. BMC Geriatr. 2021; 21:262Nilsson L, Andersson C, Sjödahl R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879078 11. The impact of frailty on survival in elderly intensive care patients with COVID- 19: the COVIP study. Crit Care 2021; 25:149Jung C, Flaatten H, Fjølner J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874987 12. A Retrospective Study Assessing the Effect of Diabetes on Mortality in Patients With COVID-19 at a Teaching Hospital in the United Kingdom. Cureus 2021; 13:e13902Ahmed FW, Kirresh OZ, Robinson AV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880258 13. The Association of Acute Kidney Injury With Disease Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Cureus 2021; 13:e13894Menon T, Sharma R, Kataria S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880250 14. Development of a multivariable model predicting mortality risk from comorbidities in an Italian cohort of 18,286 confirmed COVID-19 cases aged 40 years or older. Epidemiol. Prev. 2021; 45:100-109Andreano A, Murtas R, Tunesi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884848 15. Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study. Eur. J. Epidemiol. 2021:1-6Batty GD, Deary IJ, Gale CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893922 16. Corona and Coffee on your commute: A spatial analysis of COVID-19 mortality and commuting flows in England in 2020. Eur. J. Public Health 2021; Francetic I, Munford L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871592 17. The Association Between Alpha-1 Adrenergic Receptor Antagonists and In- Hospital Mortality From COVID-19. Front Med (Lausanne) 2021; 8:637647Rose L, Graham L, Koenecke A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869251 18. Poverty and Covid-19: Rates of Incidence and Deaths in the United States During the First 10 Weeks of the Pandemic. Front Sociol 2020; 5:47Finch WH, Hernández Finch ME. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869454 19. Association of neutrophil-to-lymphocyte and lymphocyte-to-C-reactive protein ratios with COVID-19-related mortality. Gac Med Mex 2020; 156:553- 558Albarrán-Sánchez A, González-Ríos RD, Alberti-Minutti P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877103 20. Population-level mortality burden from novel coronavirus (COVID-19) in Europe and North America. Genus 2021; 77:7Soneji S, Beltrán-Sánchez H, Yang JW, Mann C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879923 21. The presence of care homes and excess deaths during the COVID-19 pandemic: Evidence from Italy. Health Econ. 2021; Alacevich C, Cavalli N, Giuntella O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884695 22. Fatalities of COVID-19 are rather attributable to multisystem inflammatory syndrome than infectious meningitis or sepsis. Indian J. Med. Microbiol. 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867206 23. The role of hemogram parameters and CRP in predicting mortality in COVID- 19 infection. Int J Clin Pract 2021:e14256Acar E, Demir A, Yıldırım B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887100 24. Predictive value of d-dimer/albumin ratio and fibrinogen/albumin ratio for in- hospital mortality in patients with COVID-19. Int J Clin Pract 2021:e14263Küçükceran K, Ayranci MK, Girişgin AS, Koçak S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891337 25. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med 2021:1-11Corradini E, Ventura P, Ageno W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893976 26. Role of Ascertainment Bias in Determining Case Fatality Rate of COVID-19. J Epidemiol Glob Health 2021; Smith MP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33876593 27. Cause of death based on systematic postmortem studies in patients with positive SARS-CoV2 tissue PCR during the COVID-19 pandemic. J Intern Med 2021; Romanova ES, Vasilyev VV, Startseva G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872433 28. A Clinical Risk Score to Predict In-hospital Mortality from COVID-19 in South Korea. J Korean Med Sci 2021; 36:e108Her AY, Bhak Y, Jun EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876588 29. Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study. J Multidiscip Healthc 2021; 14:839-852Alwafi H, Naser AY, Qanash S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883900 30. Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain. Lancet Reg Health Eur 2021; 3:100041Garcia-Vidal C, Cózar-Llistó A, Meira F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870249 31. Incidence and Mortality of COVID-19-associated Pulmonary Aspergillosis: A Systematic Review and Meta-analysis. Mycoses 2021; Mitaka H, Kuno T, Takagi H, Patrawalla P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896063 32. Factors influencing the COVID-19 daily deaths' peak across European countries. Public Health 2021; 194:135-142Jabłońska K, Aballéa S, Toumi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=3389235

Online – IT – Apps (96 articles)

1. Using Dynamic Virtual Microscopy to Train Pathology Residents During the Pandemic: Perspectives on Pathology Education in the Age of COVID-19. Acad Pathol 2021; 8:23742895211006819Christian RJ, VanSandt M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884292 2. Effects of social support on mental health for critical care nurses during the coronavirus disease 2019 (COVID-19) pandemic in Japan: A web-based cross- sectional study. Acute Med Surg 2021; 8:e645Tatsuno J, Unoki T, Sakuramoto H, Hamamoto M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868689 3. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial. Addict. Sci. Clin. Pract. 2021; 16:24Hser YI, Ober AJ, Dopp AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879260 4. Working in Creative Partnership with Students to Co-Produce Neuroanatomy e-Learning Resources in a new era of Blended Learning. Anat Sci Educ 2021; Border S, Woodward C, Kurn O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33871948 5. NewsMeSH: A new classifier designed to annotate health news with MeSH headings. Artif. Intell. Med. 2021; 114:102053Pita Costa J, Rei L, Stopar L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875160 6. Mass Media Influence on Changing Healthy Lifestyle of Community People During COVID-19 Pandemic in Bangladesh: A Cross-Sectional Survey. Asia Pac. J. Public Health 2021:10105395211011030Islam MN, Islam A, Hossain MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870719 7. Online medical conference became favorite in China during COVID-19, will it become a routine model in the future? Asian J. Surg. 2021; Peng D, Cheng YX, Liu XY, Wang CY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879360 8. Making a Traditional Spine Surgery Clinic Telemedicine-Ready in the "New Normal" of Coronavirus Disease 2019. Asian Spine J 2021; 15:164-171Liu KG, Tan WLB, Yip WLJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866765 9. Commitment, Collaboration, and Problem Resolution to Promote and Sustain Access to Multifaceted Applied Behavior-Analytic Services Utilizing Telepractice. Behav Anal Pract 2021:1-23Frederick JK, Rogers VR, Raabe GR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875928 10. A longitudinal and geospatial analysis of COVID-19 tweets during the early outbreak period in the United States. BMC Public Health 2021; 21:793Cuomo RE, Purushothaman V, Li J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894745 11. Remote care for mental health: qualitative study with service users, carers and staff during the COVID-19 pandemic. BMJ Open 2021; 11:e049210Liberati E, Richards N, Parker J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888531 12. How has technology been used to deliver cardiac rehabilitation during the COVID-19 pandemic? An international cross-sectional survey of healthcare professionals conducted by the BACPR. BMJ Open 2021; 11:e046051O'Doherty AF, Humphreys H, Dawkes S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33879492 13. Patient satisfaction scores with telemedicine in the neurosurgical population. Clin. Neurol. Neurosurg. 2021; 205:106605Porche K, Vaziri S, Mehkri Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894681 14. Comparative analysis of Student's live online learning readiness during the coronavirus (COVID-19) pandemic in the higher education sector. Comput Educ 2021; 168:104211Tang YM, Chen PC, Law KMY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879955 15. Conducting conservation social science surveys online. Conserv. Biol. 2021; Wardropper CB, Dayer AA, Goebel MS, Martin VY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887800 16. E-Handover in Surgery Improves Clinical Efficiency and Adherence to COVID- 19 Infection Control Measures. Cureus 2021; 13:e13967Jacob N, Chaudhary O, Darwish NM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880300 17. Assessment of the Efficacy of Telephone Medicine Consultations in Trauma and Orthopaedics During COVID-19 Using the Ashford Clinic Letter Score. Cureus 2021; 13:e13871Raad M, Ndlovu S, Neen D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868835 18. Internet-Related Behaviors and Psychological Distress Among Schoolchildren During the COVID-19 School Hiatus. Cyberpsychol Behav Soc Netw 2021; Chen CY, Chen IH, Pakpour AH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33877905 19. Online examination course instead of classroom teaching: adaptation of medical student teaching during the COVID-19 pandemic. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2021; Wiedenmann C, Wacker K, Böhringer D et al. 20. Telephonic Triage in Times of COVID-19: Experiences at a Telemedicine Centre in India. Disaster Med Public Health Prep 2021:1-5Ray A, Sharma S, Sadasivam B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888174 21. 'I'm just ringing to get a repeat prescription for my contraceptive pill, doctor': developing authentic simulated telephone consultations for medical students. Educ. Prim. Care 2021:1-5Beddows J, Abdalla M, Blanchard D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890545 22. Participatory syndromic surveillance as a tool for tracking COVID-19 in Bangladesh. Epidemics 2021; 35:100462Mahmud AS, Chowdhury S, Sojib KH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887643 23. Behaviours and attitudes in response to the COVID-19 pandemic: insights from a cross-national Facebook survey. EPJ Data Sci 2021; 10:17Perrotta D, Grow A, Rampazzo F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880320 24. End-to-End AI-Based Point-of-Care Diagnosis System for Classifying Respiratory Illnesses and Early Detection of COVID-19: A Theoretical Framework. Front Med (Lausanne) 2021; 8:585578Belkacem AN, Ouhbi S, Lakas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869239 25. Humor in Times of COVID-19 in Spain: Viewing Coronavirus Through Memes Disseminated via WhatsApp. Front. Psychol. 2021; 12:611788Cancelas-Ouviña LP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868083 26. Gender Differences in Digital Learning During COVID-19: Competence Beliefs, Intrinsic Value, Learning Engagement, and Perceived Teacher Support. Front. Psychol. 2021; 12:637776Korlat S, Kollmayer M, Holzer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868109 27. How E-Learning Environmental Stimuli Influence Determinates of Learning Engagement in the Context of COVID-19? SOR Model Perspective. Front. Psychol. 2021; 12:584976Yang J, Peng MY, Wong S, Chong W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868072 28. A Glimpse of the First Eight Months of the COVID-19 Literature on Microsoft Academic Graph: Themes, Citation Contexts, and Uncertainties. Front Res Metr Anal 2020; 5:607286Chen C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870064 29. Youth Networks' Advances Toward the Sustainable Development Goals During the COVID-19 Pandemic. Front Sociol 2020; 5:589539Barber K, Mostajo-Radji MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869518 30. Influences of digital media use on children and adolescents with ADHD during COVID-19 pandemic. Global Health 2021; 17:48Shuai L, He S, Zheng H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874977 31. Contact tracing apps for the COVID-19 pandemic: a systematic literature review of challenges and future directions for neo-liberal societies. Health Inf Sci Syst 2021; 9:18Akinbi A, Forshaw M, Blinkhorn V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868671 32. Cyberbullying, social stigma, and self-esteem: the impact of COVID-19 on students from East and Southeast Asia at the University of Jordan. Heliyon 2021; 7:e06711Alsawalqa RO. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869877 33. The role of nanotechnology in current COVID-19 outbreak. Heliyon 2021; 7:e06841Tavakol S, Zahmatkeshan M, Mohammadinejad R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880422 34. CRISPR/Cas-New Molecular Scissors in Diagnostics and Therapeutics of COVID-19. Indian J. Clin. Biochem. 2021:1-9Gadwal A, Roy D, Khokhar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879980 35. Contribution of machine learning approaches in response to SARS-CoV-2 infection. Inform Med Unlocked 2021; 23:100526Mottaqi MS, Mohammadipanah F, Sajedi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869730 36. Web-based Medical Education During COVID-19 Lockdown: A Step Back or a Leap to the Future? Int. J. Low. Extrem. Wounds 2021:15347346211011848Eleftheriou A, Rokou A, Argyriou C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890811 37. Emergency upscaling of video consultation during the COVID-19 pandemic: Contrasting user experience with data insights from the electronic health record in a large academic hospital. Int. J. Med. Inform. 2021; 150:104463Barsom EZ, Meijer HAW, Blom J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872824 38. Information seeking behavior and COVID-19 pandemic: A snapshot of young, middle aged and senior individuals in Greece. Int. J. Med. Inform. 2021; 150:104465Skarpa PE, Garoufallou E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887589 39. Comparing telehealth with office-based visits for common pediatric otolaryngology complaints. Int J Pediatr Otorhinolaryngol 2021; 145:110712Kolb CM, Born K, Banker K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887549 40. COVID-19 in the Age of Artificial Intelligence: A Comprehensive Review. Interdiscip Sci 2021:1-23Rasheed J, Jamil A, Hameed AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886097 41. Mental health services in primary care: Evidence for the feasibility of telehealth during the COVID-19 pandemic. J Affect Disord Rep 2021; 5:100146Frank HE, Grumbach NM, Conrad SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870261 42. Mental health services in primary care: Evidence for the feasibility of telehealth during the COVID-19 pandemic. J Affect Disord Rep 2021; 5:100146Frank HE, Grumbach NM, Conrad SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870261 43. Impact of Rapid Transition to Telemedicine-Based Delivery on Allergy/Immunology Care during COVID-19. J Allergy Clin Immunol Pract 2021; Tsao LR, Villanueva SA, Pines DA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894393 44. From the Cochrane Library: Teledermatology for Diagnosing Skin Cancer in Adults. J Am Acad Dermatol 2021; Sivesind TE, Szeto MD, Matin RN, Dellavalle RP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894319 45. Telemental health policies for college students during COVID-19. J. Am. Coll. Health 2021:1-5Huilgol YS, Torous J, Gold JA, Goldman ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891526 46. A fusion of data science and feed-forward neural network-based modelling of COVID-19 outbreak forecasting in IRAQ. J. Biomed. Inform. 2021; 118:103766Aljaaf AJ, Mohsin TM, Al-Jumeily D, Alloghani M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895377 47. Building An OMOP Common Data Model-Compliant Annotated Corpus for COVID-19 Clinical Trials. J. Biomed. Inform. 2021:103790Sun Y, Butler A, Stewart LA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887457 48. Reimagining the pipeline: Saturday Academy at New York University College of Dentistry goes virtual. J. Dent. Educ. 2021; Burns LE, Pezzullo C, Dief S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893653 49. Digital Inclusion of Older Adults during COVID-19: Lessons from a Case Study of Older Adults Technology Services (OATS). J Gerontol Soc Work 2021:1- 13Weil J, Kamber T, Glazebrook A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882782 50. Evaluation of an Intrahospital Telemedicine Program for Patients Admitted With COVID-19: Mixed Methods Study. J Med Internet Res 2021; 23:e25987Legler S, Diehl M, Hilliard B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872187 51. Development and Utilization of a Medical Student Surgery Podcast During COVID-19. J. Surg. Res. 2021; 265:95-99Anteby R, Amiel I, Cordoba M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894454 52. Conducting Internet-Based Visits for Onboarding Populations With Limited Digital Literacy to an mHealth Intervention: Development of a Patient-Centered Approach. JMIR Form Res 2021; 5:e25299Hernandez-Ramos R, Aguilera A, Garcia F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872184 53. Mobile Sensing Apps and Self-management of Mental Health During the COVID-19 Pandemic: Web-Based Survey. JMIR Form Res 2021; 5:e24180Suruliraj B, Bessenyei K, Bagnell A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872181 54. Teaching Telemedicine: The Next Frontier for Medical Educators. JMIR Med Educ 2021; 7:e29099Alcocer Alkureishi M, Lenti G, Choo ZY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878011 55. One Year of Pandemic Learning Response: Benefits of Massive Online Delivery of the World Health Organization's Technical Guidance. JMIR Public Health Surveill 2021; 7:e28945Utunen H, Van Kerkhove MD, Tokar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881404 56. Digital innovation in medicine: the COVID-19 pandemic as an accelerator of “digital health”. Journal fur Urologie und Urogynakologie 2021; 28Mumm JN, Rodler S, Mumm ML et al. 57. Curricular response to COVID-19: real-time interactive telehealth experience (RITE) program. Med. Educ. Online 2021; 26:1918609Safdieh JE, Lee JI, Prasad L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886434 58. Telemedicine review in neuro-oncology: comparative experiential analysis for Barrow Neurological Institute and Geisinger Health during the 2020 COVID-19 pandemic. Neurooncol Pract 2021; 8:109-116Fonkem E, Gatson NTN, Tadipatri R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889416 59. Uptake of telehealth in Parkinson's disease clinical care and research during the COVID-19 pandemic. Parkinsonism Relat. Disord. 2021; 86:97-100Shivkumar V, Subramanian T, Agarwal P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895540 60. It's a conspiracy: Covid-19 conspiracies link to psychopathy, Machiavellianism and collective narcissism. Pers. Individ. Dif. 2021; 171:110559Hughes S, Machan L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867616 61. Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients. Proc Natl Acad Sci U S A 2021; 118Ni X, Ouyang W, Jeong H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893178 62. Using social media data to assess the impact of COVID-19 on mental health in China. Psychol. Med. 2021:1-8Zhu Y, Cao L, Xie J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875036 63. Experience, experts, statistics, or just science? Predictors and consequences of reliance on different evidence types during the COVID-19 infodemic. Public Underst Sci 2021:9636625211009685Lu H, Chu H, Ma Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892612 64. Feasibility of tele-rehabilitation in survivors of COVID-19 pneumonia. Pulmonology 2021; Paneroni M, Vitacca M, Bernocchi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893061 65. Creative social media use for Covid-19 prevention in Bangladesh: a structural equation modeling approach. Soc Netw Anal Min 2021; 11:38Islam MM, Islam MM, Ahmed F, Rumana AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868509 66. The Content and Accessibility of Spine Surgery Fellowship Websites and the North American Spine Surgery (NASS) Fellowship Directory. Spine J 2021; Gerlach EB, Plantz MA, Swiatek PR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895376 67. Organizational and External Factors Associated with Video Telehealth Use in the Veterans Health Administration Before and During the COVID-19 Pandemic. Telemed J E Health 2021; Jacobs J, Ferguson JM, Van Campen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887166 68. Implementation and Monitoring of a Telemedicine Model in Acromegalic Outpatients in a Low-Income Country During the COVID-19 Pandemic. Telemed J E Health 2021; Naves LA, Rosa IN, Lima TAS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877890 69. [Annual meeting of the German Society for Rheumatology going virtual- successfully defying the pandemic]. Z. Rheumatol. 2021:1-7Richter JG, Chehab G, Knitza J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877456

Other – Miscellaneous (105 articles)

1. Ambient temperature and COVID-19 outcomes. Adv Respir Med 2021; Madan M, Pahuja S, Tyagi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881162 2. Convicted drinking and driving offenders: Comparing alcohol use before and after the pandemic outbreak. Alcohol. Clin. Exp. Res. 2021; Manning AR, Romano E, Diebold J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871077 3. New Year. Anasthesiologie und Intensivmedizin 2021; 62:2Geldner G. 4. Crowd management COVID-19. Annu Rev Control 2021; Polanco LD, Siller M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867812 5. Reciprocal Trust as an Ethical Response to the COVID-19 Pandemic. Asian Bioeth Rev 2021:1-20Chan HY. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875921 6. COVID-19: challenges faced by Nepalese migrants living in Japan. BMC Public Health 2021; 21:752Bhandari D, Kotera Y, Ozaki A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874937 7. Lifestyle habits of adults during the COVID-19 pandemic lockdown in Cyprus: evidence from a cross-sectional study. BMC Public Health 2021; 21:786Kolokotroni O, Mosquera MC, Quattrocchi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892688 8. Impact of COVID-19 on household food insecurity and interlinkages with child feeding practices and coping strategies in Uttar Pradesh, India: a longitudinal community-based study. BMJ Open 2021; 11:e048738Nguyen PH, Kachwaha S, Pant A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883156 9. Impact of COVID-19 on Migrants' Access to Primary Care and Implications for Vaccine Roll Out: A National Qualitative Study. Br. J. Gen. Pract. 2021; Knights F, Carter J, Deal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875420 10. COVID-19, Seignorage, Quantitative Easing and the Fiscal-Monetary Nexus. Comp Econ Stud 2021:1-19Cukierman A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33867661 11. Safe Distance-Based Vehicle Routing Problem: Medical Waste Collection Case Study in COVID-19 Pandemic. Comput Ind Eng 2021:107328Eren E, Rıfat Tuzkaya U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879956 12. Letter to the editor regarding article: Impact of COVID-19 outbreak on lifestyle behaviour: A review of studies published in India (Rawat et al.). Diabetes Metab Syndr 2021; Mirzaei F, Tavilani A, Abbasi-Oshaghi E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895088 13. The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects. Drug Discov Today 2021; Qiu T, Wang Y, Liang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892148 14. Infectious disease, the climate, and the future. Environ Epidemiol 2021; 5:e133Tong S, Ebi K, Olsen J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870009 15. Effect of large-scale social restriction (PSBB) during COVID-19 on outdoor air quality: Evidence from five cities in DKI Jakarta Province, Indonesia. Environ. Res. 2021; 197:111164Anugerah AR, Muttaqin PS, Purnama DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872645 16. The impact of COVID-19 lockdown on atmospheric CO(2) in Xi'an, China. Environ. Res. 2021; 197:111208Wu S, Zhou W, Xiong X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895110 17. Characterization of littered face masks in the southeastern part of Turkey. Environ. Sci. Pollut. Res. Int. 2021:1-11Akarsu C, Madenli Ö, Deveci E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895953 18. COVID-19 and municipal solid waste (MSW) management: a review. Environ. Sci. Pollut. Res. Int. 2021:1-16Das AK, Islam MN, Billah MM, Sarker A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877522 19. Effect of COVID-19 lockdown on noise pollution levels in an Indian city: a case study of Kanpur. Environ. Sci. Pollut. Res. Int. 2021:1-13Mishra A, Das S, Singh D, Maurya AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884552 20. Threshold effects of COVID-19-confirmed cases on change in pollutants changes: evidence from the Chinese top ten cities. Environ. Sci. Pollut. Res. Int. 2021:1-9Wang Q, Wang X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876371 21. Ethical challenges of nurses related covid-19 pandemic in inpatient wards: an integrative review. Ethics Med Public Health 2021:100669Firouzkouhi M, Alimohammadi N, Kako M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869710 22. Estimating Employment Gains of the Proposed Infrastructure Stimulus Plan in Post-Covid-19 South Africa. Eur J Dev Res 2021:1-28Habiyaremye A, Molewa O, Lekomanyane P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879979 23. Ethical Challenges Related to the Novel Coronavirus (COVID-19) Outbreak: Interviews With Professionals From Saudi Arabia. Front Med (Lausanne) 2021; 8:620444Alahmad G, Richi H, BaniMustafa A, Almutairi AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869243 24. The Impact of COVID-19 Pandemic and Lockdown on Alcohol Consumption: A Perspective From Hair Analysis. Front Psychiatry 2021; 12:632519Alladio E, Visintin L, Lombardo T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889098 25. Heterogeneity in Risk-Taking During the COVID-19 Pandemic: Evidence From the UK Lockdown. Front. Psychol. 2021; 12:643653Guenther B, Galizzi MM, Sanders JG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868115 26. Dual Careers of Athletes During COVID-19 Lockdown. Front. Psychol. 2021; 12:657671Izzicupo P, Di Baldassarre A, Abelkalns I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868131 27. Save for Safe: Effect of COVID-19 Pandemic on Consumers' Saving and Spending Behavior in China. Front. Psychol. 2021; 12:636859Jin X, Zhao Y, Song W, Zhao T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868106 28. Warning Messages in Crisis Communication: Risk Appraisal and Warning Compliance in Severe Weather, Violent Acts, and the COVID-19 Pandemic. Front. Psychol. 2021; 12:557178Rahn M, Tomczyk S, Schopp N, Schmidt S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868065 29. Not All in the Same Boat. Socioeconomic Differences in Marital Stress and Satisfaction During the Covid-19 Pandemic. Front. Psychol. 2021; 12:635148Turliuc MN, Candel OS. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868101 30. From Normal to Viral Body: Death Rituals During Ordinary and Extraordinary Covidian Times in Pakistan. Front Sociol 2020; 5:619913Ali I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869536 31. Predicting the Patriarchal Politics of Pandemics From Mary Shelley to COVID- 19. Front Sociol 2021; 6:624909Botting EH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869576 32. War Metaphors in Political Communication on Covid-19. Front Sociol 2020; 5:583680Castro Seixas E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869509 33. The Articulation of the Indigenous Peoples of Brazil in Facing the Covid-19 Pandemic. Front Sociol 2021; 6:611336da Silva LL, Nascimento PE, Araújo OCG, Pereira TMG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869556 34. Credibility Contests: Media Debates on Do-It-Yourself Coronavirus Responses and the Role of Citizens in Health Crises. Front Sociol 2020; 5:592666Erikainen S, Stewart E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869520 35. Status Construction During COVID-19: Antibody Positive People's Rising Prestige. Front Sociol 2020; 5:576827Evans MDR, Kelley J, Kelley S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869503 36. Covid-19 as a Social Crisis and Justice Challenge for Cities. Front Sociol 2020; 5:583638Haase A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869508 37. Case Report: Indigenous Sovereignty in a Pandemic: Tribal Codes in the United States as Preparedness. Front Sociol 2021; 6:617995Hiraldo D, James K, Carroll SR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869571 38. COVID-19 Pandemic Management Strategies and Outcomes in East Asia and the Western World: The Scientific State, Democratic Ideology, and Social Behavior. Front Sociol 2020; 5:575588Ho HK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869501 39. Covid-19 Response From Global Makers: The Careables Cases of Global Design and Local Production. Front Sociol 2021; 6:629587Kieslinger B, Schaefer T, Fabian CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869577 40. Unequal and Invisible: A Feminist Political Economy Approach to Valuing Women's Care Labor in the COVID-19 Response. Front Sociol 2020; 5:588279Lokot M, Bhatia A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869516 41. The Juggernaut of Modernity Collapses. The Crisis of Social Planification in the Post COVID-19 era. Front Sociol 2020; 5:611885Lusardi R, Tomelleri S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869527 42. The Covid-19 Pandemics: why Intersectionality Matters. Front Sociol 2021; 6:642662Maestripieri L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869589 43. COVID-19: Technology, Social Connections, Loneliness, and Leisure Activities: An International Study Protocol. Front Sociol 2020; 5:574811Marston HR, Ivan L, Fernández-Ardèvol M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869500 44. Our Collective Needs and Strengths: Urban AI/ANs and the COVID-19 Pandemic. Front Sociol 2021; 6:611775Maudrie TL, Lessard KH, Dickerson J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869561 45. Development and Dissemination of a Strengths-Based Indigenous Children's Storybook: "Our Smallest Warriors, Our Strongest Medicine: Overcoming COVID-19". Front Sociol 2021; 6:611356O'Keefe VM, Maudrie TL, Ingalls A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869558 46. Creativity, Resilience and Resistance: Black Birthworkers' Responses to the COVID-19 Pandemic. Front Sociol 2021; 6:636029Oparah JC, James JE, Barnett D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869584 47. "Soldiers of the System": Maternity Care in Russia Between Bureaucratic Instructions and the Epidemiological Risks of COVID-19. Front Sociol 2021; 6:611374Ozhiganova A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869559 48. Disinformation and Conspiracy Theories in the Age of COVID-19. Front Sociol 2020; 5:560681Pereira PS, Silveira ADS, Pereira A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869496 49. Socio-Economic Implications of COVID-19 Pandemic in South Asia: Emerging Risks and Growing Challenges. Front Sociol 2021; 6:629693Rasul G, Nepal AK, Hussain A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869579 50. Born in Captivity: The Experiences of Puerto Rican Birth Workers and Their Clients in Quarantine. Front Sociol 2021; 6:613831Reyes E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869565 51. What Makes Young People Think Positively About Social Distancing During the Corona Crisis in Germany? Front Sociol 2020; 5:61Rieger MO. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869467 52. Transitions in Black and Latinx Community-Based Doula Work in the US During COVID-19. Front Sociol 2021; 6:611350Rivera M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869557 53. Pregnancy During the Global COVID-19 Pandemic: Canadian Experiences of Care. Front Sociol 2021; 6:611324Rudrum S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869555 54. On the Outside Looking In: A Global Doula Response to COVID-19. Front Sociol 2021; 6:613978Searcy JJ, Castañeda AN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869566 55. Impact of the COVID-19 Pandemic on Loneliness Among Older Adults. Front Sociol 2020; 5:590935Seifert A, Hassler B. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869519 56. The Covid-19 Emergency and the Risk of Social Fragmentation in the Palermo Case. Front Sociol 2020; 5:624160Siino AR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869539 57. Tino Rangatiratanga and Well-being: Māori Self Determination in the Face of Covid-19. Front Sociol 2021; 6:613340Te One A, Clifford C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869564 58. The Italian Deaf Community at the Time of Coronavirus. Front Sociol 2020; 5:612559Tomasuolo E, Gulli T, Volterra V, Fontana S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869529 59. Covid-19 Requires a Social Medicine Response. Front Sociol 2020; 5:579991Trout LJ, Kleinman A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869507 60. COVID-19 in New Mexico Tribal Lands: Understanding the Role of Social Vulnerabilities and Historical Racisms. Front Sociol 2020; 5:610355Yellow Horse AJ, Deschine Parkhurst NA, Huyser KR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869526 61. Social policy as an integral component of pandemic response: Learning from COVID-19 in Brazil, Germany, India and the United States. Glob Public Health 2021:1-14Greer SL, Jarman H, Falkenbach M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876715 62. Youth and the COVID-19 crisis: Lessons learned from a human rights-based prevention programme for youths in São Paulo, Brazil. Glob Public Health 2021:1-14Paiva V, Garcia MRV, França-Jr I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870865 63. Addressing COVID-19 vulnerabilities: How do we achieve global health security in an inequitable world. Glob Public Health 2021:1-11Šehović AB, Govender K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870859 64. Unmet health care need and income-Related horizontal equity in use of health care during the COVID-19 pandemic. Health Econ. 2021; Davillas A, Jones AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890334 65. The role of parliamentarians in promoting self-care interventions for sexual and reproductive health and rights: applying COVID-19 lens in the Eastern Mediterranean region. Health Res. Policy Syst. 2021; 19:45Abou-Taleb H, Mohamed N, Gholbzouri K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33882960 66. Colliding worlds: Family carers' experiences of balancing work and care in Ireland during the COVID-19 pandemic. Health Soc Care Community 2021; Lafferty A, Phillips D, Dowling-Hertherington L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891356 67. Food insecurity associated with elevated eating disorder symptoms, impairment, and eating disorder diagnoses in an American University student sample before and during the beginning of the COVID-19 pandemic. Int. J. Eat. Disord. 2021; Christensen KA, Forbush KT, Richson BN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885180 68. Coronavirus Legislation and Obligations of Lessee in Jordan: Some Preliminary Reflections/Considerations. Int J Semiot Law 2021:1-7El-Haija MIA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867695 69. Nurses' stories from Beirut: The 2020 explosive disaster on top of a pandemic and economic crises. Int Nurs Rev 2021; 68:1-8Jabbour R, Harakeh M, Dakessian Sailan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891770 70. 'Code-95' rapid response calls for patients under airborne precautions in the COVID-19-era: a cross-sectional survey of healthcare worker perceptions. Intern. Med. J. 2021; 51:494-505Subramaniam A, Zuberav A, Wengritzky R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890372 71. COVID-19 Global Humanitarian Response Plan: An optimal distribution model for high-priority countries. ISA Trans. 2021; Hezam IM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867131 72. "Trying My Best": Sexual Minority Adolescents' Self-Care During the COVID-19 Pandemic. J. Adolesc. Health 2021; O'Brien RP, Parra LA, Cederbaum JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875330 73. Changes in the Health of Adolescent Athletes: A Comparison of Health Measures Collected Before and During the CoVID-19 Pandemic. J Athl Train 2021; McGuine TA, Biese K, Hetzel SJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887766 74. Beyond political affiliation: an examination of the relationships between social factors and perceptions of and responses to COVID-19. J. Behav. Med. 2021:1- 12Franz B, Dhanani LY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877532 75. Habitat loss and the risk of disease outbreak. J. Environ. Econ. Manage. 2021; 108:102451Barbier EB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867599 76. Identification of behaviour patterns in waste collection and disposal during the first wave of COVID-19 in Regina, Saskatchewan, Canada. J. Environ. Manage. 2021; 290:112663Richter A, Ng KTW, Vu HL, Kabir G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887640 77. Unequal impact of the COVID-19 crisis on minority ethnic groups: a framework for understanding and addressing inequalities. J. Epidemiol. Community Health 2021; Katikireddi SV, Lal S, Carrol ED et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883198 78. Exploring the Impact of COVID-19 Pandemic on Economic Activities and Well- being of Older Adults in South-eastern Nigeria: Lessons for Gerontological Social Workers. J Gerontol Soc Work 2021:1-16Agbawodikeizu PU, Ezulike CD, Ekoh PC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882781 79. COVID-19 Blind Spots: A Consensus Statement on the Importance of Competent Political Leadership and the Need for Public Health Cognizance. J. Glob. Infect. Dis. 2020; 12:167-190Papadimos TJ, Soghoian SE, Nanayakkara P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888955 80. The Economic Impact of COVID-19 Treatment at a Hospital-level: Investment and Financial Registers of Brazilian Hospitals. J Health Econ Outcomes Res 2021; 8:36-41Beck da Silva Etges AP, Bertoglio Cardoso R, Marcolino MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889651 81. Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of- illness analysis. J Hosp Infect 2021; Maltezou HC, Giannouchos TV, Pavli A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894306 82. Virtual Seminar on Coronavirus 2019 for the US-Mexico Border Region: Building Opportunities for Communication and Collaboration. J Immigr Minor Health 2021:1-4Aceves B, Lopez-Galvez N, Rangel G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881680 83. Attitude and practices of parents toward their children's oral health care during COVID-19 pandemic. J. Indian Soc. Pedod. Prev. Dent. 2021; 39:22- 28Goswami M, Grewal M, Garg A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33885383 84. "It's ok, mom. I got it!": Exploring the experiences of young adults with intellectual disabilities in a postsecondary program affected by the COVID-19 pandemic from their perspective and their families' perspective. J Intellect Disabil 2021:17446295211002346Spencer P, Van Haneghan JP, Baxter A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878973 85. Accommodating workers with disabilities in the post-Covid world. J. Occup. Environ. Hyg. 2021:1-8McNamara KA, Stanch PM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891510 86. Indigenous data sovereignty and COVID-19 data issues for American Indian and Alaska Native Tribes and populations. J Popul Res (Canberra) 2021:1- 5Yellow Horse AJ, Huyser KR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33867817 87. Assessing Attitudes Toward COVID-19 Prevention: Defining Two Attitudes Crucial for Understanding Systemic and Social Variables Associated with Disparities. J Racial Ethn Health Disparities 2021:1-10Rivers AS, Clifton M, Pizzuto AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876408 88. Learning to Interpret Pediatric Vocal Fold Mobility: A Laryngeal Ultrasound Training Module. Laryngoscope 2021; Alexander NL, Tran B, Zhu H, Ongkasuwan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890677 89. [COVID-19 and Its Environment: From a History of Human Medicine Towards an Ecological History of Medicine?]. Ntm 2021:1-9Diener L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871662 90. Which lives are worth saving? Biolegitimacy and harm reduction during COVID-19. Nurs. Inq. 2021:e12417Larocque C, Foth T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886134 91. Understanding effective nurse leadership styles during the COVID-19 pandemic. Nurs. Stand. 2021; Harrington A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33884778 92. The risk perception of COVID-19 and practice of precautionary measures amongst healthcare workers in the National Health Insurance Scheme Clinic of a tertiary hospital in Nigeria. Pan Afr. Med. J. 2021; 38:73Enabulele O, Esther A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889239 93. Assessment of activities of daily living in patients post COVID-19: a systematic review. PeerJ 2021; 9:e11026Pizarro-Pennarolli C, Sánchez-Rojas C, Torres-Castro R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868804 94. Why Should Natural Principles Be Simple? Philosophia (Ramat Gan) 2021:1- 15Tozzi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879931 95. Ambient air pollution and cardiovascular disease: learnt from the COVID-19 pandemic. Postgrad. Med. 2021; Ejaz A, Malik AO, Lopez-Candales A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888043 96. A qualitative study exploring older smokers' attitudes and motivation toward quitting during the COVID-19 pandemic. Prev Med Rep 2021; 22:101359Cordon M, Eyestone E, Hutchison S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868901 97. Level of Community Readiness for the Prevention of COVID-19 Pandemic and Associated Factors Among Residents of Awi Zone, Ethiopia: A Community- Based Cross-Sectional Study. Risk Manag. Healthc. Policy 2021; 14:1509- 1524Adane D, Yeshaneh A, Wassihun B, Gasheneit A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883957 98. Epistemic and Political Confrontations Around the Public Policies to Fight COVID-19 Pandemic. Sci Educ (Dordr) 2021:1-25Moura CB, Nascimento MM, Lima NW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879974 99. Evaluating the presence of SARS-CoV-2 RNA in the particulate matters during the peak of COVID-19 in Padua, northern Italy. Sci Total Environ 2021; 784:147129Pivato A, Amoruso I, Formenton G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894607 100. The Content and Accessibility of Spine Surgery Fellowship Websites and the North American Spine Surgery (NASS) Fellowship Directory. Spine J 2021; Gerlach EB, Plantz MA, Swiatek PR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895376 101. Still ignored and still invisible: the situation of displaced people and people affected by disasters in the COVID-19 pandemic. Sustain Sci 2021:1-4Abeldaño Zuñiga RA, González Villoria AM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868495 102. Impact of lockdown due to COVID-19 pandemic on groundwater salinity in Punjab, India: some hydrogeoethics issues. Sustain Water Resour Manag 2021; 7:27Krishan G, Sudarsan N, Sidhu BS, Vashisth R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869731 103. Industry update covering January 2021. Ther. Deliv. 2021; Simpson I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876655 104. Effect of the COVID-19 pandemic on health insurance coverage among trauma patients: a study of six level I trauma centers. Trauma Surg Acute Care Open 2021; 6:e000640Sercy E, Duane TM, Lieser M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884306 105. SARS-CoV-2: Cross-scale Insights from Ecology and Evolution. Trends Microbiol. 2021; Snedden CE, Makanani SK, Schwartz ST et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893024 106. Personal health data in times of a pandemic—legal and ethical aspects. Wien. Med. Wochenschr. 2021; 171:9-15Schmidhuber M, Stöger K.

Pathology (5 articles)

1. Using Dynamic Virtual Microscopy to Train Pathology Residents During the Pandemic: Perspectives on Pathology Education in the Age of COVID-19. Acad Pathol 2021; 8:23742895211006819Christian RJ, VanSandt M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884292 2. A Framework for Maintaining a Fully Operational Autopsy Service at a Large Academic Teaching Institution During a Global Pandemic. Acad Pathol 2021; 8:23742895211006821Fu L, Zak T, Shanes E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884293 3. Systematic Review of Microthrombi in COVID-19 Autopsies. Acta Haematol. 2021:1-8Parra-Medina R, Herrera S, Mejia J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33873184 4. Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review. Front. Pharmacol. 2021; 12:614586Mondello C, Roccuzzo S, Malfa O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867981 5. Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Leg. Med. (Tokyo) 2021; 51:101895Edler C, Klein A, Schröder AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895650

Protection (20 articles)

1. Skin Reactions to Personal Protective Equipment among First-Line COVID-19 Healthcare Workers: A Survey in Northern Morocco. Ann Work Expo Health 2021; Marraha F, Al Faker I, Charif F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33876214 2. Mitigation of Aerosols Generated during Exercise Testing with a Portable High-Efficiency Particulate Air (HEPA) Filter with Fume Hood. Chest 2021; Garzona-Navas A, Sajgalik P, Ibolya C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895130 3. Dental team and infection control for the COVID-19: (A short review of the current guidelines). Dent. Res. J. (Isfahan) 2020; 17:409-411Torabinia N, Nilchian F, Razavi SM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889344 4. Simple quantitative assessment of the outdoor versus indoor airborne transmission of viruses and COVID-19. Environ. Res. 2021:111189Rowe BR, Canosa A, Drouffe JM, Mitchell JBA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872644 5. Characterization of littered face masks in the southeastern part of Turkey. Environ. Sci. Pollut. Res. Int. 2021:1-11Akarsu C, Madenli Ö, Deveci E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895953 6. Elective open "Shield Tracheostomy" in patients with COVID-19. Eur Arch Otorhinolaryngol 2021:1-7Šifrer R, Benedik J, Aničin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881578 7. Covid-19: a call for mobilizing geriatric expertise. Eur. Geriatr. Med. 2021:1- 4O'Hanlon S, Dhesi J, Aronson L, Inouye SK. http://www.ncbi.nlm.nih.gov/pubmed/? term=33891278 8. Position paper of the Association for Aerosol Research on the occurrence of SARS-CoV-2 infection. Gefahrstoffe Reinhaltung der Luft 2021; 81:60Asbach C. 9. Effective design of barrier enclosure to contain aerosol emissions from COVID-19 patients. Indoor Air 2021; Daniel D, Lin M, Luhung I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876847 10. Monitoring social distancing through human detection for preventing/reducing COVID spread. Int J Inf Technol 2021:1-10Ansari MA, Singh DK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870073 11. Pyrolysis kinetic behaviour and TG-FTIR-GC-MS analysis of Coronavirus Face Masks. J Anal Appl Pyrolysis 2021; 156:105118Yousef S, Eimontas J, Striūgas N, Abdelnaby MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875899 12. COVID-19 transmission in Hong Kong despite universal masking. J Infect 2021; Martín-Sánchez M, Lim WW, Yeung A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895227 13. Suction mask device: a simple, inexpensive, and effective method of reducing spread of aerosolized particles during endoscopic endonasal surgery in the era of COVID-19. J. Neurosurg. 2021:1-7Hara T, Zachariah MA, Li R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892478 14. COVID-19 related pressure injuries in patients and personnel: A systematic review. J Tissue Viability 2021; Yu JN, Wu BB, Feng LP, Chen HL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895045 15. Protection against COVID-19: How effective are face masks? Monatsschr. Kinderheilkd. 2021; Kerbl R. 16. COVID-19 Mitigation With Appropriate Safety Measures in an Essential Workplace: Lessons for Opening Work Settings in the United States During COVID-19. Open Forum Infect Dis 2021; 8:ofab086Haigh KZ, Gandhi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880391 17. Pandemic Risk Management using Engineering Safety Principles. Process Saf Environ Prot 2021; Alauddin M, Khan F, Imtiaz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879978 18. Prevention and control measures of the coronavirus disease 2019 (COVID-19) in low-risk departments: The spine surgery department example. Sci. Prog. 2021; 104:368504211009670Zheng Y, Zhang X, Fang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878962 19. Perceptions of healthcare workers in high-risk areas of a Singapore hospital during COVID-19: a cross-sectional study. Singapore Med J 2021; Au-Yong PA, Peh WM, Koh FH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866717 20. SARS-CoV-2, surgeons and surgical masks. World J Clin Cases 2021; 9:2170- 2180Khalil MI, Banik GR, Mansoor S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869593

Pulmonary disease (13 articles)

1. GOLD 2021 guidelines for COPD - what's new and why. Adv Respir Med 2021; Gupta N, Malhotra N, Ish P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881161 2. Dysregulation of ion transport in the lung epithelium infected with SARS-CoV- 2. Am J Physiol Lung Cell Mol Physiol 2021; Dada LA, Vagin O, Sznajder JI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881360 3. Pneumatocele after recovering from COVID-19. BMJ Case Rep. 2021; 14Sugimoto H, Era Y, Sugimoto K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875514 4. Pulmonary Fibrosis After COVID-19 Pneumonia. Cureus 2021; 13:e13923Malik B, Abdelazeem B, Ghatol A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868858 5. What good came out of the Covid-19 outbreak for workers with occupational asthma? Expert Rev. Respir. Med. 2021:1-3Burge S, Moore VC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866901 6. Inhalation dosimetry of nasally inhaled respiratory aerosols in the human respiratory tract with locally remodeled conducting lungs. Inhal. Toxicol. 2021:1-17Si XA, Talaat M, Su WC, Xi J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870835 7. Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis. J. Asthma 2021:1-13Martínez Rivera C, Crespo-Lessman A, Arismendi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882776 8. Rehabilitation of Patients with Platypnea-Orthodeoxia Syndrome in COVID-19 Pneumonia: Two Case Reports. J Rehabil Med Clin Commun 2020; 3:1000044Tham SL, Ong PL, Lee AJY, Tay MRJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884145 9. Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic. Respir Investig 2021; Shibata Y, Muro S, Yokoyama A, Hashimoto S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893068 10. Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation. Respir. Med. 2021; 182:106401Maniscalco M, Ambrosino P, Fuschillo S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33873099 11. Validity of the 6-Minute Walk Test in Patients with End-Stage Lung Diseases Wearing an Oronasal Surgical Mask in Times of the COVID-19 Pandemic. Respiration 2021:1-6Just IA, Schoenrath F, Passinger P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878758 12. Post COVID-19 MSSA pneumonia. SAGE Open Med Case Rep 2021; 9:2050313x211005996Chaudhry B, Alekseyev K, Didenko L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889412 13. Pleural complications of Covid-19 pneumonia. Turk J Med Sci 2021; Şatir Türk M, Akarsu I, Tombul I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890447

Renal disease (13 articles)

1. Dialysis circuit clotting in critically ill patients with COVID-19 infection. BMC Nephrol. 2021; 22:141Khoo BZE, Lim RS, See YP, Yeo SC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879086 2. Cardiorenal syndrome in COVID-19. BMJ Case Rep. 2021; 14Ali UA, Sadiq MS, Yunus MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893131 3. Kidney disease and COVID-19 disease severity-systematic review and meta- analysis. Clin. Exp. Med. 2021:1-11Singh J, Malik P, Patel N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891214 4. The Association of Acute Kidney Injury With Disease Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Cureus 2021; 13:e13894Menon T, Sharma R, Kataria S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880250 5. Continuous renal replacement therapy in intensive care patients with COVID- 19; survival and renal recovery. J Crit Care 2021; 64:125-130Eriksson KE, Campoccia-Jalde F, Rysz S, Rimes-Stigare C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878517 6. Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. J Infect 2021; Li KK, Woo YM, Stirrup O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895226 7. Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment. J Infect Chemother 2021; Yoshinaga K, Araki M, Wada K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893036 8. SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population. Kidney Int 2021; Anft M, Blazquez-Navarro A, Paniskaki K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887319 9. Low immunization rates among kidney transplant recipients who received two doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 2021; Benotmane I, Gautier-Vargas G, Cognard N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887315 10. Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA Covid-19 vaccine. The war is far from being won. Kidney Int 2021; Torreggiani M, Blanchi S, Fois A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887320 11. Experience with SARS-COV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int 2021; Yanay NB, Freiman S, Shapira M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887318 12. A patient with end-stage renal disease who recovered from coronavirus disease 2019 then received a kidney transplant. Transpl. Immunol. 2021:101395Wang T, Qiu T, Wang M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33895261 13. Recovery of kidney function after AKI due to COVID-19 in kidney transplant recipients. Transpl Int 2021; Bajpai D, Deb S, Bose S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884672

Reviews (23 articles)

1. An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review. Acta Haematol. 2021:1-5Kornowski Cohen M, Sheena L, Shafir Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895748 2. Systematic Review of Microthrombi in COVID-19 Autopsies. Acta Haematol. 2021:1-8Parra-Medina R, Herrera S, Mejia J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33873184 3. Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs. Appl. Microbiol. Biotechnol. 2021:1-14Ashaolu TJ, Nawaz A, Walayat N, Khalifa I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876282 4. Artificial intelligence (AI) for medical imaging to combat coronavirus disease (COVID-19): a detailed review with direction for future research. Artif Intell Rev 2021:1-31Soomro TA, Zheng L, Afifi AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875900 5. Misleading clinical evidence and systematic reviews on ivermectin for COVID- 19. BMJ Evid Based Med 2021; Garegnani LI, Madrid E, Meza N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888547 6. Trends in Coronavirus Disease 2019 Hospitalization and Prognosis: Gender Effect. Curr Med Sci 2021; 41:312-317Shi MJ, Lv JG, Lin L, Guo JY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877547 7. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review. Curr. Pharm. Biotechnol. 2021; Agrawal N, Goyal A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882805 8. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Front. Endocrinol. (Lausanne) 2021; 12:609470Corrao S, Pinelli K, Vacca M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868163 9. Genetics Insight for COVID-19 Susceptibility and Severity: A Review. Front. Immunol. 2021; 12:622176Fricke-Galindo I, Falfán-Valencia R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868239 10. Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review. Front. Pharmacol. 2021; 12:614586Mondello C, Roccuzzo S, Malfa O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867981 11. COVID-19: a basic approach to understanding potential treatments. Gac Med Mex 2020; 156:570-575Cedillo-Alvarez C, Gallardo-Ortiz IA, López LT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877122 12. Contact tracing apps for the COVID-19 pandemic: a systematic literature review of challenges and future directions for neo-liberal societies. Health Inf Sci Syst 2021; 9:18Akinbi A, Forshaw M, Blinkhorn V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868671 13. Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study. Infect Dis Poverty 2021; 10:53Lin SN, Rui J, Chen QP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874998 14. COVID-19 in the Age of Artificial Intelligence: A Comprehensive Review. Interdiscip Sci 2021:1-23Rasheed J, Jamil A, Hameed AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886097 15. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature. Ital. J. Pediatr. 2021; 47:95Medaglia AA, Siracusa L, Gioè C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874991 16. Pandemics and education: A historical review. J. Dent. Educ. 2021; Spielman AI, Sunavala-Dossabhoy G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876429 17. Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review. J. Neuroimmunol. 2021; 355:577577Sheikh AB, Chourasia PK, Javed N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895700 18. An unusual and atypical presentation of the novel coronavirus: A case report and brief review of the literature. J Taibah Univ Med Sci 2021; Alshoabi SA, Haider KH, Mostafa MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867909 19. Myelopathy associated with SARS-COV-2 infection. A systematic review. Neurol. Res. 2021:1-9Artemiadis A, Liampas A, Hadjigeorgiou L, Zis P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870878 20. Assessment of activities of daily living in patients post COVID-19: a systematic review. PeerJ 2021; 9:e11026Pizarro-Pennarolli C, Sánchez-Rojas C, Torres-Castro R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868804 21. Brazilian essential oils as source for the discovery of new anti-COVID-19 drug: a review guided by in silico study. Phytochem Rev 2021:1-20Amparo TR, Seibert JB, Silveira BM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867898 22. The Impact of COVID-19 on the Latinx Population: A Scoping Literature Review. Public Health Nurs. 2021; Moore KS. http://www.ncbi.nlm.nih.gov/pubmed/? term=33876506 23. Can vital signs recorded in patients' homes aid decision making in emergency care? A Scoping Review. Resusc Plus 2021; 6:100116Hamza M, Alsma J, Kellett J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870237

Risk factors (48 articles) 1. Does taking an angiotensin inhibitor increase the risk for COVID-19? - a systematic review and meta-analysis. Aging (Albany NY) 2021; 13Ma Z, Wang MP, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886504 2. Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients. Alzheimers Dement 2021; Tahira AC, Verjovski-Almeida S, Ferreira ST. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881211 3. On-admission anemia predicts mortality in COVID-19 patients: A single center, retrospective cohort study. Am J Emerg Med 2021; 48:140-147Oh SM, Skendelas JP, Macdonald E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895645 4. Hospital-Level Variation in Death for Critically Ill Patients with COVID-19. Am J Respir Crit Care Med 2021; Churpek MM, Gupta S, Spicer AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891529 5. Determinants of mortality of patients with COVID-19 in Wuhan, China: a case- control study. Ann Palliat Med 2021; Li J, Yang L, Zeng Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894714 6. Risk factors for mortality of coronavirus disease 2019 (COVID-19) patients during the early outbreak of COVID-19: a systematic review and meta-analysis. Ann Palliat Med 2021; Wu Y, Li H, Zhang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894729 7. The multidimensional prognostic index (MPI) for the prognostic stratification of older inpatients with COVID-19: A multicenter prospective observational cohort study. Arch. Gerontol. Geriatr. 2021; 95:104415Pilotto A, Azzini M, Cella A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882420 8. Lupus anticoagulant single positivity at acute phase is not associated with venous thromboembolism or in-hospital mortality in COVID-19. Arthritis Rheumatol 2021; Gendron N, Dragon-Durey MA, Chocron R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881229 9. ABO blood groups, COVID-19 infection and mortality. Blood Cells Mol. Dis. 2021; 89:102571Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33894687 10. The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients. BMC Infect. Dis. 2021; 21:371Wang L, Cheng X, Dong Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879073 11. Laboratory predictors of severe Coronavirus Disease 2019 and lung function in followed-up. Clin. Respir. J. 2021; Pan M, Wang RR, Chen X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896114 12. A Retrospective Study Assessing the Effect of Diabetes on Mortality in Patients With COVID-19 at a Teaching Hospital in the United Kingdom. Cureus 2021; 13:e13902Ahmed FW, Kirresh OZ, Robinson AV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880258 13. Calculating outcome predictors of COVID-19 requires inclusion of multiple determinants. Disaster Med Public Health Prep 2021:1-4Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888177 14. Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine 2021:103339Castro de Moura M, Davalos V, Planas-Serra L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867313 15. Development of a multivariable model predicting mortality risk from comorbidities in an Italian cohort of 18,286 confirmed COVID-19 cases aged 40 years or older. Epidemiol. Prev. 2021; 45:100-109Andreano A, Murtas R, Tunesi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884848 16. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection. Epigenomics 2021; Shirvaliloo M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876664 17. The Association Between Alpha-1 Adrenergic Receptor Antagonists and In- Hospital Mortality From COVID-19. Front Med (Lausanne) 2021; 8:637647Rose L, Graham L, Koenecke A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869251 18. Association of neutrophil-to-lymphocyte and lymphocyte-to-C-reactive protein ratios with COVID-19-related mortality. Gac Med Mex 2020; 156:553- 558Albarrán-Sánchez A, González-Ríos RD, Alberti-Minutti P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877103 19. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with COVID-19-associated pneumonia. Gac Med Mex 2020; 156:527-531Carpio-Orantes LD, García-Méndez S, Hernández-Hernández SN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877106 20. IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Genome Med. 2021; 13:64Zhang F, Mears JR, Shakib L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879239 21. Fatalities of COVID-19 are rather attributable to multisystem inflammatory syndrome than infectious meningitis or sepsis. Indian J. Med. Microbiol. 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867206 22. The role of hemogram parameters and CRP in predicting mortality in COVID- 19 infection. Int J Clin Pract 2021:e14256Acar E, Demir A, Yıldırım B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887100 23. Predictive value of d-dimer/albumin ratio and fibrinogen/albumin ratio for in- hospital mortality in patients with COVID-19. Int J Clin Pract 2021:e14263Küçükceran K, Ayranci MK, Girişgin AS, Koçak S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891337 24. Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): findings from hospital based cross-sectional study. Int J Infect Dis 2021; Arnaud DE, Apoline SK, Risgou OA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894354 25. Serum Calcium and Vitamin D levels correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman. Int J Infect Dis 2021; Osman W, Al Fahdi F, Khamis F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892191 26. Differential alteration trend of white blood cells (WBCs) and monocytes count in severe and non-severe COVID-19 patients within a 7-day follow-up. Iran J Microbiol 2021; 13:8-16Pirsalehi A, Salari S, Baghestani A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889357 27. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol 2021; Dorgham K, Quentric P, Gökkaya M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894209 28. Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study. J Eur Acad Dermatol Venereol 2021; Georgakopoulos JR, Mufti A, Vender R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872431 29. Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19. J Infect Dis 2021; Syed F, Li W, Relich RF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885811 30. Effect of environmental pollution PM2.5, carbon monoxide, and ozone on the incidence and mortality due to SARS-CoV-2 infection in London, United Kingdom. J King Saud Univ Sci 2021; 33:101373Ayoub Meo S, Adnan Abukhalaf A, Sami W, Hoang TD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867776 31. A Clinical Risk Score to Predict In-hospital Mortality from COVID-19 in South Korea. J Korean Med Sci 2021; 36:e108Her AY, Bhak Y, Jun EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876588 32. Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study. J Multidiscip Healthc 2021; 14:839-852Alwafi H, Naser AY, Qanash S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883900 33. Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study. J. Neurol. Neurosurg. Psychiatry 2021; Tsivgoulis G, Fragkou PC, Karofylakis E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879534 34. Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study. Lancet Reg Health Eur 2021; 5:100097Bennett KE, Mullooly M, O'Loughlin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880459 35. D-Dimer and Serum ferritin as an Independent Risk Factor for Severity in COVID-19 Patients. Mater Today Proc 2021; A MH, Taha ZB, Gailan Malek A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868964 36. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio 2021; 12Adeniji OS, Giron LB, Purwar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879594 37. The role of carbohydrate antigen 125 in COVID-19. Med. Hypotheses 2021; 151:110590Dökümcü E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33873150 38. Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis. Mult Scler Relat Disord 2021; 52:102922Bose G, Galetta K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895693 39. COVID-19 and mutations a threat level assessment. Nepal J Epidemiol 2021; 11:983-987Robinson J, Banerjee I, Leclézio A, Sathian B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868743 40. Angiotensin-converting enzyme 2 (ACE2): role in the pathogenesis of diseases outside of COVID-19. Nephrologe 2021; Mülling N, Rohn H. 41. Does higher Body Mass Index increase COVID-19 severity?: a systematic review and meta-analysis. Obes Med 2021:100340Chowdhury AI, Alam MR, Rabbi MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875972 42. Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts. Open Heart 2021; 8Ruperti-Repilado FJ, Tobler D, Greutmann M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883228 43. COVID-19 severity in relation to sociodemographics and vitamin D use. Open Med (Wars) 2021; 16:591-609Abdulateef DS, Rahman HS, Salih JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869781 44. Factors influencing the COVID-19 daily deaths' peak across European countries. Public Health 2021; 194:135-142Jabłońska K, Aballéa S, Toumi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892351 45. Sleep deficit in COVID-19 health-care workers may increase the infection risk. Scand J Public Health 2021:14034948211007679Ishikura IA, Rosa DS, Hachul H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870776 46. Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis. Sleep Med. 2021; 82:47-53Hariyanto TI, Kurniawan A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33892451 47. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study. Virulence 2021; 12:1199-1208Xiao Y, Wu D, Shi X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33870852 48. Burden and prevalence of risk factors for severe COVID-19 in the ageing European population - a SHARE-based analysis. Z Gesundh Wiss 2021:1- 10Ahrenfeldt LJ, Nielsen CR, Möller S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868899

Safety (13 articles)

1. Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'. Ann. Rheum. Dis. 2021; Martelli Júnior H, Marques NP, Marques NCT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883160 2. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021; 14Patel SU, Khurram R, Lakhani A, Quirk B. http://www.ncbi.nlm.nih.gov/pubmed/? term=33888484 3. Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination. BMJ Case Rep. 2021; 14Uwaydah AK, Hassan NMM, Abu Ghoush MS, Shahin KMM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883119 4. Potent Toxic Effects of Taroxaz-104 on the Replication of SARS-CoV-2 Particles. Chem. Biol. Interact. 2021:109480Rabie AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887223 5. First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection. Clin Infect Dis 2021; Lillie PJ, O'Brien P, Lawtie M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893480 6. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers. J Korean Med Sci 2021; 36:e110Song JY, Cheong HJ, Kim SR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876589 7. Covid-19 mRNA Vaccination: Age and Immune Status and its Association with Axillary Lymph Node PET/CT Uptake. J Nucl Med 2021; Eifer M, Tau N, Alhoubani Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893188 8. Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Leg. Med. (Tokyo) 2021; 51:101895Edler C, Klein A, Schröder AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895650 9. Toxicity of hydroxychloroquine, a potential treatment for COVID-19, on free- living marine nematodes. Mar. Pollut. Bull. 2021; 167:112361Ben Ali M, Hedfi A, Almalki M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33873039 10. Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve 2021; Mahajan S, Zhang F, Mahajan A, Zimnowodzki S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890680 11. Pandemic Risk Management using Engineering Safety Principles. Process Saf Environ Prot 2021; Alauddin M, Khan F, Imtiaz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879978 12. "Unilateral axillary lymphadenopathy following COVID-19 vaccination: A case report and imaging findings". Radiol Case Rep 2021; Dominguez JL, Eberhardt SC, Revels JW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868525 13. Developing standard safety outcomes for COVID-19 vaccines. Vaccine 2021; Buttery JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888324

Treatment options (72 articles)

1. Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities. Adv. Appl. Bioinform. Chem. 2021; 14:71-85Villoutreix BO, Krishnamoorthy R, Tamouza R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880039 2. Pulmonary thromboembolism post-COVID convalescent plasma therapy: adding fuel to a smoldering fire! Adv Respir Med 2021; Marwah V, Choudhary R, Peter D, Bhati G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881163 3. Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19. Aging (Albany NY) 2021; 13Wu L, Zheng Y, Liu J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879634 4. Pharmacist outreach Program for COVID-19 monoclonal antibody distribution. Am. J. Health Syst. Pharm. 2021; Malashock C, Keifer A, Reisbig K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895795 5. A narrative review of COVID-19: magnesium isoglycyrrhizinate as a potential adjuvant treatment. Ann Palliat Med 2021; Tang C, Ding H, Sun Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894736 6. Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study. Ann Palliat Med 2021; Xu X, Zhang J, Zheng W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894725 7. Approach to Sedation and Analgesia in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation. Ann. Pharmacother. 2021:10600280211010751Dreucean D, Harris JE, Voore P, Donahue KR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882694 8. Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'. Ann. Rheum. Dis. 2021; Martelli Júnior H, Marques NP, Marques NCT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883160 9. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Antiviral Res 2021; 190:105078Zhao J, Guo S, Yi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894278 10. Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs. Appl. Microbiol. Biotechnol. 2021:1-14Ashaolu TJ, Nawaz A, Walayat N, Khalifa I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876282 11. Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2. Aquaculture 2021; 541:736783Sumon TA, Hussain MA, Hasan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883784 12. Phytochemistry and pharmacological activity of the genus artemisia. Arch. Pharm. Res. 2021:1-36Bisht D, Kumar D, Kumar D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893998 13. Prediction of Anti-COVID 19 Therapeutic Power of Medicinal Moroccan Plants Using Molecular Docking. Bioinform. Biol. Insights 2021; 15:11779322211009199Nouadi B, Ezaouine A, El Messal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888980 14. Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy. Biomed. Pharmacother. 2021; 139:111626Kelleni MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894625 15. Development of ciclesonide analogues that block SARS-CoV-2 RNA replication. Bioorg. Med. Chem. Lett. 2021; 43:128052Tsuji G, Yonemitsu K, Ito T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887440 16. Misleading clinical evidence and systematic reviews on ivermectin for COVID- 19. BMJ Evid Based Med 2021; Garegnani LI, Madrid E, Meza N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888547 17. Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections. Br. J. Clin. Pharmacol. 2021; Böhm R, Bulin C, Waetzig V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871897 18. Computational Design and Modeling of Nanobodies toward SARS-CoV-2 Receptor Binding Domain. Chem. Biol. Drug Des. 2021; Yang J, Zhang Z, Yang F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894099 19. Potent Toxic Effects of Taroxaz-104 on the Replication of SARS-CoV-2 Particles. Chem. Biol. Interact. 2021:109480Rabie AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887223 20. A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection. Clin. Cosmet. Investig. Dermatol. 2021; 14:385-387Lv S, Wang L, Zou X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889006 21. Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset. Comput. Biol. Med. 2021; 133:104364García R, Hussain A, Koduru P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895457 22. SARS-CoV-2 Entry inhibitors targeting virus-ACE2 or virus-TMPRSS2 interactions. Curr Med Chem 2021; Lin H, Cherukupalli S, Feng D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33881969 23. Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: A retrospective study with propensity score matching sensitivity analysis. Curr. Med. Res. Opin. 2021:1Alamer A, Alrashed AA, Alfaifi M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33890544 24. A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19). Curr Med Sci 2021; 41:297-305Yang BY, Wang HZ, Ma ZZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877545 25. COVID-19 and Disease-Modifying Anti-rheumatic Drugs. Curr. Rheumatol. Rep. 2021; 23:28D'Silva KM, Wallace ZS. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893890 26. Early adoption of non-pharmaceutical interventions and COVID-19 mortality. Econ. Hum. Biol. 2021; 42:101003Amuedo-Dorantes C, Borra C, Rivera-Garrido N, Sevilla A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894688 27. Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine. Epidemiol. Prev. 2021; 45:28-36Lilli C, Biggeri A, Zingaretti C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884840 28. Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report. Eur J Hosp Pharm 2021; Kroes JA, Zielhuis SW, Bethlehem C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883206 29. Immunomodulatory Extracellular Vesicles: An alternative to cell therapy for COVID-19. Expert Opin Biol Ther 2021; Gupta A, Kashte S, Kadam S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886388 30. The role of IL-6 and IL-6 blockade in COVID-19. Expert Rev. Clin. Immunol. 2021; Potere N, Batticciotto A, Vecchié A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33874829 31. Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease. Front Chem 2021; 9:622898Mengist HM, Dilnessa T, Jin T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889562 32. New Roles for Vitamin D Superagonists: From COVID to Cancer. Front. Endocrinol. (Lausanne) 2021; 12:644298Easty DJ, Farr CJ, Hennessy BT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868174 33. Why Haven't We Found an Effective Treatment for COVID-19? Front. Immunol. 2021; 12:644850Spicer AJ, Jalkanen S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868280 34. Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:660688Barreira DF, Lourenço RA, Calisto R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889590 35. COVID-19: a basic approach to understanding potential treatments. Gac Med Mex 2020; 156:570-575Cedillo-Alvarez C, Gallardo-Ortiz IA, López LT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877122 36. Inferring molecular mechanisms of dexamethasone therapy in severe COVID- 19 from existing transcriptomic data. Gene 2021; 788:145665Sharma A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887367 37. CRISPR/Cas-New Molecular Scissors in Diagnostics and Therapeutics of COVID-19. Indian J. Clin. Biochem. 2021:1-9Gadwal A, Roy D, Khokhar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879980 38. Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study. Infect Dis Poverty 2021; 10:53Lin SN, Rui J, Chen QP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874998 39. The Role for Tocilizumab in COVID-19 Patients: Reflections on Monza Cohort Data. Infect Drug Resist 2021; 14:1389-1392Capici S, Sala L, Galimberti S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880043 40. Immunopharmacological perspective on zinc in SARS-CoV-2 infection. Int Immunopharmacol 2021; 96:107630Asl SH, Nikfarjam S, Majidi Zolbanin N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882442 41. Potential Antioxidative, Anti-inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection. Int. J. Pept. Res. Ther. 2021:1-9Jafari A, Sadeghpour S, Ghasemnejad-Berenji H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880115 42. In Silico Identification of Multi-target Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins. Int. J. Pept. Res. Ther. 2021:1-11Wong FC, Ong JH, Kumar DT, Chai TT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867899 43. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med 2021:1-17Chaudhuri D, Sasaki K, Karkar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876268 44. High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool? Intern Emerg Med 2021:1-2Cameli P, Bergantini L, d'Alessandro M, Bargagli E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876321 45. Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study. J. Clin. Pathol. 2021; Klein MN, Wang EW, Zimand P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893156 46. Baricitinib: From Rheumatoid Arthritis to COVID-19(5). J. Clin. Pharmacol. 2021; Assadiasl S, Fatahi Y, Mosharmovahed B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870531 47. Experimental therapies under investigation for COVID-19. J Community Hosp Intern Med Perspect 2021; 11:187-193Golamari R, Kapoor N, Devaraj T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889318 48. Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia. J Comp Eff Res 2021; Agirbasli M, Tanrıkulu A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887951 49. In silico approach for identifying natural lead molecules against SARS-COV-2. J. Mol. Graph. Model. 2021; 106:107916Gupta SS, Kumar A, Shankar R, Sharma U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892297 50. Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. J. Mol. Liq. 2021; 335:116185Mishra D, Maurya RR, Kumar K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879934 51. Molecular Insights of Hyaluronic Acid-Hydroxychloroquine Conjugate as a Promising Drug in Targeting SARS-CoV-2 Viral Proteins. J. Mol. Struct. 2021:130457Thirumalaisamy R, Aroulmoji V, Iqbal MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867575 52. REPLY TO LETTER TO THE EDITOR: POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19. J Nucl Med 2021; Pillarsetty N, Carter L, Lewis JS, Reiner T. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893187 53. Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. J Tradit Complement Med 2021; Vardhan S, Sahoo SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868970 54. MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak. J Transl Med 2021; 19:164Jamalkhah M, Asaadi Y, Azangou-Khyavy M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888147 55. Toxicity of hydroxychloroquine, a potential treatment for COVID-19, on free- living marine nematodes. Mar. Pollut. Bull. 2021; 167:112361Ben Ali M, Hedfi A, Almalki M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33873039 56. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma. mBio 2021; 12Natarajan H, Crowley AR, Butler SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879585 57. Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 - A theoretical perspective. Med. Hypotheses 2021; 151:110592Yaqinuddin A, Ambia AR, Elgazzar TA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33878626 58. Management of COVID-19: Current Status and Future Prospects. Microbes Infect 2021:104832Kabir MA, Ahmed R, Chowdhury R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872807 59. Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission. Nutrition 2021; 89:111236Sukkar SG, Cogorno L, Pisciotta L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895559 60. Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors. Open Heart 2021; 8DiNicolantonio JJ, Barroso-Aranda J, McCarty MF. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875563 61. Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective. Pharmacol. Rep. 2021:1-16Hamidi SH, Kadamboor Veethil S, Hamidi SH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880743 62. Brazilian essential oils as source for the discovery of new anti-COVID-19 drug: a review guided by in silico study. Phytochem Rev 2021:1-20Amparo TR, Seibert JB, Silveira BM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867898 63. Impact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trial. Porto Biomed J 2021; 6:e134Tavares M, Farraia M, Silva S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869886 64. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021). Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2021; 42:5-18Panovska-Stavridis I, Ridova N, Stojanoska T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894123 65. Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases. Rheumatol Adv Pract 2021; 5:rkab014Pham K, Torres H, Satlin MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875975 66. Interactions between SARS coronavirus 2 papain-like protease and immune system: a potential drug target for the treatment of COVID-19. Scand. J. Immunol. 2021:e13044Mahmoudvand S, Shokri S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872387 67. Old Treatment for a New Disease: Can Rectal Ozone Insufflation Be Used for COVID-19 Management? A Case Report. SN Compr Clin Med 2021:1-4Hendawy HA, Mosallam W, Abuelnaga ME, Sabry AM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875977 68. Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID-19 infection. -A retrospective observational study. Ther. Apher. Dial. 2021; Matsushita Y, Kusaoi M, Hiki M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887110 69. [Not Available]. Therapie 2021; Billy E, Clarot F, Depagne C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892936 70. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology. Top Curr Chem (Cham) 2021; 379:23Zhuo LS, Wang MS, Yang JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886017 71. Exploring the utility of extracellular vesicles in ameliorating viral infection- associated inflammation, cytokine storm and tissue damage. Transl. Oncol. 2021; 14:101095Pillalamarri N, Abdullah, Ren G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887552 72. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial. Trials 2021; 22:288McEvoy NL, Clarke JL, Mc Elvaney OJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3387498

Trials (16 articles)

1. Randomized Clinical Trial to Evaluate a Routine Full Anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) Admitted to Hospital: Rationale and Design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV Trial. Am. Heart J. 2021; Lopes RD, de Barros ESPGM, Furtado RHM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891907 2. The multidimensional prognostic index (MPI) for the prognostic stratification of older inpatients with COVID-19: A multicenter prospective observational cohort study. Arch. Gerontol. Geriatr. 2021; 95:104415Pilotto A, Azzini M, Cella A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882420 3. Study protocol medical rehabilitation after COVID-19 disease: an observational study with a comparison group with obstructive airway disease / Re_Co. BMC Health Serv. Res. 2021; 21:373Rutsch M, Frommhold J, Buhr- Schinner H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888104 4. Conducting an ongoing HIV clinical trial during the COVID-19 pandemic in Uganda: a qualitative study of research team and participants' experiences and lessons learnt. BMJ Open 2021; 11:e048825Muwanguzi PA, Kutyabami P, Osingada CP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883157 5. Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic. Contemp Clin Trials 2021; 105:106407Moon SJE, Dabbs AD, Hergenroeder AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887443 6. Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine. Epidemiol. Prev. 2021; 45:28-36Lilli C, Biggeri A, Zingaretti C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33884840 7. Deficiencies in Planning Interventional Trial Registration of COVID-19 in China. Front Med (Lausanne) 2021; 8:618185Li X, Zhang S, Zhou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869242 8. Psychological Differences Among Healthcare Workers of a Rehabilitation Institute During the COVID-19 Pandemic: A Two-Step Study. Front. Psychol. 2021; 12:636129Panzeri A, Rossi Ferrario S, Cerutti P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868105 9. COVID-19 Trial Graph: A Linked Graph for COVID-19 Clinical Trials. J Am Med Inform Assoc 2021; Du J, Wang Q, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895839 10. Building An OMOP Common Data Model-Compliant Annotated Corpus for COVID-19 Clinical Trials. J. Biomed. Inform. 2021:103790Sun Y, Butler A, Stewart LA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887457 11. Negative Effects of COVID-19 Stay-at-Home Mandates on Physical Intervention Outcomes: A Preliminary Study. J. Parkinsons Dis. 2021; Templeton JM, Poellabauer C, Schneider S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867363 12. Impact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trial. Porto Biomed J 2021; 6:e134Tavares M, Farraia M, Silva S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869886 13. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021). Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2021; 42:5-18Panovska-Stavridis I, Ridova N, Stojanoska T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894123 14. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial. Trials 2021; 22:288McEvoy NL, Clarke JL, Mc Elvaney OJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874981 15. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond. Trials 2021; 22:296Sethi S, Kumar A, Mandal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879208 16. Burden and prevalence of risk factors for severe COVID-19 in the ageing European population - a SHARE-based analysis. Z Gesundh Wiss 2021:1- 10Ahrenfeldt LJ, Nielsen CR, Möller S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33868899

Vaccines (42 articles)

1. COVID-19 VACCINE: THE CHALLENGE OF HERBAL MEDICINE COMMUNITY BELIEF IN A DEVELOPING COUNTRY - LETTER TO THE EDITOR. Afr J Infect Dis 2021; 15:1-2Makrufardi F, Saputri A, Phillabertha PS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889795 2. Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID-19 vaccines in Europe. Allergy 2021; Wagner R, Meißner J, Grabski E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887070 3. Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center. Am. J. Health Syst. Pharm. 2021; Li Q, Norman S, Guthrie P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895789 4. Association between Influenza Vaccination and severe COVID-19 outcomes at a designated COVID-only hospital in Brooklyn. Am. J. Infect. Control 2021; Umasabor-Bubu OQ, Bubu OM, Mbah AK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891988 5. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021; 14Patel SU, Khurram R, Lakhani A, Quirk B. http://www.ncbi.nlm.nih.gov/pubmed/? term=33888484 6. Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination. BMJ Case Rep. 2021; 14Uwaydah AK, Hassan NMM, Abu Ghoush MS, Shahin KMM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33883119 7. Cocooning against COVID-19: The argument for vaccinating caregivers of patients with cancer. Cancer 2021; Woodfield MC, Pergam SA, Shah PD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891713 8. First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection. Clin Infect Dis 2021; Lillie PJ, O'Brien P, Lawtie M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893480 9. Status Report on COVID-19 Vaccines Development. Curr. Infect. Dis. Rep. 2021; 23:9Kumar A, Dowling WE, Román RG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33867863 10. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review. Curr. Pharm. Biotechnol. 2021; Agrawal N, Goyal A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33882805 11. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters. Emerg Microbes Infect 2021:1-27Zhang BZ, Wang X, Yuan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890550 12. Perspectives on RNA Vaccine Candidates for COVID-19. Front Mol Biosci 2021; 8:635245Borah P, Deb PK, Al-Shar'i NA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33869282 13. The role of nanotechnology in current COVID-19 outbreak. Heliyon 2021; 7:e06841Tavakol S, Zahmatkeshan M, Mohammadinejad R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880422 14. Stability analysis of SEIR model related to efficiency of vaccines for COVID-19 situation. Heliyon 2021; 7:e06812Wintachai P, Prathom K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880423 15. The COVID-19 vaccine social media infodemic: healthcare providers' missed dose in addressing misinformation and vaccine hesitancy. Hum Vaccin Immunother 2021:1-3Hernandez RG, Hagen L, Walker K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890838 16. Safety survey by clinical pharmacists on COVID-19 vaccination from a single center in China. Hum Vaccin Immunother 2021:1-5Wang G, Zhu L, Zhu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33886411 17. COVID-19 vaccine acceptance in pregnant women. Int J Gynaecol Obstet 2021; Goncu Ayhan S, Oluklu D, Atalay A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872386 18. Acceptability of COVID-19 Vaccine in Africa. Int J MCH AIDS 2021; 10:134- 138Wirsiy FS, Nkfusai CN, Ako-Arrey DE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868778 19. The importance of a timely second dose of the 2021 COVID-19 mRNA vaccine depends on the protection afforded by a first dose and subsequent risk of anaphylaxis. J Allergy Clin Immunol Pract 2021; Shaker M, Phillips E, Blumenthal KG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892171 20. The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers. J. Community Health 2021:1-8Biswas N, Mustapha T, Khubchandani J, Price JH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877534 21. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol 2021; Rabinowich L, Grupper A, Baruch R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892006 22. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers. J Korean Med Sci 2021; 36:e110Song JY, Cheong HJ, Kim SR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33876589 23. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis. J Med Internet Res 2021; 23:e28973Eibensteiner F, Ritschl V, Nawaz FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872185 24. Covid-19 mRNA Vaccination: Age and Immune Status and its Association with Axillary Lymph Node PET/CT Uptake. J Nucl Med 2021; Eifer M, Tau N, Alhoubani Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33893188 25. State estimation-based control of COVID-19 epidemic before and after vaccine development. J Process Control 2021; 102:1-14Rajaei A, Raeiszadeh M, Azimi V, Sharifi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867698 26. India's role in COVID-19 vaccine diplomacy. J Travel Med 2021; Sharun K, Dhama K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870417 27. Returning to a Normal Life via COVID-19 Vaccines in the United States: A Large-scale Agent-Based Simulation Study. JMIR Med Inform 2021; 9:e27419Li J, Giabbanelli P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872188 28. Antibody response to BNT162b2 vaccine in maintenance hemodialysis patients. Kidney Int 2021; Attias P, Sakhi H, Rieu P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887317 29. Low immunization rates among kidney transplant recipients who received two doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 2021; Benotmane I, Gautier-Vargas G, Cognard N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887315 30. Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients on haemodialysis. A call to arms. Kidney Int 2021; Billany RE, Selvaskandan H, Adenwalla SF et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33887316 31. Experience with SARS-COV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int 2021; Yanay NB, Freiman S, Shapira M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33887318 32. Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Leg. Med. (Tokyo) 2021; 51:101895Edler C, Klein A, Schröder AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895650 33. Lessons from the United Kingdom's COVID-19 vaccination strategy. Med. J. Aust. 2021; Harnden A, Earnshaw A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893643 34. [Attitude towards vaccination against SARS-CoV-2 : Survey among employees in hospitals before and after the start of vaccinations in German hospitals]. Med Klin Intensivmed Notfmed 2021:1-10Janssens U, Kluge S, Marx G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33877427 35. Management of COVID-19: Current Status and Future Prospects. Microbes Infect 2021:104832Kabir MA, Ahmed R, Chowdhury R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33872807 36. Why are COVID-19 vaccines still in short supply? MRS Bull 2021:1-2Pradhan R, Allen A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33867658 37. Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve 2021; Mahajan S, Zhang F, Mahajan A, Zimnowodzki S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890680 38. Development and implementation of a potential coronavirus disease 2019 (COVID-19) vaccine: A systematic review and meta-analysis of vaccine clinical trials. Nepal J Epidemiol 2021; 11:959-982Sathian B, Asim M, Banerjee I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868742 39. "Unilateral axillary lymphadenopathy following COVID-19 vaccination: A case report and imaging findings". Radiol Case Rep 2021; Dominguez JL, Eberhardt SC, Revels JW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868525 40. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond. Trials 2021; 22:296Sethi S, Kumar A, Mandal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879208 41. Developing standard safety outcomes for COVID-19 vaccines. Vaccine 2021; Buttery JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33888324 42. Using Contingent Valuation Method to Estimate Adults' Willingness to Pay for a Future Coronavirus 2019 Vaccination. Value Health Reg Issues 2021; 24:240- 246Vo NX, Huyen Nguyen TT, Van Nguyen P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33895642

Women – pregnancy (36 articles)

1. COVID-19 in pregnancy - characteristics and outcomes of pregnant women admitted to hospital because of SARS-CoV-2 infection in the Nordic countries. Acta Obstet Gynecol Scand 2021; Engjom H, Aabakke AJ, Klungsøyr K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885150 2. Decision-to-delivery interval and neonatal outcomes for category-1 caesarean sections during the COVID-19 pandemic. Anaesthesia 2021; Bhatia K, Columb M, Bewlay A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891311 3. Gynaecological and IVF procedures billed through the Medicare Benefits Schedule (MBS) during the COVID-19 pandemic. Aust N Z J Obstet Gynaecol 2021; Alonso A, Deans R, Nesbitt-Hawes E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33890300 4. COVID-19 in Women's health reducing the risk of infection to patients and staff during acute and elective hospital admission for gynaecological surgery. Best Pract. Res. Clin. Obstet. Gynaecol. 2021; Odejinmi F, Egbase E, Clark TJ, Mallick R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879364 5. 2. Labour and birth. Best Pract. Res. Clin. Obstet. Gynaecol. 2021; Ross-Davie M, Brodrick A, Randall W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879365 6. Prioritisation of outpatient appointments and elective surgery in gynaecology. Best Pract. Res. Clin. Obstet. Gynaecol. 2021; Sairally BZF, Clark TJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883091 7. Induction of labour during the COVID-19 pandemic: a national survey of impact on practice in the UK. BMC Pregnancy Childbirth 2021; 21:310Harkness M, Yuill C, Cheyne H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33874913 8. Severe metabolic ketoacidosis as a primary manifestation of SARS-CoV-2 infection in non-diabetic pregnancy. BMJ Case Rep. 2021; 14van Amesfoort JE, Werter DE, Painter RC, Hermans FJR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33875510 9. Changes to medication abortion clinical practices in response to the COVID-19 pandemic. Contraception 2021; Tschann M, Ly ES, Hilliard S, Lange HLH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33894247 10. The influence of the COVID-19 outbreak on European trainees in obstetrics and gynaecology: A survey of the impact on training and trainee. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 261:52-58Boekhorst F, Khattak H, Topcu EG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33892209 11. Retrospective observational RT-PCR analyses on 688 babies born to 843 SARS-CoV-2 positive mothers, placental analyses and diagnostic analyses limitations suggest vertical transmission is possible. Facts Views Vis Obgyn 2021; 13:53-66Bahadur G, Bhat M, Acharya S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889861 12. The impact of COVID-19 on obstetrics and gynaecology trainees; how do we move on? Facts Views Vis Obgyn 2021; 13:9-14Mallick R, Odejinmi F, Sideris M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33889856 13. A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway. Front. Psychol. 2021; 12:614451Reyes-Lagos JJ, Abarca-Castro EA, Echeverría JC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868085 14. Emergent Change in a Mexican Midwifery Center Organization Amidst the COVID-19 Crisis. Front Sociol 2021; 6:611321Alonso C, Storey AS, Fajardo I, Borboleta HS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869554 15. When Maintaining Relationships and Social Connectivity Matter: The Case of New Zealand Midwives and COVID-19. Front Sociol 2021; 6:614017Crowther S, Maude R, Bradford B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869567 16. Pivoting to Childbirth at Home or in Freestanding Birth Centers in the US During COVID-19: Safety, Economics and Logistics. Front Sociol 2021; 6:618210Daviss BA, Anderson DA, Johnson KC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869572 17. Pregnancy, Birthing, and Postpartum Experiences During COVID-19 in the United States. Front Sociol 2021; 6:611212DeYoung SE, Mangum M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869553 18. Protecting Women's and Newborns' Rights in a Public Maternity Unit During the COVID-19 Outbreak: The Case of Dra. Eloísa Díaz - La Florida Hospital in Santiago, Chile. Front Sociol 2021; 6:614021Leiva G, Sadler M, López C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869568 19. Where the System Failed: The COVID-19 Pandemic's Impact on Pregnancy and Birth Care. Glob Qual Nurs Res 2021; 8:23333936211006397Altman MR, Gavin AR, Eagen-Torkko MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869668 20. Prevalence and associated factors of intimate partner violence (IPV) against women in Bangladesh amid COVID-19 pandemic. Heliyon 2021; 7:e06619Rayhan I, Akter K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33869852 21. Information Needs of Pregnant Women in the COVID-19 Pandemic from Experts' Point of View: A Qualitative Study. Int J Community Based Nurs Midwifery 2021; 9:139-151Rezaei F, Masaeli Z, Atighechian G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33875966 22. Hematologic adaptation to mask-wearing among pregnant women and obstetrical outcome during the COVID-19 pandemic. Int J Gynaecol Obstet 2021; Friedrich L, Levin G, Maixner N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872397 23. COVID-19 vaccine acceptance in pregnant women. Int J Gynaecol Obstet 2021; Goncu Ayhan S, Oluklu D, Atalay A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33872386 24. Early abortion care during the COVID-19 public health emergency in Ireland: Implications for law, policy, and service delivery. Int J Gynaecol Obstet 2021; Spillane A, Taylor M, Henchion C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33893642 25. Premature ovarian insufficiency secondary to COVID-19 infection: An original case report. Int J Gynaecol Obstet 2021; Wilkins J, Al-Inizi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896002 26. A Framework for Protecting Pregnant Women in the Era of COVID-19 Pandemic. Int J MCH AIDS 2021; 10:109-112Dongarwar D, Ajewole VB, Harris K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33868776 27. Ultrasonography as a diagnostic aid for a neonate with gingival swelling in a COVID-19 neonatal intensive care unit. J. Indian Soc. Pedod. Prev. Dent. 2021; 39:101-103Kakade A, Deshmukh B, Agarwal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885396 28. ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection. J Infect Dis 2021; Kala S, Meteleva K, Serghides L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33880537 29. Pregnant women with COVID-19: the placental involvement and consequences. J. Mol. Histol. 2021:1-9Aghaamoo S, Ghods K, Rahmanian M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33871721 30. Pregnant in the United States in the COVID-19 pandemic: A collision of crises we cannot ignore. J. Natl. Med. Assoc. 2021; Stratton P, Gorodetsky E, Clayton J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33883068 31. Substance use and mental health in pregnant women during the COVID-19 pandemic. J. Reprod. Infant Psychol. 2021:1-14Smith CL, Waters SF, Spellacy D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33870821 32. Sex-Based Differences in COVID-19 Outcomes. J Womens Health (Larchmt) 2021; 30:492-501Tejpal A, Gianos E, Cerise J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33885345 33. Neonatology in times of pandemic - Pregnant women with COVID-19: How much is the child at risk? MMW-Fortschritte der Medizin 2021; 163:27Reinhardt D. 34. Guidance for the clinical management of infants born to mothers with suspected/confirmed COVID-19 in Singapore. Singapore Med J 2021; Yeo KT, Biswas A, Ho SKY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33866749 35. Maternal insomnia during the COVID-19 pandemic: associations with depression and anxiety. Soc. Psychiatry Psychiatr. Epidemiol. 2021:1-9Wang J, Zhou Y, Qian W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33891160 36. Assessment of knowledge and opinion regarding breastfeeding practices during COVID-19 pandemic among paediatricians and obstetricians in India: an online survey. Sudan J Paediatr 2021; 21:30-35Malik S, Joshi P, Gupta PK, Sharma S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33879940

to subscribe click here

mailing address is: [email protected]

© P.J. Lansberg